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Summary
Lipopolysaccharide (LPS) is commonly implicated in the development 
and rapid progression of sepsis however no efficient diagnostic assay 
currently exists. The over-arching aim of this project was therefore to 
develop a novel biomimetic peptide-polymer hybrid system capable of 
recognising and binding LPS in a variety of biologically relevant 
environments.
Target selective peptides (both commercially available and synthesised) 
have been used as high affinity "functional monomers" in a molecular 
imprinting approach. To reduce the concept to practice, a bi- 
functionalised resin was prepared so as to allow the use of two 
independent surface attachment strategies. Controlled polymer growth 
was initiated from surface bound iniferter groups whilst the attachment 
of the peptide was achieved through amine-amine imidoester linkages 
or via azide-alkyne ""click"" chemistry. Polymyxin, a small, 
conformationally constrained cyclic peptide that possesses high affinity 
for lipopolysaccharide (LPS) was used to provide proof-of-principle.
Polymyxin resins, produced via the immobilisation of alkyne 
derivitised polymyxin B on the surface of azidomethyl polystyrene via 
""click"" chemistry, were able to efficiently bind LPS from aqueous 
solutions with an apparent Kd of ~ 0.2 pM. Although the development 
of the peptide -  polymer hybrid system using these resins appeared 
somewhat unsuccessful, whether the observed reduction in binding is 
due to changes in the Bmax or the Kd of the resin remains to be 
elucidated. The assay performed with the polymerisation samples 
produced using resin displaying polymyxin immobilised via a dimethyl 
adipimidate linker, suggest that the hypothesised approach is feasible 
but that optimisation of a number of variables is needed before 
definitive results can be obtained.
Table of Contents
Acknowledgements................................................................................... iii
Summary..................................................................................................... iv
Table of Contents........................................................................................ v
List of Figures..............................................................................................xi
List of Tables............................................................................................. xvi
Chapter O ne: General Introduction.......................................................... 1
1.1 Lipopolysaccharide...............................................................................2
1.1.1 General Overview..................................................................................2
1.1.2 Structure of Lipopolysaccharide............................................................3
1.1.2.1 Lipid A ................................................................................................4
1.1.2.2 Core regions........................................................................................6
1.1.2.3 O-specific antigen region....................................................................7
1.1.3 The function of lipopolysaccharide.........................................................8
1.1.4 Recognition of lipopolysaccharide by host.............................................9
1.1.5 Current treatment options for Gram negative infections and associated 
sepsis............................................................................................................. 15
1.1.6 Detection of lipopolysaccharide............................................................16
1.1.7 Removal of lipopolysaccharide.............................................................18
1.2 Molecular Imprinting....................................................................... 19
1.2.1 Conventional Imprinting.....................................................................19
1.2.2 Macromolecular and Bio-imprinting...................................................20
1.3 Scope of thesis......................................................................................24
1.4 Reference List.......................................................................................30
Chapter Two : Merrif ield Studies............................................................ 47
2.1 Introduction..........................................................................................48
2.1.1 General Overview................................................................................48
2.1.2 Merrifield Resin...................................................................................48
2.1.3 Living Radical Polymerisation............................................................51
2.1.4 Aims and objectives of Chapter Two.............................................55
2.2 Materials and M ethods.................................................................... 56
2.2.1 Materials..............................................................................................56
2.2.2 Synthesis of azidomethyl polystyrene..................................................56
2.2.3 Azide reduction using triflic acid to produce amine functionalised resin 
...................................................................................................................... 56
2.2.4 Azide reduction via Staudinger reaction to produce amine 
functionalised resin.......................................................................................57
2.2.5 FTIR Analysis......................................................................................57
2.2.6 Elemental Analysis..............................................................................57
2.2.7 Synthesis of benzyl diethyldithiocarbamate........................................ 57
2.2.8 Solution polymerisation studies..........................................................58
2.2.9 Attachment of sodium diethyl dithiocarbamate to Merrifield resin.... 59
2.2.10 Polymerisation studies with diethyl dithiocarbamate modified 
Merrifield..................................................................................................... 59
2.2.11 Modification of Merrifield resin with the hydrophilic iniferter species,
sodium N-(dithiocarboxy) sarcosine.............................................................59
2.3 Results and Discussion..................................................................... 61
2.3.1 Synthesis of azidomethyl polystyrene..................................................61
2.3.2 Azide reduction using triflic acid to produce amine functionalised resin 
.......................................................................................................................65
2.3.3 Azide reduction via Staudinger reaction to produce amine 
functionalised resin.......................................................................................68
2.3.4 Synthesis of benzyl diethyldithiocarbamate......................................... 71
2.3.5 Solution polymerisation studies..........................................................72
2.3.6 Coupling of the iniferter to Merrifield.................................................74
2.3.7 Polymerisation experiments with iniferter coupled Merrifield resin.. 76
vi
i
2.3.8 Polymerisation experiments until dithiocarboxysarcosine coupled
Merrifield resin.............................................................................................88
2.5 Reference List.................................................................................... 94
Chapter Three: Polymyxin Studies........................................................100
3.1 Introduction........................................................................................101
3.1.1 General Overmew..............................................................................101
3.1.2 Structure............................................................................................102
3.1.3 Interaction with LPS and mechanism of action.................................103
3.1.4 Clinical uses.......................................................................................106
3.1.5 Aims and objectives of Chapter Three........................................ 109
3.2 Materials and M ethods.................................................................. 110
3.2.1 Materials............................................................................................110
3.2.2 Synthesis of dansyl-polymyxin B ......................................................110
3.2.3 Dinitrophenylation assay...................................................................110
3.2.4 Dansyl polymyxin binding assays.....................................................I l l
3.2.5 Immobilisation of polymyxin on Merrifield Resin............................I l l
3.2.5.1 Imidoester linker.............................................................................I l l
a) Binding assays........................................................................................112
b) Effect of free polymyxin and dimethyl adipimidate on fluorescence of 
FITC-LPS....................................................................................................112
3.2.5.2 Click Chemistry..............................................................................113
a) Synthesis ofalkyne polymyxin...............................................................113
b) Immobilisation ofalkyne polymyxin on azide resin...............................113
c) Standard binding assay...........................................................................113
d) Hot-cold assay........................................................................................113
e) Selectivity assay......................................................................................114
3.2.6 HPLC analysis of polymyxin B sulfate..............................................115
3.2.7 Linear polymyxin B ...........................................................................115
vii
i
3.2.8 Synthesis of polymyxin B-polymer hybrids.................................... 115
a) Immobilisation of polymyxin B on iniferter modified resin.................... 115
b) Polymer growth assay.............................................................................116
c) Equilibrium time point assay..................................................................116
d) Polymerisation........................................................................................116
3.3 Results and Discussion................................................................... 118
3.3.1 Synthesis of dansyl-polymyxin B ......................................................118
3.3.2 Quantification of dansyl-polymyxin B via dinitrophenylation assay 121
3.3.3 Dansyl polymyxin binding assays.....................................................123
3.3.4 Immobilisation of polymyxin on Merrifield resin..............................126
3.3.4.1 Immobilisation of polymyxin on Merrifield resin using an imidoester 
linker 128
a) Binding assays........................................................................................129
b) Effect of free polymyxin and dimethyl adipimidate on the fluorescence of
FITC-LPS....................................................................................................134
3.3A.2 Immobilisation of polymyxin on Merrifield resin using click 
chemistry.....................................................................................................136
a) Synthesis ofalkyne polymyxin...............................................................137
b) Immobilisation ofalkyne polymyxin on azide modified resin.................138
c) Standard binding assay...........................................................................141
d) Hot cold assay......................................................................................... 142
e) Selectivity assay......................................................................................143
3.3.5 Linear analogue of polymyxin B........................................................ 145
3.3.6 Synthesis of the peptide-polymer hybrid............................................147
a) Polymer growth assay.......................................................................... 147
b) Determining saturation concentration of LPS for imprinting experiments. 
   148
c) Equilibrium time point assay................................
d) Evaluation of the peptide-polymer hybrid system.
151
152
3.4 Conclusion..........................................................................................156
3.5 References...........................................................................................157
Chapter Four: Magnetite Studies............................................................167
4.1 Introduction........................................................................................168
4.1.1 General Overview..............................................................................168
4.1.2 Magnetite...........................................................................................169
4.1.5 Aims and objectives of Chapter Four..........................................171
4.2 Materials and M ethods.................................................................... 172
4.2.1 Materials............................................................................................172
4.2.2 Synthesis of magnetite nanoparticles (I)...........................................172
4.2.3 Synthesis of magnetite nanoparticles (II)..........................................172
4.2.4 Immobilisation of lipopolysaccharide on magnetic nanoparticles 173
4.2.5 Raman spectroscopy...........................................................................173
4.2.6 Immobilisation of polymyxin B on magnetite nanoparticles............. 173
4.2.7 Binding assays with polymyxin modified nanoparticles...................174
4.2.8 Ligand exchange with 11-mercaptoundecanoic add .........................174
4.2.9 Conversion of thiol groups to azides..................................................174
4.3 Results and Discussion................................................................... 176
4.3.1 Synthesis of magnetite nanoparticles (I)...........................................176
4.3.2 Synthesis of magnetite nanoparticles (II)..........................................177
4.3.3 Immobilisation of lipopolysaccharide on magnetic nanoparticles 180
4.3.4 Immobilisation of polymyxin B on magnetite nanoparticles............. 185
4.3.5 Ligand exchange with 11-mercaptoundecanoic acid.........................188
4.3.6 Conversion of thiol groups to azides..................................................190
4.4 Conclusions.........................................................................................192
4.5 Reference List..................................................................................... 193
Chapter F ive: General D iscussion and Conclusions..........................200
5.1 General Overview of Thesis.............................................................201
5.2 Reference List.....................................................................................209
x
i
List of Figures
Figure 1.1: Generalised structure of lipopolysaccharide.....................................3
Figure 1.2: Structure of Escherichia coli lipid A ................................................ 4
Figure 1.3: Structure of lipid A plus two 2-keto-3-deoxyoctonic acid (KDO)
sugars..................................................................................................................7
Figure 1.4: Schematic of the immunological response observed following
infection of host with LPS.................................................................................10
Figure 1.5: Specific peptide sequences ofBPI and LBP that demonstrate highest
LPS binding activity.........................................................................................12
Figure 1.6: Schematic representation of the molecular imprinting process 19
Figure 1.7 Schematic of the formation of the peptide-polymer hybrid system. 26 
Figure 1.8: Schematic of the imprinted site when the template is larger than the
peptide species.................................................................................................. 28
Figure 2.1: Mechanism of the formation of amine functionalised polystyrene
resin via two different synthetic pathways.......................................................50
Figure 2.2: Homolytic cleavage of AIBN to generate two equally reactive
cyanopropyl radicals and nitrogen gas.............................................................51
Figure 2.3: Synthesis of a surface immobilised iniferter and subsequent
formation of the two radical species..................................................................53
Figure 2.4: FTIR spectra for Merrifield resin and the azidomethyl polystyrene 
intermediate formed following reaction of Merrifield resin with 1 mole
equivalent of sodium azide................................................................................61
Figure 2.5: Azide peak area obtained from IR analysis of Merrifield resin
following reaction with varying concentrations of sodium azide.................... 63
Figure 2.6: Conversion to azide as a function of both time & concentration... 64 
Figure 2.7: FTIR spectra demonstrating the reduction of azide to amine using
triflic acid..........................................................................................................65
Figure 2.8: FTIR analysis of the resin clearly demonstrates the detrimental 
effect that triflic acid has on the unmodified chlorine groups.......................... 66
XI
i
Figure 2.9: The proposed formation of a benzyl methyl ether species, via a 
triflate intermediate; that is hypothesised to form when Merrifield resin is
exposed to triflic acid........................................................................................ 68
Figure 2.10: Conversion of azide groups to amines via the Staudinger reaction.
......................................................................................................................... 69
Figure 2.11: FTIR spectra of Merrifield resin which has undergone the 
Staudinger reaction and then subsequently been reacted with 0.2 mmol (a) and
0.6 mmol (b) sodium azide................................................................................70
Figure 2.12: All samples are liquid prior to irradiation with UV light............72
Figure 2.13: Following 5 minutes UV irradiation...........................................73
Figure 2.14: Following 10 minutes UV irradiation.........................................73
Figure 2.15: FTIR spectra of untreated Merrifield resin and iniferter coupled
resin................................................................................................................. 75
Figure 2.16: FTIR analysis of iniferter-modified resin following 15 mins UV 
irradiation in an ethanolic acrylamide and acrylamidefmethylene bisacrylamide
solution.............................................................................................................77
Figure 2.17: Polymerisation of iniferter derivitised Merrifield resin with 
acrylamide and acrylamidefmethylene bisacrylamide mixture in ethanol after
one hour............................................................................................................78
Figure 2.18: FTIR spectra of iniferter coupled Merrifield following dispersion 
in an ethanolic solution of acrylamide and acrylamidefmethylene bisacrylamide
mixture and irradiation by UV light for 24 hours.......................................... 80
Figure 2.19: FTIR spectra of Merrifield resin control and iniferter derivitised 
resin following dispersion in an ethanolic solution of acrylamide and methylene
bisacrylamide and irradiation by UV light for 24 hours.................................. 81
Figure 2.20: IR spectra of iniferter coupled and un-modified Merrifield resin 
following polymerisation of an ethanolic solution of acrylamide and methylene 
bisacrylamide for one hour................................................................................82
xii
i
Figure 2.21: IR spectrum of amine functionalised Merrifield resin following
dispersion in an ethanolic solution of acrylamide and methylene bisacrylamide
and irradiation by UV light for 24 hours.........................................................83
Figure 2.22: Epifluorescence microscopy images of iniferter derivitised
Merrifield resin.................................................................................................84
Figure 2.23: FTIR spectra of iniferter coupled bifunctionalised Merrifield resin
following polymerisation of an ethanolic solution of acrylamide and methylene
bisacrylamide for one hour................................................................................86
Figure 2.24: Synthesis of sodium N-dithiocarboxysarcosine...........................88
Figure 2.25: Spectra of the polymerisation of dithiocarboxysarcosine
derivatised resin and unmodified Merrifield resin...........................................89
Figure 2.26: FTIR spectra of dithiocarboxysarcosine modified resin following
attachment in DMF/MeOH 50/50 mix............................................................91
Figure 2.27: FTIR spectra of Merrifield control and dithiocarboxysarcosine
modified resin following 3 hours polymerisation in an aqueous
acrylamidefmethylene bisacrylamide mixture..................................................92
Figure 3.1: General chemical structure of polymyxin B ................................102
Figure 3.2: Mechanism of action of polymyxin B ..........................................105
Figure 3.3: Reaction ofdansyl chloride with a primary amine group............118
Figure 3.4: Column purification ofdansyl -  polymyxin B  ...................119
Figure 3.5: Fractions are collected as they elute from the column..................119
Figure 3.6: Fluorescence scan of dansyl-polymyxin B ...................................120
Figure 3.7:2H NMR spectra of polymyxin B & dansyl-polymyxin B 120
Figure 3.8: Schematic of the dinitrophenylatum of amines to generate a N-
substituted 2,4-dinitroaniline.........................................................................122
Figure 3.9: UV scan of dinitrophenylated polymyxin B and example of
calibration curve.............................................................................................122
Figure 3.10 Saturation of dansyl polymyxin by E.coli 0111:B4
lipopolysaccharide...........................................................................................124
Figure 3.11: Binding isotherm ofdansyl polymyxin and E. coli LPS 125
xiii
i
Figure 3.12: Scatchard plot of the binding isotherm...................................... 125
Figure 3.23: Typical chromatogram of polymyxin B sulfate.......................... 127
Figure 3.14: Typical calibrations obtained for peak 1 and peak 2 .................. 128
Figure 3.15: Immobilisation of polymyxin B on the surface of amino-
functionalised Merrifield resin via dimethyl adipimidate...............................129
Figure 3.16: A typical calibration curve obtained following incubation of
FITC-LPS in a lml SPE cartridge.................................................................130
Figure 3.17: Amount ofFITC labelled E.coli 0111:B4 LPS bound to 10 mg of
polymyxin modified resin...............................................................................131
Figure 3.18: Effect of various concentrations of polymyxin on the fluorescence
of a 1 ftgml'1 solution ofFITC LPS................................................................134
Figure 3.19: Effect of various concentration of dimethyl adipimidate on the
fluorescence of a 1 pgml'1 solution ofFITC LPS............................................135
Figure 3.20: Disuccinimidyl suberate............................................................236
Figure 3.21: Glycidyl propargyl ether............................................................237
Figure 3.22: Carbon NMR of alkyne derivitised polymyxin (top) and
polymyxin B (bottom) in D2 0 ........................................................................138
Figure 3.23: Generation of polymyxin modified resin via the attachment of
alkyne derivitised polymyxin to azide/chloro bifunctional Merrifield resin.. 139
Figure 3.24: FTIR spectra ofbifunctionalised azide/polymyxin Merrifield resin.
........................................................................................................................ 140
Figure 3.25: Standard binding isotherm for polymyxin modified resins 242
Figure 3.26: Amount of FITC-LPS bound by 1 mg of polymyxin modified resin
at various ratios of labelled: unlabelled LPS from E. coli 0111: B4............... 143
Figure 3.27: Amount of LPS bound by 5mg of resin over a range of competitor
species............................................................................................................. 244
Figure 3.28: Sequence of the alkyne derivitised, linear analogue of polymyxin
B......................................................................................................................246
Figure 3.29: Binding isotherm far the linear analogue of polymyxin B and the
natural peptide immobilised on bifunctionalised............................................247
xiv
1
Figure 3.30: Percentage ofFTTC-LPS bound from a lpgm l1 input by 5mg of 
PMX/iniforter resin following various polymerisation periods in
acrylamidefmethylene bisacrylamide solution................................................148
Figure 3.31: Binding isotherm used to calculate the amount of LPS to incubate 
with polymyxin/iniforter resin prior to polymerisation to ensure complete
saturation of binding sites..............................................................................150
Figure 3.32: Percentage bound of a lpgm l1 FITC LPS input as a function of
time................................................................................................................ 152
Figure 3.33: Evaluation of the binding efficiency of cyclic and linear polymyxin
imprinted resins prepared from "click" immobilised resins........................... 153
Figure 3.34: Evaluation of the binding efficiency of cyclic polymyxin imprinted
resins prepared from dimethyl adipimidate linked resins...............................154
Figure 4.1: Proposed structure of2-pyrrolidone coated nanoparticle 277
Figure 4.2: Schematic of the synthesis of magnetite rumoparticles from an iron
(III) acetylacetonate precursor........................................................................178
Figure 4.3: FTIR spectra of oleic acid stabilised magnetite............................ 180
Figure 4.4: Schematic showing the proposed immobilisation of LPS on the
surface of oleic acid coated magnetite nanoparticles.......................................181
Figure 4.5: Aqueous dispersions of magnetite nanoparticles following
sonication in water and 500pg/ml LPS in water...........................................182
Figure 4.6: Raman spectra..............................................................................184
Figure 4.7: Aqueous dispersion of magnetite nanoparticles following sonication
in water and 100 m g /5 ml polymyxin B in water........................................186
Figure 4.8: Standard binding isotherm for polymyxin modified magnetite... 187 
Figure 4.9: FTIR spectra ofll-mercaptoundecanoic add coated magnetite.. 189 
Figure 4.10: Aqueous dispersion of magnetite rumoparticles following the
exchange ofoldc add surface groups with 11-mercaptoundecanoic add  189
Figure 4.11: FTIR spectrum of magnetite nanoparticles following the 
attempted conversion of thiol groups to azides...............................................190
xv
i
List of Tables
Table 2.1: Compositions of the five different mixtures used in the solution
polymerisation studies............................................   58
Table 2.2: Elemental analysis of untreated Merrifield resin and triflic acid
treated resin......................................................................................................67
Table 2.3: Elemental analysis of untreated Merrifield resin and resin that has
been subjected to the conditions used in the Staudinger.................................. 71
Table 2.4: Elemental analysis of unmodified Merrifield resin and iniferter
derivitised resin................................................................................................76
Table 3.1: Various ratios of hot (FITC-labelled) and cold (unlabelled) E. coli
0111: B4 LPS used in the hot cold assay........................................................114
Table 3.2: Raw fluorescence readings following overnight incubation of lOmg 
of resin with lpgml'1 FTTC LPS from E.coli 0111:B4....................................133
xvi
i
Chapter One: General Introduction.
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Chapter One: General Introduction
1.1 Lipopolysaccharide
1.1.2 General Overview
In 2004, the Infectious Diseases Society of America published a report 
highlighting the disparity between the dwindling number of new 
antimicrobial therapies and the increasing occurrence of bacteria 
resistant to multiple antibiotic classes (1). For a growing number of 
Gram negative infections there are no effective antimicrobial 
interventions either available or in the advanced stages of development 
(23)- With the emergence of multi-drug resistant pathogens, in an 
ageing population with an increased number of immuno-compromised 
patients, it is not surprising that infective diseases are becoming ever 
more prevalent
Sepsis is defined as "a life threatening condition that arises when the 
body's response to an infection injures its own tissues and organs" (4). 
It is a leading cause of death in non-coronary intensive care units 
worldwide with mortality rates of up to 50%. In the UK it is responsible 
for more deaths per year than breast and bowel cancer combined and 
the associated economic burden on the healthcare system is significant 
(5). Despite this, it remains under-recognised and poorly understood 
because of inadequate diagnostic assays and a lack of scientifically 
targeted clinical treatments.
Lipopolysaccharide is commonly implicated in the development and 
rapid progression of sepsis, even when the causative pathogen is of 
Gram-positive or fungal origin (6,7). Its presence in the blood is 
associated with elevated mortality rates (8), however it is not routinely 
tested for in the clinical setting.
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Chapter One: General Introduction
1.1.2 Structure o f Lipopolysaccharide
In the late 1800's the term "endotoxin" was used by Pfeiffer to describe 
the heat-stable, pyrogenic toxin associated with Vibrio cholera (9), 
however it wasn't until som e 50 years later that the structure of these 
toxins could begin to be elucidated. With the development of extraction 
and purification techniques, endotoxin was found to consist of lipid 
and polysaccharide regions and hence the term lipopolysaccharide 
(LPS) was coined (10). Today, LPS is known to consist of three distinct 
regions; Lipid A, core regions and an O-specific antigen region (Figure 
1.1). Each of these regions contributes to both the three-dimensional 
structure of LPS and its observed toxicity in vivo. Lipopolysaccharide 
occupies approximately 75 % of the surface area of the outer leaflet of 
the outer membrane of Gram-negative bacteria, with the lipid A region 
forming an integral part of the membrane while the polysaccharide 
portion extends outwards from the cell (11).
O-specific Antigen RegionLipid A Core Region
LiPid chains \J Phosphate groups Glucosam ine d issaccharide
2-keto-3-deoxyoctonic L jj c o re  oligosaccharides _  P  O -antigen 
■ L J I  acid (KDO) | i ^ 4 i g  H H H  repea ting  units
0  P h osphoe thano lam ine
Figure 1.1: Generalised structure o f  lipopolysaccharide.
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Over the past two decades, the structure of lipopolysaccharide has been 
reviewed extensively by Raetz (12,13), Rietschel (11), Holst (14), 
Morrison and Ryan (15), Caroff (10) and Lerouge (16). The following 
section will summarise the key features of each of the three distinct 
regions of this biomacromolecule.
1.1.2.1 Lipid A
Each of the enzymes responsible for the biosynthesis of lipid A from a 
uridine diphosphate-N-acetylglucosamine precursor, are encoded for 
by a single gene-copy that are highly conserved across the majority of 
Gram-negative species (13). As a result, this hydrophobic portion is the 
most preserved region of the LPS moiety between bacterial species 
consisting of a fatty acid substituted bisphosphorylated glucosamine 
disaccharide (Figure 1.2). This region is a prerequisite for viability in 
Gram-negative bacteria and functions to anchor LPS in the outer leaflet 
of the outer membrane. Lipid A is widely believed to be the "endotoxic 
centre" of LPS with synthetic lipid A (and analogues thereof) being 
capable of inducing the same immune response as wild-type lipid 
A/LPS (17,18).
Figure 1.2: Structure o f Escherichia coli lipid A .
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Although lipid A is the most conserved region of LPS, inter-species 
variation in the number of carbon atoms and degree of hydroxylation of 
the acyl chains, as well as the type of hexosamine disaccharide and 
degree of phosphorylation of the sugar exist (19). The general structure 
of enterobacteriaceae lipid A encompasses six (E.coli) or seven 
(Salmonella spp.) acyl chains that are attached via ester and amide 
linkages at the C3/3' and C2/2' positions of the glucosamine 
disaccharide (GlcN) respectively. The acyl chains typically consist of 
between 10 and 16 carbons, with hydroxylation or substitution at C3. 
The phosphorylation of the glucosamine unit gives the region an 
overall negative charge that is important for stabilisation of the outer 
membrane and also for LPS interaction with host proteins. The 6' 
position of the second GlcN residue is the location of the glycosydic 
linkage that connects lipid A to the saccharide region of the molecule.
Several studies have examined the effect of lipid A and its 
macromolecular conformation on the toxicity associated with a 
particular bacterial strain. In terms of in vivo endotoxic activity, an 
asymmetric hexaacyl lipid A (as shown for E. coli in Figure 1.2) attached 
to a phosphorylated disaccharide that adopts an overall conical shape is 
optimal (19,20). Increasing or decreasing the number of acyl chains, 
omitting the phosphate groups from the glucosamine sugar or reducing 
the disaccharide unit to a monosaccharide each significantly reduce the 
biological activity of lipid A (11). It is hypothesised that this is due to 
interaction with alternative members of the Toll-like receptor family 
that induce fewer pro-inflammatory cytokines or fail to be activated 
upon binding of LPS altogether (20). In fact tetraacyl species that form 
cylindrical structures such as the LPS found in some species of 
Rhodobacter and the lipid A precursor la, can function as antagonists to 
LPS induced activation of macrophages (21).
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1.1.2.2 Core regions
The inner core consists of two LPS specific sugars, L-glycero-D-manno 
heptose and 2-keto-3-doxyoctonic acid (KDO) that are linked to the 
glucosamine disaccharide of the lipid A moiety (Figure 1.3). The 
heptose residues have been identified in the majority of Gram-negative 
bacterial species, however KDO is unique and invariably present in all 
LPS. In terms of bacterial viability, the lipid A region plus one or two 
KDO sugars are essential for cell survival (15). The phosphorylation of 
KDO and inner core sugars leads to an accumulation of negative 
charges at the membrane of Gram-negative bacteria that is important 
for the stabilisation of the outer membrane via the interaction with 
divalent cations and also, to some degree, influences the three- 
dimensional shape and hence endotoxic activity of the lipid A region 
(22). The anionic groups are also the initial point of interaction between 
LPS and host proteins.
Whilst the outer core is significantly more variable than the inner region, 
it typically consists of three common hexose sugars i.e. glucose, 
galactose and glucosamine. Overall, the core region is usually 
conserved within a bacterial genus but remains structurally distinct 
from the cores expressed by other genii e.g. Salmonella, Shigella and 
Escherichia have similar but not identical core regions.
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Figure 1.3: S tructure o f  lipid A  p lu s tw o 2-keto-3-deoxyoctonic acid (K D O ) sugars
(circled).
1.1.23 O-specific antigen region
This region is attached via the terminal sugar of the outer core region. It 
is highly immunogenic as it protrudes from the bacterial surface and 
therefore functions as the 'point of contact' between the bacteria and the 
host system. There exist huge interspecies and intrastrain variations in 
the composition of this region, however the general structure consists of 
a repeating pattern of sugar units, typically between three and five 
sugars long with anything from zero to forty repeats of the unit, that 
contain dideoxyhexose sugars which are unique to the region (16). The 
multitude of positions within the repeating unit that the sugar can 
occupy, coupled with the type of ring structure, the conformation it 
adopts and the chemical linkages between residues gives rise to the 
variations observed (23). The overall structure of this region, coupled 
with particular sugars in the unit, especially the terminal ones, confer
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immunological specificity of the O-antigen and form the basis of O- 
serotyping. LPS molecules that possess an O-antigen are described as 
smooth while those whose structure terminates with the core region are 
defined as rough LPS, referring to the appearance of colonies when the 
respective bacterial strains are cultured on agar plates (16).
1.1.3 The function of lipopolysaccharide
LPS is essential for bacterial survival; phototropic Gram-negative 
bacteria that existed billions of years ago were found to have LPS in 
their outer membranes signifying its importance in bacterial existence 
(11). The pathogenic effects of these molecules are observed in humans 
when relatively high doses (ngml*1 quantities) are present in the 
circulatory system, however low doses of LPS are believed to be 
beneficial to the host in helping to maintain a basal level of immune 
attentiveness (14). Endogenously, it is estimated that there is a much as 
25 g of LPS in the human gastrointestinal tract (6). Although this is an 
essential feature of normal biology, during times of infection the 
mucosal barrier can become compromised allowing translocation of 
these native sources from the GI tract to the systemic circulation. 
Therefore LPS is ubiquitous in sepsis even when the causative agent is 
of Gram-positive or fungal origin (6,24).
In Gram-negative bacteria LPS is an effective diffusional barrier, much 
like the stratum comeum in humans, protecting the bacterium against 
host defense strategies, bile acids and hydrophobic antibiotics, allowing 
only low molecular weight, hydrophilic molecules to permeate (14). 
Additionally it impedes phagocytosis of the cell and may also function 
as a bacterial adhesin (25,26).
8
C hap 1 ar One; Gonera 1 1 ntroduetion.
1.1.4 Recognition of lipopolysaccharide by host
Wherever there is potential for bacterial growth and division there is 
likely to be LPS in the environment. A wide variety of environments 
therefore exist in which there is a potential for exposure to LPS via 
inhalation, ingestion or direct entry into the circulatory system (27). 
Once LPS has entered the circulation it causes increased permeability of 
the vascular endothelium, facilitating its entry into the tissue. This plus 
oedema leads to a decreased blood volume that subsequently causes 
hypotension and tissue ischaemia. Ischaemia can cause the integrity of 
the mucosal barrier of the gut to become compromised, allowing the 
influx of endogenous LPS into the systemic circulation, thus amplifying 
the problem (24).
When lipopolysaccharide is released from the bacterial cell during 
growth, division or cell lysis, it is recognised as a pathogen associated 
molecular pattern (PAMP) by pattern recognition receptors (PRR's) 
(28). Activation of these receptors that are expressed on innate immune 
cells and principally by mononuclear phagocytes, leads to an 
exaggerated systemic immune response that is disproportionate to the 
initial antigenic insult. Such recognition of LPS by the host system leads 
to a cascade of events that results in the production of cytokines and 
other inflammatory mediators (Figure 1.4). Actions of the activated 
immune cells, combined with the effect of the inflammatory cytokines 
leads to the development of the clinical symptoms associated with 
infection e.g. fever, endothelial damage, peripheral vascular dilatation, 
coagulation disorders and myocardial depression which can eventually 
produce multiorgan failure, shock and death of the host. The organ 
systems most affected are the brain, heart, kidneys, liver and lung 
giving rise to altered levels of mental alertness, myocardial depression, 
acute renal and hepatic failure and respiratory distress syndromes (29).
Chapter One: General Introduction
♦
♦ ♦ LPS in systemic circulation
♦
surface
CD14
Binding of LPS-LBP complex to  
CD14 on macrophage
 /
I
( t ) LPS is bound by LBP
Macrophage
cytokines 
(IL-6, TNFa, IL-lpe
Production of
Activation of coagulation 
cascade
Complement pathw ays 
activated
Synthesis of leukotrienes 
& prostaglandins
Figure 1.4: Schematic o f the immunological response observed following infection of 
host w ith  LPS. Following activation o f the TLR4 receptor complex, nuclear 
translocation o f nuclear factor kappa B (NF-kB) occurs, resulting in the production of  
pro-inflam m atory cytokines such as tum our necrosis factor alpha (TNFa) and a 
variety  o f  interleukins (e.g. IL-6 and IL-1/3). Subsequent activation o f other pathways  
precipitate the insult to the host system . (LPS  =  lipopolysaccharide; LBP = 
lipopolysaccharide binding protein; CD 14= cluster o f differentiation 14, a protein  
expressed on the surface o f macrophages which fun ctions as a receptor fo r  the LPS- 
LBP complex; TLR4 = toll-like receptor 4, a type o f  pattern  recognition receptor; M D 2  
= extracellular molecule associated w ith  TLR4) .
1.1.4.1 Recognition of LPS by serum proteins
There are a number of endogenous proteins that recognise and bind 
LPS when it is present in the bloodstream. Lipopolysaccharide binding 
protein (LBP) is a 60 KDa glycoprotein synthesised by hepatocytes that 
is constitutively present in normal serum at a concentration of ~ 0.5 - 10 
pgml'1. Following induction of an acute phase reaction, this level can 
increase to in excess of 200 pgmH (30-33). Basic amino acid residues 
clustered at the far end of the amino terminal mediate the initial
10
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electrostatic interactions with the negatively charged lipid A/KDO  
portion of the molecule (31). It is this half of the protein that possesses 
the LPS binding properties while the carboxyl terminal is implicated in 
the interaction of LPS with membrane bound CD14 receptors (34,35). 
The affinity of the protein for lipid A, from rough and smooth forms of 
LPS, is in the nanomolar range (36,37). LBP functions as a carrier 
protein for LPS, facilitating its interaction with membrane bound CD14 
receptors on monocytes/macrophages to initiate a cascade of immune 
responses. The principal function of LBP appears to be to enhance the 
sensitivity of the host to detect LPS early in infection; the host 
sensitivity to LPS is increased several orders of magnitude when bound 
to LBP (33). The action of LBP is therefore described as pro- 
inflammatory. Despite its high affinity for LPS, LBP does not possess 
any direct antimicrobial activity (38).
Bactericidal/permeability increasing protein (BPI) is another native 
protein that interacts with LPS in serum. It has a molecular weight of 
approximately 55 KDa and is found predominantly in the azurophilic 
granules of polymorphonuclear neutrophils (PMNs) (33,39). PMNs are 
granulocytes that are released from the bone marrow in response to 
complement proteins. They are recruited to the site of infection where 
they phagocytose invading organisms and kill them intracellularly. 
Upon ingestion of the micro-organism, degranulation of the 
granulocytes occur resulting in the release of toxic nitrogen oxides, 
cationic proteins and defensins that can kill bacteria, proteolytic 
enzymes and lysozyme (40). Whereas LBP is constitutively expressed in 
the liver, there is no significant endogenous level of BPI in the 
circulation (low ngml*1) prior to induction of an acute phase reaction, 
since there are few polymorphonuclear neutrophils present and hence 
little neutrophil derived BPI (41). The protein has good sequence
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homology with LBP (~45% amino acid sequence identity (Figure 1.5)) 
(33,42) however the two proteins have very disparate activities.
BPI:
82Asn-Ala-Asn-Ile-Lvs-Ile-Ser-Glv-Lvs-Trp-Lvs-Ala-Gln-Lvs-Arg-
Phe-Leu-Lvs-Met-Ser-Glv-Asn-Phe-Asp-Leu-Ser-Ile108
LBP:
91Trp-Lvs-Val-Arg-Lvs-Ser-Phe-Phe-Lvs-Leu-Gln-Glv-Ser-Phe-Asp-
Val-Ser-Val108
Figure 1.5: Specific peptide sequences o f BPI and LBP that demonstrate highest LPS 
binding activity. (Highlighted residues indicate homology between the two proteins.) 
Generally a repeating sequence o f alternating polar and non-polar amino acid residues 
in both sequences is observed, in addition to an overall positive charge (32,42)
Unlike LBP, BPI is anti-inflammatory. The affinity of BPI for LPS is 
approximately 20 -  100 fold higher than LBP (39,43,44) and it possesses 
both antibacterial and anti-endotoxin activities; properties that are a 
consequence of the highly cationic nature of BPI (net charge of ~ +12) 
(39,45). Binding of BPI to live Gram-negative bacteria is facilitated via 
electrostatic interactions with LPS in the outer membrane. As the 
affinity of this peptide for LPS is significantly greater than that of the 
stabilising divalent cations, BPI effectively displaces the Mg++/C a ++ 
ions to bring about destabilisation and hence increased permeability, of 
the outer membrane. Other effects of this interaction include hydrolysis 
of cellular phospholipids by phospholipases and interruption of cell 
division. Following an increased incubation period, BPI brings about 
cell kill by perturbing the inner membrane of the bacterium (46). 
Studies using the amino-terminal half of BPI have demonstrated that it 
is this domain that is responsible for both antibacterial and anti­
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endotoxin properties (43,47). Whilst the carboxy-terminal possesses 
little/no antibacterial activity, it plays a significant role in the 
neutralisation of endotoxin. It is unable to interact with membrane 
bound CD14 and therefore incapable of initiating the subsequent 
cascade of immune/inflammatory responses that is observed with the 
LPS-LBP complex, instead it promotes adhesion of bacterial cells and 
aggregates of LPS to the surface of neutrophils and monocytes to 
promote phagocytosis and clearance of LPS from the systemic 
circulation (48,49).
A soluble form of the membrane bound receptor CD14 (sCD14) also 
constitutively exists in serum (50). Several isoforms of this receptor are 
released from the surface of macrophages and monocytes in response to 
a variety of stimuli (51). At high concentrations, sCD14 appears to act as 
a decoy receptor for LPS, preventing binding to membrane bound 
CD14 and subsequent activation of the signalling cascade (52-54). It is 
thought to further neutralise the effects of LPS via a role in the transfer 
of LPS to high-density lipoproteins (55,56). However at lower 
concentrations, in cells that do not naturally express the membrane 
bound form of the receptor, it has been shown to enhance the response 
to LPS (57,58).
1.1.4.2 Recognition of LPS by membrane-bound receptors: The CD14- 
TLR4-MD2 complex
CD14 (cluster of differentiation antigen 14) a 55 KDa 
glycosylphospatidylinositol (GPI) anchored protein, was first 
recognised to have a role in the in vivo sensing of LPS in 1990 by Wright 
and colleagues (59). Inhibition of LPS induced TNFa was observed 
when cells were exposed to anti-CD14 antibody, thus suggesting a role 
of this receptor in the induction of inflammatory mediators following
13
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exposure to endotoxin. The CD14 receptor is expressed on the surface 
of macrophages, monocytes and neutrophils and binds LPS both in 
association with the serum protein LBP and as monomeric LPS (52). As 
it is a member of the GPI family of cellular proteins it lacks signalling 
capacity due to the absence of a transmembrane domain. It was 
therefore hypothesised that CD14 must be interacting with a second 
receptor to bring about the induction of inflammatory mediators (60).
The Toll-like receptors (TLRs) are a family of 10 pattern recognition 
receptors expressed on the surface of macrophages and also 
intracellularly (61). The involvement of the TLRs, specifically TLR4, in 
the recognition of LPS was first described by the group of Bruce Beutler 
in 1998 when genetic mapping of C3H/HeJ mice demonstrated a 
mutation in the gene encoding for TLR4 (62,63). As a consequence, 
these mice are hyporesponsive to LPS stimulation due to the presence 
of a defective TLR4 protein (62,64). TLR4, the first of the human Toll­
like receptors to be identified, is a homodimeric, transmembrane 
receptor that is capable of facilitating intracellular signalling to initiate 
the induction of inflammatory mediators (65). CD14 functions as a co­
receptor for TLR4. Following binding of the LPS-LBP complex by 
membrane bound CD14, the distance between CD14 and TLR4 
decreases affording appropriate presentation of the endotoxin molecule 
(66). A further accessory molecule, MD2, is required for full activation 
of the immune system by endotoxin. Although the function of MD2 has 
not been fully elucidated, its absence results in a significant reduction in 
the inflammatory response following LPS stimulation (67). It has been 
suggested that MD2 facilitates the dimerisation and cellular distribution 
of TLR4 (67-69).
The induction of inflammatory mediators resulting from the formation 
of the CD14-TLR4-MD2 complex proceeds via a number of adapter 
molecules including myeloid differentiation primary-response protein
14
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88 (MyD88) and IL-lR-associated kinases (IRAKs) (70,71). The 
consequence of this signaling cascade is the nuclear translocation of 
nuclear factor-icB (NF- kB) resulting in the transcription of a variety of 
pro-inflammatory cytokines and chemokines, including TNF a, IL-6 and 
IL-lp amongst others (Figure 1.4) (72).
1.1.4.3 Intracellular recognition of LPS
Another member of the pattern recognition receptor family, the NOD 
(nucleotide binding and oligomerisation domain) like receptors (NLRs), 
are also implicated in the recognition of Gram-negative bacteria and 
LPS (73). The NLRs share many similarities with the TLRs, for example 
they both possess leucine-rich repeats and initiate similar signalling 
cascades, however these receptors are located exclusively intracellularly
(74). They appear to act as a secondary defense mechanism should the 
membrane bound TLR be absent or unresponsive to a pathogenic 
stimuli (72). Previously, the receptors NODI and NOD2 were thought 
to be involved in the recognition of LPS (65), however it would appear 
the activation was due to contamination of the LPS preparation with 
petidoglycan (72); NODI does primarily sense Gram-negative bacteria, 
however its ligand is not LPS. Another member of the NLR family, 
NLRP3, has recently been implicated in the intracellular recognition of 
LPS (72).
1.1.5 Current treatment options for Gram negative infections and 
associated sepsis.
Suspected bacteraemia is initially treated with empirical antibiotic 
therapy until positive blood cultures can be obtained. Although 
antibiotic therapy has been shown to be more effective if started early
(75), the choice of anti-infective is critical as some promote the release of
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LPS from the bacterial surface through their lytic action (76,77), thus 
potentiating the clinical condition. Polymyxin B (discussed in more 
depth in Chapter Three) is an antimicrobial peptide that displays high 
affinity for LPS and is therefore not only bactericidal but also a potent 
anti-endotoxin. Its use nowadays is somewhat limited however as a 
consequence of associated neuro- and nephrotoxicity. The mainstay of 
current treatment is mainly supportive therapies with the aim of 
restoring hypovolaemia via fluid boluses to help rectify hypotension 
and increase tissue perfusion. Glucocorticoid therapy, anti-cytokine and 
anti-endotoxin therapies have been met with limited success (78) 
although drotrecogin alfa (Xigris®) a recombinant form of protein C, 
has been licensed for use in severe sepsis. In a worldwide clinical trial 
(PROWESS) drotrecogin alfa demonstrated an overall reduction in 28 
day mortality compared to placebo (79), however there is an increased 
risk of bleeding during treatment and a recent Cochrane Review 
suggests that treatment with Xigris should be avoided (80). Therapeutic 
targeting of a single point in the immune-inflammatory cascade is likely 
to have little effect on the overall outcome; a plethora of treatments or a 
means of more effective removal of LPS from the circulation is likely to 
be needed to have an impact. In addition, the ability to diagnose sepsis 
during the early stages with continuous realtime progression 
monitoring would revolutionise the treatment of sepsis. A 6 -  10% 
increase in risk of death is observed for every hour that sepsis remains 
undiagnosed (81).
1.1.6 Detection of lipopolysaccharide
In the 1940's the rabbit pyrogen test was introduced to allow for the 
detection of endotoxin contamination of pharmaceutical products 
(82,83). The febrile response of a rabbit following injection of the 
formulation was monitored; if the rise in temperature exceeded that
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outlined in previously established limits the solution was deemed to 
contain endotoxin at an unacceptable level. Although this test mimics 
the human response to endotoxin, there are significant limitations 
associated with this assay. Not only is the process time consuming, 
expensive and subject to animal welfare issues, certain 
formulations/ pharmaceutical products cannot be tested in this way due 
to associated severe toxicity or as a result of the drug itself modulating 
the temperature of the animal, for example, antipyretics (84). As a 
result, the rabbit pyrogen test has largely been superseded by the 
Limulus amoebocyte lysate (LAL) assay. Developed by Levin and Bang 
in the 1960's (85,86), the assay relies on the coagulation of haemocytes 
from the horseshoe crab, Limulus polyphemus, on exposure to 
lipopolysaccharide (87). Factor C, the main factor sensitive to LPS in 
the clotting cascade, is activated by endotoxin that in turn activates 
factor B, thus activating a clotting enzyme that subsequently converts 
coagulogen into the insoluble coagulin (88). Although easier to perform 
than the rabbit pyrogen test, interference from drugs and other test 
substances is possible and therefore careful sample preparation is vital 
(89). A study to assess the suitability of the assay for the initial 
diagnosis of peritonitis in peritoneal dialysis patients by Hausmann et 
al. (90) found that despite the assay being very efficient at 
distinguishing between Gram-positive and Gram-negative infections, 
false positive results were obtained in some patients as a result of a 
fungal peritoneal infection. It is a component of the cell wall of the 
fungus (p glucans) that is able to activate clotting enzymes in the 
amoebocyte cells by interacting with factor G (91). Although the LAL 
assay has found considerable use in the detection of endotoxin in 
pharmaceutical formulations, its use in the clinical setting is limited due 
to non-specific sequestration of LPS by serum proteins and cellular 
components (92).
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Spectral diagnostics have recently developed an endotoxin activity 
assay (EAA) that was approved by the FDA (93) as a result of a 
multinational clinical trial (MEDIC, (6)). The assay indirectly measures 
LPS, relying on the priming of host neutrophils by LPS-antibody 
complexes to generate a chemiluminescent response via the oxidation 
of luminol. The assay is semi-quantitative indicating whether endotoxin 
level is low, intermediate or high (94).
1.1.7 Removal o f lipopolysaccharide
Due to the potent biological activity of LPS, the FDA have imposed an 
endotoxin limit of 5 EU /kg for intravenous formulations and 0.2 EU /kg  
for those intended for intrathecal use (1 EU is equivalent to ca. 100 pg of 
LPS) (95). The risk of contamination should be minimised during the 
manufacture stage as LPS is a ubiquitously stable macromolecule, 
resistant to extremes of temperature and pH (96,97) and its removal is 
therefore somewhat cumbersome. Conventional autoclaving and 
sterilisation techniques fail to inactivate endotoxin, with prolonged 
exposure to temperatures in excess of 180 °C or extremes of pH 
required (98). Such conditions often have a detrimental effect on the 
formulation in question. Chromatographic clean-up (96,99,100), two- 
phase extractions (101) and ultrafiltration (102,103) have all been 
investigated as alternative methods for the removal of endotoxin, with 
varying degrees of success.
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1.2 M olecu lar Im p rin tin g
1.2.1 Conventional Im printing
Molecular imprinting, as a means of achieving molecular recognition  
through the generation of m olecule specific cavities within a synthetic 
material, was first demonstrated in the 1940s in the laboratories of 
double Nobel Laureate Linus Pauling. Ironically, it was his theory of 
antibody production (104), later show n to be incorrect, that led Dickey, 
one of Pauling's research students, to investigate whether silica gels 
could be prepared w ith pre-defined substrate selectivity (105). 
Following these early studies it w as not until the 1970s that Wulff first 
demonstrated molecular imprinting in an organic polymer (106). The 
approach w as popularised in the early 1990s when the work of 
Mosbach on antibody mimicry w as published in Nature (107). The 
general protocol for producing such receptor mimics is outlined  
schematically in Figure 1.6.
*
Tem plate
Non-covalent m onom ers 
Covalent m onom ers
T em plate-m onom er com plex
Polym erisation
in p re se n c e ^ f  
cross-linker
T em pla te  rem oval
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Im printed site  w ithin th e  
polym er matrix
Figure 1.6: Schem atic representation o f  the m olecular im prin tin g  process (m odified
from  (108)).
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Molecularly imprinted polymers (MIPs) have the potential to serve as 
efficient, robust, cost effective synthetic alternatives to antibodies. 
Typically, MIPs have been generated using relatively small, highly 
functional molecules as templates, for example beta-blockers, 
corticosteroids and hormones. Such systems are efficient in re-binding 
and separating the target molecule from complex mixtures, however 
affinities are generally an order of magnitude or more below those 
achieved with commercially available antibodies. The field of molecular 
imprinting has been reviewed extensively both in peer-reviewed 
journals (108-112) and in dedicated textbooks (113-116).
All too often the preparation of such materials is a poorly controlled, 
random, affair that results in a population of heterogeneous binding 
sites. Consequently, reproducibility is poor, binding capacities are low 
and non-specific binding problematic (see review references above). 
Furthermore, nearly all of the high affinity data reported in the 
literature is carried out in non-polar solvents whilst the aqueous 
compatibility of traditional imprinted polymer formats is, at best, poor 
(117,118).
1.2.2 Macromolecular and Bio-imprinting
To date the imprinting of biological macromolecules has been hindered 
by a number of complicating factors. The size, complexity, 
conformational flexibility and environmental sensitivity of such 
macromolecules, coupled with poor target specificity and the lack of 
recognition by conventional imprinted polymers outside organic media, 
has prevented this technology reaching its true potential as a feasible 
alternative to antibodies as recognition elements (119-121). However, 
some success has been achieved in the field through careful design and 
optimisation of the imprinted system.
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Conventional bulk imprinting approaches and the synthesis of 
imprinted soft gels both suffer from inefficient removal of the template 
and poor mass transfer upon re-incubation with their target species 
(122). As a result, efforts have primarily focused on the use of surface 
imprinting approaches to allow for unhindered access to recognition 
sites. Early studies employed metal ion co-ordinated imprinting as an 
approach for the recognition of proteins (123-125). Although the 
systems were efficient at rebinding their templates, this imprinting 
technique requires the use of metal-ion coordinating monomers such as 
N-(4-vinyl)-benzyl iminodiacetic acid and proteins that express 
histidine residues on their surface. The application of this methodology 
is therefore somewhat limited. Hierarchial imprinting has also been 
used to generate recognition elements for peptides. This technique 
involves the immobilisation of peptidic targets to the surface of a 
porous, sacrificial solid support such as silica, followed by 
polymerisation of monomers within the pores and subsequent removal 
of the support. This allows for the generation of surface confined 
binding sites that are more homogenous than those generated in 
conventional imprinted polymer systems (126,127). This homogeneity 
arises from the fact that the template is immobilised during the 
imprinting process and is therefore less flexible. The main drawback of 
such approaches is the necessity for harsh conditions (e.g. the use of 
glass etchants such as ammonium hydrogen fluoride) to bring about 
removal of the solid support.
In 2000 -  2001, Rachkov and Minoura demonstrated the epitope 
approach to molecular imprinting for the first time (128,129). They 
imprinted a tetra-peptide sequence from the natural peptidic hormone, 
oxytocin, in acetonitrile (97%)/water (3%). Importantly recognition of 
the full peptide could be achieved through the imprinting of an 
exposed epitope from its structure, thus demonstrating the feasibility of
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this approach in the area of protein/ bio-imprinting. The polymers 
performed well in chromatographic evaluation studies where the 
mobile phase consisted mainly of acetonitrile (95%) however when the 
amount of water in the mobile phase was increased to 70%, significant 
reductions in retention time were observed due to the loss of hydrogen 
bonding interactions between the template and the polymer. Further 
increasing the water content to 90% led to increased retention times due 
to ionic and/or hydrophobic interactions dominating. The system was 
sensitive to pH and ionic concentration of the aqueous mobile phase. 
The polymers were produced by conventional bulk polymerisation and 
therefore, although they demonstrated effectiveness in recognising the 
templated tetra-peptide sequence and the natural 9-mer peptide 
oxytocin, larger targets are likely to suffer from inefficient mass transfer 
upon rebinding. The Shea group further progressed this technique, 
achieving recognition of larger protein structures (cytochrome C, 
bovine serum albumin and alcohol dehydrogenase) through the 
imprinting of a nonapeptide sequence isolated from the C-terminus of 
the protein (130). Unlike the work of Rachkov and Minoura, a surface 
imprinting approach was adopted to generate thin molecularly 
imprinted films. The nonapeptides were immobilised on a silicon 
surface and a solution of monomers photochemically polymerised on 
the surface. The polymer-modified surfaces were soaked in buffer 
overnight to separate the polymer films from the support, thus 
generating micron thick films capable of recognising not only the 
template nonapeptide but also the full protein under native (aqueous 
buffer) conditions. The MIP films selectively bound their target protein 
from mixtures composed of five different proteins. Rebinding studies 
with the BSA MIP film using nonapeptides derived from BSA in which 
a single amino acid had been substituted resulted in complete loss of 
recognition, demonstrating the specificity for the system for its 
template.
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Recently the same group demonstrated the use of molecularly 
imprinted polymers in an in vivo system for the first time (131). The 
polymers, imprinted with the 26 amino acid peptide Melittin from bee 
venom, demonstrated affinities in the picomolar range that was 
comparable to those achieved with antibodies (132,133). To achieve 
such affinities for a biological macromolecule, through polymerisation 
in wholly aqueous conditions, is a significant advancement for the field 
of molecular imprinting. The nanoparticles, synthesised using an 
optimised monomer/cross-linker combination identified during a prior 
screening study, were capable of neutralising the toxic, fatal effects of 
Melittin when injected into live mice.
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The over-arching aim of this project was to develop a peptide-polymer 
hybrid system capable of recognising and binding LPS in a variety of 
biologically relevant environments. The ability to detect endotoxin on 
admission to hospital and to be able to continuously monitor levels 
throughout treatment would offer significant clinical benefits. 
Furthermore, it was hoped that technology developed would provide a 
platform for the development of novel therapeutic agents for the 
treatment of Gram-negative infections and associated sepsis.
We hypothesised that through the integration of target specific peptide 
receptors, into the backbone of a polymer support, the issues 
surrounding the imprinting of biomacromolecules could be 
circumvented. Our approach would require that a template selective 
peptide would be surface immobilised (Figure 1.7 a) and encouraged 
into its binding conformation through exposure to the template (Figure
1.7 b). Subsequently, following addition of monomers (Figure 1.7 c), this 
complex would be locked in place by a polymerisation or capture stage 
(Figure 1.7 d). Finally the removal of the template would expose the 
peptide, but leave it secured in its binding conformation, essentially 
lining a portion or the entirety of the polymer cavity. Rebinding of the 
template would result due to reciprocal peptide-template and polymer- 
template interactions (Figure 1.7 e). By analogy with conventional 'co­
polymer7 molecular imprinting, the peptide performs the role of a 
'super' functional monomer in that it demonstrates affinity and 
selectivity for the target prior to polymerisation. Whilst possessing the 
robustness and adaptability of conventionally imprinted polymers, 
synthesis of these materials would not rely on organic solvents and 
would be prepared and applied in aqueous environments. 
Furthermore, this strategy builds upon the success achieved with
24
Chapter One: General. Introduction
surface imprinting and template immobilisation techniques. It is 
therefore envisaged that the binding sites should be readily accessible 
and homogenous in nature, thus allowing for efficient recognition and 
mass transfer kinetics.
From a conventional molecular imprinting perspective, a number of 
'temp la ting' processes would occur during pre-polymerisation/ 
polymerisation and all would contribute to the formation and function 
of the resulting imprinted site. Firstly interaction between the template 
and the peptide controls and dictates peptide conformation prior to 
formation of a pre-polymerisation complex with monomer species. 
Importantly pre-polymerisation interactions are also established 
between the peptide and monomers and also, depending on the size of 
the template relative to the size of the peptide and the degree of 
polymerisation from the surface, exposed (non-peptide complexed) 
parts of the template with monomer species. The subsequent capture of 
these complexes results in an imprinted site where the peptide is 
effectively sandwiched, in its binding conformation, between template 
and polymer whilst sections of the template are involved in 
conventional monomer residue-template interactions.
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Polym erisation is in itia ted  from  surface-bound in itiators via irradiation w ith  U V  ligh t (d) fo rm in g  a po lym er m atrix around the peptide-target com plex  
that, on rem oval o f  the target molecule, leaves an im prin ted  site  that is lined w ith  a conform ationally restricted peptide (e).
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It is important to note that the schematic presented in Figure 1.7 
illustrates the process for a target that is of similar size to the peptide 
species and therefore the imprinted site is entirely lined by the peptide. 
In the current study, it is possible that the template is considerably 
larger than the peptide; the length of rough LPS has been calculated to 
be 2.4 -  4.4 nm while those species possessing an O -  antigen can be 
well in excess of lOnm depending on the number of repeating units 
present (26,134). It is therefore possible that the peptide only occupies a 
portion of the imprinted site, thus allowing further interactions 
between the monomer(s) and template to be established (Figure 1.8). 
The degree of interaction between the template and polymer is 
obviously dependent on the choice of monomer (presence of 
complementary functionality) but also on the height of polymer grafted 
from the surface of the solid support relative to the size of the target. In 
the case of a small target (as depicted in Figure 1.7), care must be taken 
to avoid growing the polymer beyond the peptide-template complex to 
ensure that the template does not become irreversibly entrapped with 
in the system. For larger targets, the polymerisation period may need to 
be extended to allow the polymer to grow around a portion of the 
molecule for template-polymer interactions to play a role (Figure 1.8).
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Removed of 
tem plate
R ebinding
Figure 1.8: Schematic o f  the im prin ted  site  w hen the template is larger than the 
peptide species. Figure key is sam e as in Figure 1.7.
The objective in Chapter Two was to develop an efficient and robust 
solid support to facilitate the co-immobilisation of a LPS specific 
peptide and an iniferter group capable of initiating controlled polymer 
growth. Standard Merrifield resin was chosen as the solid support as it 
was readily available and possessed a chloromethyl group to which an 
iniferter could readily be attached. It was also anticipated that the 
versatility of the chloromethyl functionality would additionally allow  
for further chemical modification with relative ease to generate bi- 
functionalised resins w ith pre-defined loadings of each tether.
Chapter Three investigated the use of the bacterial derived peptide 
polym yxin B, as a model peptide to provide evidence for the proposed  
polymer system. Polymyxin B has a high affinity for lipopolysaccharide 
and has therefore traditionally been used clinically as an anti­
endotoxin. The peptide was immobilised onto the solid supports 
described in Chapter Two using a variety of attachment strategies and
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binding assays conducted to determine affinities and binding 
capacities. Following full characterisation of the immobilised peptide, 
polymer growth was initiated from surface bound iniferter groups 
around the peptide when bound to LPS and the binding efficiency of 
the system evaluated.
The studies outlined in Chapter Four were undertaken to allow the 
transfer of the work described in Chapters Two and Three to a more 
biologically useful strategy for the detection and/or in vivo 
sequestration of lipopolysaccharide. Magnetic nanoparticles were 
synthesised and polymyxin immobilised to the surface. The ability of 
the nanoparticles to remove lipopolysaccharide from solution was then 
evaluated.
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2.1.1 General Overview
Previous studies within our laboratory that attempted to develop the 
peptide-polymer hybrid recognition system described in Chapter One 
via conventional, bulk imprinting, techniques failed because the 
template became irreversibly trapped within the peptide-polymer 
system. It is imperative that access to the peptide is not unduly 
hindered by the polymer in order for the system to remain viable. We 
hypothesised that ligand access would be maintained if both peptide 
and polymerisation initiator were co-immobilised on a surface and 
polymer growth carefully controlled so as not to "overgrow" the 
peptide/target complex (shown schematically in Figure 1.7, Chapter 
One).
2.1.2 Merrifield Resin
Co-immobilisation of two different chemical species at a pre-defined 
molar ratio is extremely difficult to achieve using a homo-functional 
solid support. A sequential approach requires that the first attachment 
step is carried out with very precise control and that the chemistry 
involved does not affect the chemical tethers destined for 
immobilisation of the second moiety. Likewise, simultaneous strategies 
require extensive optimisation and are vulnerable to minor variations in 
reactant quality and reaction conditions.
Bifunctional resins have been prepared by co-polymerising monomers 
possessing more than one type of functional group but these require 
extensive optimisation of reaction conditions and careful consideration 
of monomer ratios and reactivities (1). Where multifunctional 
attachment or cleavage strategies are required, bifunctional non­
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integral linkers or multiple non-integral linkers have more commonly 
been used to develop co-immobilisation strategies (2,3). However, it is 
not always desirable to significantly increase spacer length in order to 
bifunctionalise a resin and simultaneous or sequential modifications of 
a resin with multiple mono-functional linkers can again be vulnerable 
to minor variations in reactant quality and reaction conditions. Elegant 
enzymatic and optical approaches have led to spatially-resolved surface 
modifications giving rise to multifunctional resin surfaces, however 
these approaches involve serial protection/deprotection and rely on 
sophisticated microscopy for characterization (4,5).
Merrifield resin, a macroporous chloromethylated polystyrene, was 
developed by Robert Bruce Merrifield in 1969 as a platform for the 
solid-phase synthesis of peptides (6). As a support for the synthesis of 
small organic molecules, the resin (and the techniques developed from 
its use) has allowed a large number of reactions to move to solid-phase 
and has been critical in the development of powerful, modem, 
combinatorial chemistries (7). The usefulness of Merrifield resin is due 
in part, to the versatility of the chloromethyl functionality (Figure 2.1); a 
property that has been exploited in the current study. Furthermore, the 
resin has variable loading properties and is stable under a wide range 
of reaction conditions. One of the objectives of this study was to 
bifunctionalise Merrifield resin, in a controllable manner, in order to 
bring about the co-immobilisation of peptide and a surface bound 
initiator species at a pre-definable molar ratio.
The native chloromethyl group can be used to readily attach a 
polymerisation initiator species, however the immobilisation of a 
peptide requires an alternative functional group, for example a primary 
amine. It was hypothesised that controlled conversion of functional 
groups would allow a bifunctional support to be developed. 
Nucleophilic substitution of the chlorine group by an azide followed by
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a Schmidt rearrangement using triflic (trifluromethanesulfonic) acid has 
been reported as an efficient method for the production of amino 
polystyrene resins from Merrifield resin (8). An alternative approach 
w ould be to use the Staudinger reaction; a mild technique that also 
reduces azide groups to amines in good yield with very few  side 
products (9,10). Both mechanisms are outlined in Figure 2.1 and have 
been investigated in this study.
^  "^ci
a 0 '"
Merrifield resin 
(Chloromethyl polystyrene)
N a N , /  DMF, 7 ( fC . 2 4  h o u rs
Reduction of azide u sn g  trifkc acid
TfO H  /  C H f i l i  CfC. 1 h ou r
9 o ~ '
Azidomethyl polystyrene
Reduction of azide via Staudinger reaction
P P h y  d ry  THF, 2  h o u rs R T
IIV
M
ITU n 
Q  "
Methyleneiminium intermediate
M e O H /H iO , R T , 1 hour
•-P-
1.5  equ iv . H 2O, R T , 4  h ou rs
Amine functionaised  resin
Figure 2.1: M echanism  o f  the form ation  o f  am ine fun ctionalised  p o lystyren e resin via  
tw o different syn th etic  pa th w ays. G reater experim ental detail is provided  in sections
2.2.2 to 2.2.4.
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2.2.3 Living Radical Polymerisation
Conventional molecular imprinting methodologies typically rely on the 
use of an azo-type free radical initiator, commonly 
azobisisobutyronitrile (AIBN), to bring about and propagate 
polymerisation. These initiators are versatile, cost effective and efficient 
and, upon application of heat or UV radiation, undergo homolytic 
cleavage to generate two identical, short-lived, active cyanopropyl 
radicals and nitrogen gas (Figure 2.2). This type of polymerisation is a 
random process that generates the typical monolithic and bead polymer 
formats seen in bulk and precipitation polymerisation respectively.
Figure 2.2: Homolytic cleavage o f A IBN  to generate two equally reactive cyanopropyl
radicals and nitrogen gas.
In comparison, controlled/living radical polymerisation techniques can 
be used to control the polymerisation process to produce polymers with 
precise molecular weights and low poly-dispersity indices (11). By 
utilising such an approach in the current study, it was anticipated that 
polymer growth could be carefully controlled to allow for the formation 
of the peptide polymer receptor as described in section 1.2.2 of Chapter 
One.
Possible mechanisms to achieve such controlled polymer growth 
include atom-transfer radical polymerisation (ATRP) (12), nitroxide- 
mediated polymerisation (NMP) (13) and reversible addition- 
fragmentation transfer polymerisation (RAFT) (14). These techniques 
however typically require elevated temperatures, careful choice of 
monomers and the use of organic solvents (15); conditions not
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conducive to the physicochemical properties of the target species and 
peptide moiety. Furthermore, RAFT agents generally require synthesis 
before polymerisation, as few are available commercially (16) and 
ATRP results in contamination of the polymer with the cuprous halide 
catalyst used in the reaction that often requires further clean-up 
procedures (15). An alternative method of achieving controlled polymer 
growth is through the use of an iniferter species (17,18). In 1982 Otsu 
and Yoshida coined the term iniferter (referring to the ability of their 
initiator species to function as an initiator, transfer agent and 
terminator) following studies investigating the polymerisation of 
styrene with tetraethylthiuram disulphide. They found that the 
polymers produced were end-capped with the radical group and were 
therefore capable of re-initiating polymerisation following the addition 
of another monomer (19). Further studies found that those molecules 
containing the N,N-diethyldithiocarbamyl group served as excellent 
iniferters (20). These dithiocarbamate-type species will readily react 
with the chloromethyl groups on the surface of Merrifield resin to 
produce the active initiator species. Following irradiation with UV 
light, the iniferter decomposes to form one surface-bound (active) and 
one solution-phase (inactive) radical species (Figure 2.3).
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orcr° Na+*S^N'Rl
Q T ^
More active radical species Less active radical species
Figure 2.3: Synthesis o f a surface immobilised iniferter and subsequent formation of 
the two radical species. Polymerisation proceeds from the surface bound, active radical 
species. Ri, R2 : CH2CH3 (sodium diethyldithiocarbamate), Ri: CH3 , R2: CH2COOH,
(sodium dithiocarboxysarcosine)
The formation of two unequal radicals is important. The immobilised 
surface bound reactive radical initiates polymerisation, whilst the 
solution phase inactive radical provides a mechanism by which 
polymerisation can be controlled. During polymerisation, the dynamic 
recombination reaction of the two radicals means that polymer growth 
occurs in a stepwise, controlled manner. Additionally the less reactive 
radical species prevents solution phase polymerisation. The limited 
growth coupled with the absence of solution phase gelation, will ensure 
that the polymer will not occlude the peptide binding sites.
Iniferters have been successfully employed as radical sources in the 
polymerisation of a range of monomers, under a multitude of reaction 
conditions, to suit a variety of application needs (reviewed in (20,24)). 
Over the last decade iniferters (and the polymers derived from them) 
have been investigated as potential chemical sensors (22,23), used in the 
development of micropattemed surfaces for cell 
adhesion/ encapsulation (24) and bioconjugation (25), as 
chromatographic stationary phases (26,27) and in the production of
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telechelic polymers (28). More specifically, in the area of molecular 
imprinting, iniferters have found utilisation in the preparation of multi­
functional nanoparticles (29-32) and in biomacromolecule 
recognition/separations (33,34). Studies investigating iniferter-derived 
polymers as imprinted chromatographic stationary phases have 
demonstrated several advantages over conventionally-prepared 
imprinted materials for this application (27,35,36).
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2.1.4 Aims and objectives of Chapter Two
The overall aim of this section of work was to synthesise a bifunctional 
solid support to allow for the controlled immobilisation of iniferter and 
peptide species, from which the peptide-polymer hybrid system can be 
developed *
The key objectives of this work were:
1. To investigate two synthetic pathways to generate a solid 
support capable of possessing two different chemical 
functionalities at a pre-defined molar ratio.
2. To immobilise an iniferter species on the surface of said support.
3. To demonstrate controlled growth of polymer from the surface 
of the support.
* The chemistries involved in the immobilisation of the peptide species 
will be discussed in Chapter Three.
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2.2 Materials and Methods
2.2.1 Materials
All chemicals were purchased from Sigma-Aldrich, Poole, UK and were 
used as received unless otherwise stated. All organic solvents were of 
HPLC grade and were obtained from Fisher Scientific, Loughborough, 
UK unless otherwise stated.
2.2.2 Synthesis of azidomethyl polystyrene
The method outlined by Arseniyadis (8) was used, with some 
modifications, to generate the azidomethyl polystyrene intermediate. 
Merrifield resin (250 mg, ~2 mmol Cl g-1, 1 % cross-linked with DVB, 
200 - 400 mesh) was reacted with sodium azide in dry DMF (10 ml). The 
exact quantities of azide used depended on the degree of conversion 
required (0.1 molar equivalent to 4 fold excess). The resin was washed 
with DMF/water (50/50, 50 ml), DMF, water, ethanol, ether (50 ml 
volumes of each through two cycles) and dried under vacuum for 16 
hours.
2.2.3 Azide reduction using triflic acid to produce amine functionalised 
resin
Azidomethyl polystyrene (250 mg, ~0.5 mmol azide) was dispersed in 
dichloromethane (2.5 ml) to which was added triflic acid (350 pi, 3.95 
mmol). The reaction mixture was stirred at 0 °C for one hour. Methanol 
(2.5 ml) was added and the suspension stirred at room temperature for 
a further hour. The resin was washed with methanol/water (50/50,100 
ml), methanol/triethylamine (50/50, 100 ml) and dichloromethane (50 
ml) and then dried under vacuum at 40 °C overnight (8).
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2.2.4 Azide reduction via Staudinger reaction to produce amine 
functionalised resin
Azidomethyl polystyrene (250 mg, -0.5 mmol azide) was dispersed in 
dry THF (4 ml) to which was added triphenylphosphine (131 mg, 0.5 
mmol). The reaction mixture was stirred at room temperature for two 
hours. Approximately three equivalents of water (27 pi, 1.5 mmol) was 
added and the mixture left to stir for a further four hours before being 
filtered and washed with DMF, ethanol, ether, DMF, ether, ethanol and 
ether (10 ml of each). The resin was dried overnight at 40 °C under 
vacuum.
2.2.5 FTIR Analysis
All analysis was carried out on a Varian 3100 Excalibur FTIR (Agilent 
Technologies UK Limited, Cheshire, UK) using the Varian Resolutions 
Pro software. Samples were analysed as finely ground powders.
2.2.6 Elemental Analysis
Resin samples were sent for elemental analysis (Medac Ltd, Surrey) to 
determine carbon, hydrogen, nitrogen, sulphur and chlorine content.
2.2.7 Synthesis of benzyl diethyldithiocarbamate
The method outlined in Titirici (37) was used to produce the benzyl 
diethyldithiocarbamate iniferter species. Briefly, sodium 
diethyldithiocarbamate (4.1 g, 18 mmol) dissolved in ethanol (20 ml) 
was added to a two-neck round-bottomed flask under a nitrogen 
atmosphere at 0 °C. Benzyl chloride (2.55 g, 20 mmol) in 5 ml ethanol 
was added drop-wise over 30 minutes with stirring. The reaction 
mixture was allowed to gradually warm to room temperature and
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stirred for a further 65 hours. Sodium chloride, formed as a precipitate 
during the reaction, was filtered off and the remaining solution was 
concentrated under vacuum. The fined solution and all starting 
materials were confirmed using NMR before being used in subsequent 
polymerisation experiments.
2.2.8 Solution polymerisation studies
Solution polymerisation experiments were conducted to assess the 
efficacy of the iniferter species and to also provide further evidence of 
the successful formation of benzyl diethyldithiocarbamate. Studies 
were carried out using a 1 : 1 molar ratio of methacrylic acid to either 
benzyl diethyldithiocarbamate or benzyl chloride (Table 2.1). 
Methacrylic acid, benzyl chloride and benzyl diethyldithiocarbamate 
alone were also included as further controls. All reactions were carried 
out in HPLC autosampler vials, the mixtures purged with nitrogen for 
five minutes and then subjected to UV light (100 mw/cm2, 325 run at a 
distance of 8 inches) for ten minutes. The mixtures were observed at 0,5  
and 10 minutes and their physical characteristics recorded.
MAA BDTC BC
1 84 (il (86 m g, 1 m m ol) 240 (il (239 m g , 1 m m ol) -
2 84 (il - 115 (il (126 m g, 1 
m m ol)
3 84 (il - -
4 - - 115 (il
5 - 240 (il -
Table 2.1: Compositions of the five different mixtures used in the solution 
polymerisation studies (MAA = methacrylic acid, BDTC = benzyl 
diethyldithiocarbamate and BC = benzyl chloride).
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2.2.9 Attachment of sodium diethyl dithiocarbamate to Merrifield resin 
A  modified version of the method employed by Riickert et al. (38) was 
used in this study. Merrifield resin (1 g, -2  mmol Cl) was dispersed in 
anhydrous ethanol (5 ml) in a 20 ml polymerisation vial. A solution of 
sodium diethyldithiocarbamate (1.8 g, 8 mmol) in dry ethanol (14 ml) 
was added and the reaction mixture stirred at 60 °C for 72 hours. 
Throughout the reaction, the polymerisation vial was covered in foil to 
protect the mixture from light. The resin was filtered and washed twice 
with water (100 ml), methanol (100 ml) and ethanol (100 ml), before 
being dried under vacuum at 40 °C overnight. The resins were analysed 
by FTIR.
2.2.10 Polymerisation studies with diethyl dithiocarbamate modified 
Merrifield
The method outlined in (34) was used in this study with minor 
modifications. Briefly, iniferter-modified Merrifield resin (200 mg), 
acrylamide (280 mg) and methylene bisacrylamide (30 mg) were 
dispersed in ethanol or deionised water (4 ml). All samples were stirred 
gently (-100 rpm) whilst irradiated with UV light (100 m w/cm2, 325 
nm at a distance of 8 inches) for various periods of time. The samples 
were then filtered and washed with ethanol (5 x 20 ml), before being re­
incubated with ethanol (10 ml) and vortexed for 1 minute. The sample 
was then filtered again, washed with a further 20 ml ethanol and dried 
under vacuum at 40 °C overnight. The resins were analysed by FTIR.
2.2.11 Modification of Merrifield resin with the hydrophilic iniferter 
species, sodium N-(dithiocarboxy) sarcosine
A  hydrophilic iniferter was synthesised (39) to allow for the 
polymerisation of the resin-polymer complex under aqueous
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conditions. Sodium N-(dithiocarboxy)sarcosine was coupled to 
Merrifield resin by dispersing 836 mg (4 mmol) in 10 ml deionised 
water (or 10 ml methanol/10 ml DMF) and adding 500 mg resin (1 
mmol Cl). The mixture was stirred at 40 °C for 72 hours, then filtered 
and washed with water and ethanol before being dried under vacuum 
at 40 °C overnight, protected from light. The resins were polymerised in 
the same manner as described in section 2.2.10 and subsequently 
analysed by FTIR and elemental analysis.
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2.3 Results and Discussion.
2.3.1 Synthesis o f  az idom ethyl polystyrene
FTIR analysis confirmed the successful synthesis of the azidom ethyl 
intermediate (Figure 2.4b). Following incubation with a mole equivalent 
of sodium  azide, an azidom ethyl polystyrene intermediate was formed, 
indicated by the presence of a strong band at ~2100 cm-1 that was 
absent in the spectra of control Merrifield resin (Figure 2.4a).
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Figure 2.4: FTIR spectra fo r  a) M errifield  resin and b) the azidom ethyl po lystyren e  
in term ediate form ed fo llo w in g  reaction o f  M errifield  resin w ith  1 mole equ iva len t o f  
sodium  azide (vn=n=n ~ 2 1 0 0 cm -\ circled in red in spectrum  b)
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Further investigation demonstrated that it was possible to control the 
conversion to azide groups by varying both concentration of sodium 
azide and reaction time. The results are shown in Figures 2.5 and 2.6 
respectively. A total of thirteen different concentrations of sodium azide 
were reacted with the resin and the peak areas obtained from IR 
analysis recorded. The graph of azide concentration against peak area 
presented in Figure 2.5 suggest that a maximum conversion of 
chloromethyl groups to azide is achieved when Merrifield resin (500 
mg, 2 mmol Cl g-1) is reacted with > 2 mmol sodium azide, as 
demonstrated by attainment of a plateau in the plot. Increasing the 
molar ratio of Merrifield resin to sodium azide from 1: 4 to 1:10 has no 
effect on azide peak area. Figure 2.6 demonstrates the effect of reaction 
time on the conversion to azidomethyl polystyrene. Two concentrations 
of sodium azide (4 mmol and 0.5 mmol) were taken forward into a time 
point study to assess the rate of conversion of chloro groups to azide. 
Both concentrations display the same time dependency, suggesting 
completion of the reaction within 6 hours regardless of concentration of 
sodium azide used. The plateau obtained for the reaction of 0.5 mmol 
sodium azide with Merrifield resin (1 mmol Cl) is obviously lower them 
that observed with 4 mmol azide (maximum conversion) as the reaction 
is also limited by the concentration of sodium azide available to react 
with.
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Figure 2.5: A zide  peak area obtained from  IR analysis o f  M errifield resin fo llow in g  
reaction w ith  vary in g  concentrations o f  sodium  azide (N aN 3). In all cases 
concentration o f  resin w as equ ivalen t to 1 m m ol chlorine while the concentration o f  
azide ranged from  0.1 m m ol to 10 m m ol. Spectra (top) show the azide stretch  at 2100  
cm-7 fo r  resin reacted w ith  a) 0 m m ol N a N 3, b) O .lm m ol N a N 3, c) 0.5 m m ol N aN san d  
d) lm m o l N a N 3 . Spectra are offset fo r  clarity.
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Figure 2.6: Conversion to azide as a fu n ction  o f  both tim e and concentration. Two  
concentrations w ere in vestiga ted  (1 m m ol resin to 0 .5 m m ol and 4 m m ol sodium  
azide) a t eight tim e po in ts over 24 hours. Spectra (top) show azide stretch  fo r  resin  
reacted w ith  4 m m ol N a N sfo r  a) 0 m ins, b) 10 m ins, c) 30  m ins, d) 120 m ins, e) 360  
m ins a n d f)  24 hours. Spectra are offset fo r  clarity.
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2.3.2 A zide  reduction using triflic acid to produce amine functionalised  
resin
The addition of triflic acid to azidom ethyl polystyrene successfully  
produced amine-modified resin as demonstrated by the spectra show n  
in Figure 2.7. Loss of the azide stretch w as observed and new  
vibrational bands appeared in the region of 3300-3500 cm4, indicative 
of amine functionality (v n - h  ~3400 cm-1).
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Figure 2.7: FTIR spectra dem on stra tin g  the reduction o f  azide to am ine u sin g  triflic  
acid. The azide peak is clearly visib le  a t ~ 2100  cm-1 in spectrum  a (resin produced via  
the reaction w ith  an excess o f  sodium  azide). Following reaction w ith  triflic acid, the 
azide is converted to an am ine, dem onstra ted  by the loss o f  the azide stretch  (dashed  
circle in spectrum  b) and the appearance o f  a vibrational nodes a t -3 4 0 0  cm-1 (N -H  
stretch), ~2600 cm-1 (N -H  bend) (circled in spectrum  b).
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A study was undertaken to assess the effect of triflic acid on the 
chlorine groups that had not been converted to azide. In order to 
successfully produce bifunctionalised resin it w as imperative that the 
reaction conditions involved in creating the amine groups did not effect 
the remaining chloro functionality. These groups must be unm odified  
to allow for the attachment of the iniferter group. To investigate this, 
untreated Merrifield resin w as subjected to the triflic acid reduction  
step and then subsequently treated with an excess of sodium  azide. If 
the chlorine groups were unaffected by the triflic acid reaction, then the 
addition of azide w ould  lead to the formation of azidom ethyl 
polystyrene. The IR spectrum given  in Figure 2.8 clearly demonstrates 
that following treatment w ith triflic acid, reaction of Merrifield resin 
w ith sodium  azide does not give rise to the characteristic azide signal at 
2100 cm-1 thus suggesting loss of chloro functionality.
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Figure 2.8: FTIR analysis o f  the resin clearly dem onstrates the detrim en ta l effect that 
triflic acid has on the unm odified chlorine groups. The main spectrum  show s that 
fo llo w in g  trea tm ent w ith  triflic acid and su bsequ en t incubation w ith  a ten-fold excess 
o f  sodium  azide, no azide peak is v isib le  (dashed circle, main spectrum ). The in set 
spectra is M errifield  resin that has been reacted w ith  an excess o f  sodium  azide, the 
azide stretch  is visib le  a t ~2100cm  A, circled.
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Elemental analysis further confirmed the loss of chlorine functionality 
following reaction with triflic acid; resin treated with triflic acid showed 
a significant decrease in chlorine content (from 7.6 % in the Merrifield 
resin control to 0.21 %) while the carbon content of the resin increased 
from -84.0 % to -91 % (Table 2.2).
MR 
% (mmol/g)
TfOH MR 
% (mmol/g)
c 84.09 (70.08) 91.03 (75.86)
H 7.26 (72.60) 7.50 (75.00)
N <0.10 (<0.07) 0.30 (0.21)
Cl 7.68 (2.19) 0.21 (0.06)
Table 2.2: Elemental analysis o f untreated M errifield resin (MR) and triflic acid 
treated resin (TfOH M R). Values are expressed as both percentage composition and as
mmol/g of resin
A possible explanation for the loss of chlorine functionality following 
incubation of the resin with triflic acid is the formation of a benzyl 
methyl ether species via a benzyl triflate intermediate (Figure 2.9). The 
resin, when suspended in dichloromethane, is a creamy yellow colour 
that turns dark red on the addition of triflic acid. This colour is reversed 
when methanol is added suggesting the formation of two species.
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Figure 2.9: The proposed formation of a benzyl methyl ether species, via a triflate 
intermediate, that is hypothesised to form when Merrifield resin is exposed to triflic
acid.
2.3.3 Azide reduction via Staudinger reaction to produce amine 
functionalised resin
As a consequence of the results obtained from the triflic acid studies i.e. 
the loss of viable chlorine groups following triflic acid treatment, an 
alternative method for the conversion of azide to amine was needed. 
The Staudinger reaction is reported to be the mildest method for the 
production of amines from azide groups (9) involving only reaction 
with triphenylphosphine using tetrahydrofuran and water. 
Experiments were undertaken to assess the efficiency of this reaction to 
convert azidomethyl polystyrene to amine functionalised resin and to 
determine its effect on any remaining, unmodified chlorine groups. 
Figure 2.10 shows that the Staudinger reaction was able to successfully 
reduce the azide groups to amines; the azide stretch at -2100 cm*1 
present in spectrum (a) is absent following reduction with 
triphenylphosphine and vibrational nodes indicative of amine 
functionality are apparent at -  3400 cm*1 and 1600 cm*1.
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Figure 2.10: Conversion o f  azide grou ps to am ines via  the Staudinger reaction. The 
azide peak is clearly visib le in the resin prior to S taudinger treatm ent a t -2 1 0 0  cm -1 
(circled in spectra (a)). Following reaction w ith  triphenylphosphine the azide is 
converted  to an amine, dem onstra ted  by the loss o f  the azide stretch (dashed circle 
spectru m  b) and the appearance o f  a vibra tion al nodes at -3 4 0 0  cm-1 (N -H  stretch), 
~2600 cm-1 (N -H  bend) (circled in spectra b) (b).
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Studies were undertaken to determine the effect of the Staudinger 
reaction on unm odified chloro groups. Unm odified resin w as subjected 
to the Staudinger reaction conditions and then incubated w ith sodium  
azide. N ot only did the Staudinger reaction not have an effect on the 
chloro functionality of the resin, concentration studies show  that the 
conversion to azide w as still concentration dependent. FTIR spectra of 
resin reacted w ith 0.2 mmol and 0.6 mmol sodium azide are given in 
Figure 2.11 as examples. The area of the peak between the spectra 
increases approximately three-fold. These peak areas are in line with  
those obtained for similar concentrations of sodium azide reacted with  
Merrifield resin unexposed to the Staudinger conditions.
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Figure 2.11: FTIR spectra o f M errifield  resin which has undergone the S taudinger  
reaction and then su bsequ en tly been reacted w ith  0.2 mmol (a) and 0.6 m m ol (b) 
sodium  azide. The azide peak area (circled in spectra) is seen to be concentration  
dependent, su ggestin g  no detrim ental effect on chloro fu n ctio n a lity  by the reaction
conditions.
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Again elemental analysis was used to confirm these observations (Table 
2.3). No significant change in chlorine content was observed following 
incubation of the resin under the conditions used in the Staudinger 
reaction. Additionally, elemental analysis was used to provide further 
evidence for the synthesis of a bifunctionalised resin and amino- 
polystyrene (Bifunc'MR and MR-NH2 in Table 2.3 respectively). 
Nitrogen content in MR-NH2 was attributed to the amine functionality 
since the presence of residual azide functionality was ruled out by the 
absence of the characteristic vibrational band at 2100 cm*1.
MR 
% (mmoj/g)
PPh3 MR 
% (mmol/g)
Bifunc' MR 
% (mmol/g)
MR-NHi 
% (mmol/g)
c 84.09 (70.08) 84.36 (70.30) 83.39 (69.49) 85.52 (71.27)
H 7.26 (72.60) 7.16 (71.6) 7.73 (77.30) 7.37 (73.70)
N <0.10 (<0.07) 0.24 (0.17) 2.09 (1.49) 3.03 (2.16)
Cl 7.68 (2.19) 7.08 (2.02) 3.00 (0.86) 0.09 (0.03)
Table 2.3: Elemental analysis o f untreated Merrifield resin (MR), resin that has been 
subjected to the conditions used in the Staudinger reaction (PPh3 M R), resin 
displaying both chloro and amine functionality (Bifunc' M R) and amino-modified 
Merrifield (M R-NH 2). Values are expressed as both percentage composition and as
mmol/g o f resin.
2.3.4 Synthesis of benzyl diethyldithiocarbamate 
The reaction between benzyl chloride and sodium 
diethyldithiocarbamate, outlined in Figure 2.3 and in section 2.2.7, 
succesfully produced the benzyl diethyldithiocarbamate iniferter 
species and was confirmed by NMR. PH NMR (500MHz, Toluene-d8) 8 
7.10-7.00 (5H, m), 4.6 (2H, s), 3.5 (4H, m), 1.10 (6H, t)].
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2.3.5 Solution po lym erisa tion  studies
Solution polym erisation studies were carried out as described in section  
2.2.8. Figures 2.12 - 2.14 show  the polymerisation process at three time 
points; 0, 5 and 10 minutes. Prior to polymerisation all sam ples were  
liquid. The methacrylic acid /benzyl dithiocarbmate (M AA/BDTC) 
solution had polym erised by 5 minutes, the methacrylic acid /benzyl 
chloride (M AA/BC) mixture had thickened while all controls remained  
liquid. At 10 m inutes, the M A A /B C  mix had completely polym erised  
w hilst the other controls rem ained liquid.
Figure 2.12: A ll sam ples are liqu id  p rio r to irradiation  w ith  U V  light. (M A A /B D T C  : 
m ethacrylic acid /ben zyl d ie thyldith iocarbam ate m ix ture , M A A /B C  : m ethacrylic  
acid /ben zy l chloride m ix ture , AAAA : m ethacrylic acid, BC : benzyl chloride and  
B D T C : b en zy l d iethyldith iocarbam ate).
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Figure 2.13: F ollow ing 5 m in u tes U V  irradiation  the M A A /B D T C  m ixture had 
po lym erised  (solid), the M A A /B C  m ix tu re  had thickened, w h ils t the M A A , BC and
B D T C  con trols rem ained liqu id.
Figure 2.14: F ollow ing 10 m in u tes U V  irradiation  the M A A /B C  m ix tu re  had 
po lym erised  (solid) w h ils t the M A A , BC and B D T C  controls rem ained liquid.
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It was probable that the polymerisation observed with the MAA/BC 
mixture was due to the formation of a benzyl radical upon irradiation 
with UV light and is discussed in more depth later (section 2.3.7) The 
process was however slower than when the iniferter species, BDTC, 
was used.
2.3.6 Coupling of the iniferter to Merrifield
Rtickert et al. (38) used approximately 6 mmol iniferter to 10 mmol resin 
(expressed as chlorine concentration) and heated the reaction mixture at 
60 °C for 50 hours. Elemental analysis of the product suggested that this 
resulted in only 0.1 mmol dithiocarbamate groups per gram of resin., 
however a time study included in the same work suggested that much 
higher conversions were possible. For the purposes of this study, a 
four-fold excess of iniferter was used and the reaction mixture was 
stirred at 60 °C for 72 hours to encourage maximal coupling of iniferter 
to resin. Figure 2.15 shows the IR spectra for untreated Merrifield resin 
and Merrifield resin to which the iniferter species has been coupled. 
Stretches in the region of 1275 - 1030cm*1 are indicative of the 
thiocarbonyl group, C=S of the iniferter species.
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Figure 2.15: FTIR spectra o f  u n trea ted  M errifield  resin (green) and in iferter coupled  
resin (red). Stretches in the region o f  1275-1030  cm -1 (dashed circle) are in dica tive o f  
the thiocarbonyl grou p  (C =S) o f  the in iferter species, the stretch observed a t -1 2 1 0  
cm-'1 (solid circle) is a ttr ibu tab le to the C -N  bond. Spectra are offset fo r  clarity .
S a m p les w ere  a g a in  sen t for e lem en ta l a n a ly sis  to con firm  th e  
attach m en t o f th e  in iferter g ro u p  to th e  su rface o f the resin  an d  to  
d eterm in e  d eg ree  o f fu n ctio n a lity . T he resu lts , ex p ressed  as p ercen ta g e  
c o m p o sitio n  and m m o l/g  o f  resin , are p resen ted  in Table 2.4 an d  
su g g e s t  that a p p ro x im a te ly  1 m m o l o f in iferter w a s  im m o b ilised  per  
gram  o f M errifie ld  resin . T his is  in  g o o d  a g reem en t w ith  Q in  e t  al. w h o  
report 1.70 % n itro g en  co n ten t fo llo w in g  a 48 hour reaction  b e tw e en  
M errifie ld  resin  and  so d iu m  d ie th y l d ith iocarb am ate u n d er th e  sa m e  
co n d it io n s  (34).
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MR 
% (mmol/g)
MR-I 
% (mmol/g)
c 84.65 (70.54) 80.50 (67.08)
H 7.13 (71.30) 7.34 (73.40)
N <0.10 (<0.07) 1.94 (1.39)
S <0.10 (<0.03) 5.88 (0.92)
Cl 7.73 (2.21) NA
Table 2.4: Elemental analysis o f unmodified Merrifield resin (MR) and iniferter 
derivitised resin (MR-I). Values are expressed as both percentage composition and 
mmol/g o f resin. N A  =  not analysed.
2.3.7 Polymerisation experiments with iniferter coupled Merrifield resin 
Concurrently, preliminary experiments were being performed in our 
laboratory using the phage-display derived peptide TR401 that displays 
high affinity (Kd 0.27nM) for the fluorescent probe Texas Red (40). 
Stability studies and binding assays suggested that the peptide was 
stable and capable of recognising its target in both aqueous and 
ethanolic solutions (41). Using the method outlined in Qin et al (34), 
polymerisation studies using iniferter-modified resin were undertaken. 
Initial experiments employed water as a solvent however due to poor 
dispersibility, the aggregation of the resin during polymerisation was 
problematic. Ethanol was therefore used in subsequent studies. 
Samples were polymerised for various periods of time and 
subsequently analysed by FTIR.
The spectra shown in Figures 2.16 - 2.18 clearly demonstrated the effect 
of polymerisation time on the growth of polymer from the surface of 
the resin. Following 15 minutes irradiation there was little evidence of
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polym erisation (conferred from the lack of a carbonyl stretch at ~1675 
cm 4 from acrylam ide/m ethylene bisacrylamide); all three spectra were 
virtually identical (Figure 2.16). When the polymerisation time w as 
increased to one hour (Figure 2.17), a carbonyl peak was observed in 
the acrylamide and acrylam ide/m ethylene bisacrylamide sam ples but 
not in the control resin spectra suggesting polymer growth on the 
surface of the resin.
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Figure 2.16: FTIR analysis o f  in iferter-m odified resin fo llow in g  15 m ins U V  
irradiation  in an ethanolic acrylam ide (green) and acrylam ide/m ethylene  
bisacrylam ide (red) solution. There w as no evidence o f  polym erisation  (on the basis o f  
the absence o f  a carbonyl stretch  a t ~ 1675  cm-1); the spectra were the sam e as the 
control resin (iniferter-m odified resin, no m onom er/cross-linker, black). The 
characteristic thiocarbonyl stretch  o f  the in iferter species (~1030 cm-1) w as p resen t in
all three spectra (circled).
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Figure 2.17: P olym erisation  o f  in iferter d er iv itised  M errifield  resin w ith  acrylam ide  
(green) and acrylam ide/m eth ylen e b isacrylam ide m ix tu re  (red) in ethanol after one 
hour. P olym erisation  appeared to be m ore s ign ifican t, based on relative carbonyl peak 
areas (*), when the m ix tu re  w as used. In both p o lym er sam ples, the thiocarbonyl 
stretch  o f  the in iferter species a t ~2030 cm A (circled) rem ains su ggestin g  successful 
endcapping o f  the p o lym er w ith  the d ith iocarbam yl radical (Black line : spectra  
obtained fo r  the con trol in iferter-m odified resin i.e resin irradiated in ethanol bu t in
the absence o f  m onom er).
The use of the m onom er com bination (acrylamide /  m ethylene 
bisacrylamide) appeared to result in a greater carbonyl peak area being 
observed on the FTIR spectrum compared to the spectrum of 
acrylamide alone. Considering the molar ratio of acrylamide : 
m ethylene bisacrylamide used in this study (ca. 20 : 1), the increase in 
carbonyl peak area observed betw een the two sam ples appears 
som ewhat disproportionate. A ssum ing an equal molar ratio, a possible 
explanation for the increase observed w ould be the increased rate of 
reactivity of m ethylene bisacrylamide compared to acrylamide; 
m ethylene bisacrylamide is likely to be incorporated at tw ice the rate of
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acrylamide due to the presence of two polymerisable groups. 
Additionally, since methylene bisacrylamide contains two carbonyl 
groups it would have a greater contribution (peak area) to the IR signal 
observed at -  1675 cm'1 than acrylamide would. Therefore, on this basis 
and assuming equimolar incorporation in to the polymer, a four-fold 
increase may be envisaged. In this study however, this is complicated 
by the fact that the starting molar ratio of acrylamide to methylene 
bisacrylamide is approximately 20 : 1 and therefore one would expect 
the signal from the acrylamide carbonyl to be of more significance. This 
is not what was observed in Figure 2.17. The data suggests that the 
reactivity of the methylene bisacrylamide acrylamide groups is greater 
than that of acrylamide alone and therefore methylene bisacrylamide 
became incorporated into the polymer preferentially during the early 
stages of the polymerisation process. Following 24 hours the difference 
in carbonyl area is minimal (Figure 2.18) suggesting that whilst 
methylene bisacrylamide polymerisation predominates early in the 
reaction the large molar excess of acrylamide results in acrylamide rich 
polymer growth later in the process.
Importantly, the thiocarbonyl stretches (~1030cm'1) were still apparent 
in the spectrum of resin polymerised for one hour suggesting successful 
endcapping of the polymer chains with the stable dithiocarbamyl 
species (Figure 2.17). On increasing the polymerisation period to 24 
hours, FTIR analysis suggested significant growth of polymer on the 
surface of the resin (Figure 2.18), however there is no evidence of a 
dithiocarbamyl end group on the spectrum (loss of characteristic signal 
at -1030 cm'1). Chain transfer with solvent molecules or dimerization of 
the dithiocarbamyl species may have occurred leading to loss of the 
dithiocarbamyl radical during the washing and filtration process. 
Alternatively there is evidence to suggest that dithiocarbamate iniferter 
species can decompose via the loss of carbon disulphide to generate an
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aminyl radical (42). If this radical species is formed and is capable of 
end-capping the polym er chains, a thiocarbonyl stretch w ould  be 
absent from the spectra.
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Figure 2.18: FTIR spectra o f  in iferter coupled M errifield  fo llo w in g  dispersion in an 
ethanolic so lu tion  o f  acrylam ide (green) and acrylam ide/m ethylene bisacrylam ide  
m ixture (red) and irradiation  by U V  ligh t fo r  24  hours. The large peak seen a t -1 6 5 0  
cm-1 (*1) is in d ica tive o f  the carbonyl grou p o f  the m onom er w hile the stretch  observed  
at 3 4 0 0 -3 2 0 0  cm-1 (*2) represents the am ide grou ps. The th iocarbonyl stretch  o f  the 
in iferter (~ 1030 cm-1) is absent fro m  both spectra.
Surprisingly, there w as no discernible difference follow ing  
polym erisation between the iniferter coupled resin and the control resin  
sam ple (unmodified Merrifield, Figure 2.19) used in the study. Benzyl 
chloride is known to form radicals upon exposure to UV radiation (43). 
Unlike the iniferter species, there is no stable radical species formed 
follow ing photoolytic cleavage of the carbon-chlorine bond and 
therefore polym erisation proceeds in an uncontrolled fashion. 
Following 24 hours UV irradiation, significant solution phase
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polym erisation w as also evident and the resin had aggregated to form a 
disc-like structure on the surface of the solvent.
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Figure 2.19: FTIR spectra  o f  M errifie ld  resin con tro l (green) and in iferter deriv itised  
resin (red) fo llo w in g  dispersion in an ethanolic so lu tion  o f  acrylam ide and m ethylene  
bisacrylam ide and irradiation by  U V  ligh t fo r  24  hours. There is no discern ible  
difference betw een  the tw o  spectra.
The control resin was also polym erised for 1 hour and compared to the 
iniferter m odified species. The spectra demonstrated that even w hen  
the polym erisation period w as reduced, the control resin continued to 
initiate polymerisation. In fact, Figure 2.20 suggested that the control 
resin m ay be more efficient at initiating the process than the iniferter, as 
the carbonyl and am ide stretches observed were more significant.
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Figure 2.20: IR spectra  o f  in iferter coupled (red) and un-m odified M errifield  resin  
(green) fo llo w in g  po lym erisa tion  o f  an ethanolic so lu tion  o f  acrylam ide and m ethylene  
bisacrylam ide fo r  one hour. The spectra show  that a grea ter degree o f  po lym erisa tion  
w as s till observed w ith  the M errifield  control com pared to the in iferter-coupled resin  
even when the po lym erisa tion  tim e w as reduced. Iniferter coupled M errifield  that had  
n ot been po lym erised  is show n on the spectra  in black. The thiocarbonyl stretch  at 
~ 1030  cm -1 is p resen t in the spectra o f  the in iferter coupled resin pre- and p o st­
po lym erisa tion  (red and black) bu t is absent from  the control po lym erised  resin
(green).
Am ine functionalised resin w as investigated as a further control. 
Am ino-polystyrene w as irradiated w ith UV in the presence of 
acrylamide and m ethylene bisacrylamide (Figure 2.21). The FTIR 
spectrum show s no signs of polym erisation, therefore suggesting that 
the amine functionalisation successfully inhibited the formation of an 
active benzyl radical species
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Figure 2.21: IR spectrum o f amine functionalised M errifield resin following dispersion 
in an ethanolic solution o f acrylamide and methylene bisacrylamide and irradiation by 
U V  light for 24 hours. Stretches in the region 3400 - 3200 cm-1 and at ~1600 cm-1 are 
attributable to the amine functionality o f the resin.
The advantage of using an iniferter species, rather than just allowing 
the resin itself to initiate polymerisation, is the degree of control over 
polymer growth that can be attained. The presence of the less reactive 
radical species in solution following cleavage of benzyl 
diethyldithiocarbamate minimises solution phase polymerisation; the 
chloride radical produced when non-derivatised resin is used is much 
less stable than the diethyldithiocarbamate radical and therefore more 
reactive, leading to polymerisation of the monomer solution. This was 
evident when the resins were examined by microscopy (Figure 2.22). 
All iniferter derivitised resin remained as individual spheres following 
polymerisation, whilst the control resin had become aggregated due to 
the uncontrolled nature of the polymerisation. There was also evidence 
of solution phase polymerisation; small, irregular, polymer particles 
were observed.
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Figure 2.22: Ejjifluorescence m icroscopy im ages o fin ife rte r  deriv itised  M errifield  
resin pre- (a) and post-po lym erisa tion  (b). F ollow ing po lym erisa tion  o f  the control 
resin the po lystyren e  spheres had aggregated (c) and there w as evidence o f  solution  
phase po lym erisa tion . (Scale bar = 15pm )
The aim of these studies w as to better understand how  iniferter 
initiated polymer growth might be utilised to bring about 
polym erisation around the co-im m obilised peptide-template com plex  
to give rise to our hypothesised synthetic receptor (Figure 1.7). A key  
consideration was therefore being able to control the depth of polymer 
growth so as not to hinder ligand access to the receptor. Data from  
w ithin our laboratory (39) has show n that by varying irradiation times, 
polym er growth from iniferter m odified silicon wafers can be tightly 
controlled. Using atomic force microscopy a gradual increase in 
polymer height, to a m axim um  of -3 0  nm, over 60 m inutes w as 
observed. The polymer layer w as show n to be hom ogenous over an 
area of 3 pm2.
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Since bifunctionalisation of the resin, to allow independent 
immobilisation of both peptide and iniferter, would give rise to a lower 
number of polymer initiation sites than had been present in earlier 
studies, experiments to confirm that the bifunctional resin would 
support polymer growth were also conducted. Bifunctionalised resin 
(azido- and chloromethyl) was produced and the iniferter moiety 
attached. The conversion of chloromethyl groups to amine was 
interrupted at the azide intermediate to allow for clear visualisation of 
the bifunctionalisation. Following polymerisation, FTIR was again used 
to confirm the presence of both polymer and azide on the surface of the 
resin (Figure 2.23). Small stretches at ~1650 cm'1 and 3200 - 3400 cm-1 are 
indicative of the presence of carbonyl and amide groups (i.e. polymer) 
and the distinctive azide signal at 2100 cm*1 demonstrated the 
bifunctionalisation.
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Figure 2.23; FTIR spectra of iniferter coupled bifunctionalised Merrifield resin 
following polymerisation of an ethanolic solution ofacrylamide and methylene 
bisacrylamide for one hour. The azide peak is evident at -2100  cm-1 indicative of  
bifunctionalisation, while the stretches at ~1600 cm^and 3200-3400 cm-1 demonstrate 
successful polymerisation o f the sample.
For the strategy outlined in Chapter One to be successful it was 
imperative that the polymer did not interefere with the binding of the 
peptide to its target and therefore the choice of monomer was of 
paramount importance. Lipopolysaccharide (LPS) interacts via 
electrostatic and hydrophobic interactions with polymyxin B, the 
peptide species employed in this study (Chapter Three). At 
physiological pH, LPS is anionic by virtue of unique sugar residues and 
a degree of phosphorylation, therefore to reduce repulsion between the 
polymer surface and the target, monomers negatively charged at neural 
pH were disregarded. Furthermore, it was anticipated that such 
monomers might also interfere with the binding of LPS to polymyxin B, 
which carries a +5 charge at physiological pH, through direct 
interaction with the peptide. It was anticipated however that such
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interactions would be minimised through the introduction of LPS to the 
system prior to the addition of the monomers. Conversely, basic 
monomers would possess positive charges at neutral pH and although 
this may increase interaction between LPS and the polymer, it is likely 
to do so in a non-specific fashion. Cationic monomers would also be 
less likely to form a protective polymeric "shell" around the peptide 
species due to electrostatic repulsion.
The choice of solvent is also important. In traditional imprinting 
systems organic solvents are often used; these conditions are not 
conducive to working with biological molecules. Lipopolysaccharide, 
due to its amphiphilic nature, forms micelles above certain 
concentrations (critical micelle concentration, CMC) in almost all 
solvent systems, however below the critical micelle concentration for a 
particular LPS species, homogenous aqueous solutions can be achieved. 
The monomers chosen must therefore be soluble in water. Based on 
these criteria and the earlier supporting data, it was decided that 
acrylamide and N,N-methylene bisacrylamide would be retained as the 
monomer combination.
As the work progressed it became obvious that the iniferter system that 
was effective in ethanol was less effective when water was used as the 
solvent. The resin dispersed very poorly in water and even with stirring 
a homogenous dispersion could not be achieved. FTIR analysis of resins 
showed little evidence of polymerisation when water was used as a 
solvent, even with prolonged periods of UV irradiation.
The hydrophobic nature of the dithiocarbamyl radical means that is 
likely to be poorly soluble in water. It is probable that this would have 
disfavoured initiator dissociation and retarded the polymerisation 
process when water was used as the solvent. Additionally, due to the 
non-swollen nature of Merrifield resin in water, the relative densities of
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iniferter groups available to initiate polymerisation would likely have 
been significantly reduced. Insufficient deoxygenation of the system 
prior to polymerisation could also favour termination of 
polymerisation, however all water used was thoroughly degassed and 
sparged with nitrogen before use and each sample sparged with 
nitrogen for a second time prior to irradiation. These observations lead 
to the conclusion that a more hydrophilic iniferter species should be 
investigated.
2.3.8 Polymerisation experiments w ith dithiocarboxysarcosine coupled 
Merrifield resin
Matsuda and colleagues have previously used sodium N- 
(dithiocarboxy)sarcosine to successfully initiate the polymerisation of 
N,N-dimethylacrylamide and N-isopropylacrylamide in phosphate- 
buffered saline (44). One of the ethyl arms of sodium 
diethyldithiocarbamate is modified with a carboxylic acid group to 
increase the hydrophilicity of the less reactive radical species, thus 
encouraging polymerisation under aqueous conditions.
Sodium N-dithiocarboxysarcosine was synthesised from sarcosine and 
carbon disulfide (Figure 2.24) (39). The dithiocarboxysarcosine 
derivatised resin was prepared as described in section 2.2.11 and 
subsequently polymerised using the same combination of monomers as 
for the previous iniferter coupled resins (section 2.2.10). The FTIR 
spectra obtained are presented in Figure 2.25.
o s
NaOH
EtOH
O
Figure 2.24: Synthesis o f sodium N-dithiocarboxysarcosine
88
Chapter Two: M errifield Studies
100
0Oc
2
'E
80-
<n c
2h- 60-
40-
3600 3000 2400 1800 1200 600
Wavenumber (cm"1)
100
0oc0
'E0
C
80-
2
H
vO
60-
40-
6003600 3000 2400 1800 1200
Wavenumber (cm*1)
Figure 2.25: Spectra  o f  the po lym erisa tion  o f  d ith iocarboxysarcosin e deriva tised  resin  
(a, red line) an d  unm odified  M errifie ld  resin (b, red line) both overlaid w ith  the 
spectra fo r  d ith iocarboxysarcosin e d er iv itise d  M errifie ld  resin before p rio r  to
po lym erisa tio n  (green).
The spectra for the w ater-soluble iniferter derivatised resin, pre­
polym erisation (green in Figure 2.25), failed to show  any discernible 
differences from the spectra obtained for control resin; the characteristic 
thiocarbonyl group from the iniferter was absent. Sam ples w ere sent for 
elem ental analysis how ever the sulphur content of the iniferter 
functionalised resin before polym erisation w as below  lim its of
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detection (<0.1 %). The apparent lack of an iniferter species is most 
likely due to the conditions employed in the attachment of the iniferter 
species. Water was used as a solvent for the reaction due to the high 
water solubility of N-dithiocarboxysarcosine, however Merrifield resin 
is hydrophobic and therefore under these conditions would have 
existed in a non-swollen/compacted form. This would mean that only 
the chloromethyl groups exposed on the very outer surface of the resin 
would be available for reaction with the iniferter species. N- 
dithiocarboxysarcosine is also soluble in methanol, however Merrifield 
resin swells relatively poorly in this solvent compared to aprotic 
solvents (1.8 m l/g in methanol compared to ~1 m l/g in water and >3.5 
m l/g in solvents such as dichloromethane, dimethylformamide and 
tetrahydrofuran (45,46)). The attachment was therefore repeated in a 
50 : 50 mix of methanol and DMF and the samples sent for elemental 
analysis and analysed by FTIR. The spectra obtained (Figure 2.26) 
demonstrates the successful attachment of the iniferter species; the 
thiocarbonyl stretch can be observed at ~1030 cm-1 (as is the case with 
diethyl dithiocarbamate) and a carbonyl peak is present at ~1650 cm-1. 
Elemental analysis of the resin prepared under these reaction 
conditions suggest ~ 1.4 mmol of iniferter groups per gram of resin 
which is similar to values obtained with the diethyl dithiocarbamate 
iniferter species (Table 2.4).
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Figure 2.26: FTIR spectra o f dithiocarboxysarcosine modified resin following  
attachment in DM F/M eOH  50/50 mix. A  carbonyl peak at ~ 1650 cm-1 and a 
thiocarbonyl stretch at ~  1030 c m 1 suggested successful immobilisation o f the
iniferter species.
Although this confirmed the attachment of the iniferter moiety, it does 
not necessarily represent the groups available for initiation of 
polymerisation. Due to the physicochemical properties of LPS, the 
polymerisation of the resin must take place in water. Under such 
conditions, Merrifield resin will exist in a non-swollen form and 
therefore the majority of iniferter groups will be trapped within the 
resin, unable to participate in the polymerisation reaction. It is therefore 
envisaged that only those iniferter groups on the outer surface of the 
resin will be capable of initiating polymerisation. The modification 
however does make the resin significantly more hydrophilic and this 
may influence its ability to swell in aqueous solvents.
The spectra in Figure 2.25 suggested however, that a greater degree of 
polymerisation was observed with the dithiocarboxysarcosine 
derivitised resin compared to the control Merrifield under aqueous
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conditions. Additional time points were investigated and sam ples were 
analysed by FTIR and sent for elemental analysis to try and distinguish  
between the polym erisation observed with the two resins (i.e. iniferter 
m odified and control, unm odified Merrifield resin). Elemental analysis 
demonstrated clear differences between the polymerisation of iniferter 
m odified and control Merrifield resin, with the iniferter resin 
possessing 5.42% nitrogen follow ing three hours polymerisation  
compared to 2.48% in the control resin. The FTIR spectra for these 
samples are given in Figure 2.28. These results suggested that 
dithiocarboxysarcosine had been successfully attached to the resin 
under aqueous conditions, how ever the analytical techniques used in 
this study were not capable of detecting such low  densities of the 
iniferter species.
100-1
50*i-----------------1-----------------1-----------------1—
4000 3000 2000 1000
Wavenumber (cm-1)
Figure 2.27: FTIR spectra of M errifield control (green) and dithiocarboxysarcosine 
modified resin (red) follow ing  3 hours polymerisation in an aqueous 
acrylamide/methylene bisacrylamide mixture. Both carbonyl and amide stretches are 
more significant in the iniferter modified resin, suggesting a greater degree of
polymerisation.
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2.4 Conclusion
The results outlined in this chapter have shown that it is possible to 
produce bifunctionalised resin i.e. resin displaying pre-defined molar 
ratios of chloromethyl and amino groups on its surface, via the 
generation of azidomethyl polystyrene and the subsequent reduction to 
amine using the Staudinger reaction. This will allow for the attachment 
of both the peptide moiety and the iniferter species. Two different 
dithiocarbamate-type iniferters have been immobilised on the surface of 
the resin and polymerisation successfully initiated under a variety of 
conditions. Chapter three will utilise the bifunctional resins developed 
herein to immobilise a peptide moiety and to provide proof-of-principle 
of the peptide-polymer hybrid system described in Chapter one.
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3.1 Introduction
3.1.1 General Overview
Every year millions of people contract infections of bacterial, viral 
and/or fungal origin. The large majority of these will either be self- 
limiting requiring no pharmacological intervention or can be efficiently 
treated by empirical antimicrobial therapies. In recent years however, 
the incidence of multi-drug resistant infections, particularly nosocomial 
infections, has increased significantly. In 2004, the Infectious Diseases 
Society of America (IDSA) published a report that served to highlight 
the disparity between the dwindling number of new antimicrobial 
therapies and the increasing occurrence of bacteria resistant to multiple 
antibiotic classes (1). In the preceding seven years little has changed and 
the situation seems unlikely to improve in the near future. Despite 
multidrug resistant gram-positive bacterial infections such as MRSA 
being highlighted as a public health crisis, very little attention has been 
paid to the Gram-negative organisms that are rapidly developing 
resistance. As a consequence, for a growing number of Gram-negative 
infections there are no effective antimicrobial interventions currently 
available or in the advanced stages of clinical development (1,2). 
Antibiotics previously abandoned due to safety concerns are now being 
considered for those infections refractive to current treatment strategies 
(3,4).
The polymyxins are a family of cyclic polypeptides derived from the 
spore-forming soil-borne rod Bacillus Polymyxa. First discovered in the 
1940's, the polymyxins consist of five structurally related decapeptides 
two of which, Polymyxin B and E (colistin), found extensive clinical use 
against infections of Gram-negative origin until the 1970's. Reported 
neuro and nephrotoxicity associated with their use saw them cast aside 
in favour of newer, less toxic antibiotics (5,6). However, the occurrence
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of isolates of Escherichia coli, Pseudomonas spp., Klebsiella spp., 
Acinetobacter spp. and other Gram-negative pathogens displaying 
resistance to p-lactam antibiotics, aminoglycosides and 
fluoroquinolones, has initiated a resurgence in interest (4,5,7,8).
3.1.2 Structure
All members of the polymyxin family share a related pharmacophore 
consisting of a cyclic heptapeptide region and a linear tripeptide section 
to which a fatty acyl chain is attached. The general structure of 
polymyxin B is shown in Figure 3.1.
NH
HO. HN.
HNOO
HN HN
HO'
-  D-Phe -  L-Leu
Figure 3.1: General chemical structure of polymyxin B. The cyclic decapeptide 
consists of six L-2,4-diaminobutyric acid residues (L-Dab), two threonine (L-Thr), one 
phenylalanine (D-Phe) and one leucine (L-Leu) residue attached to a 6-methyloctonic
acid acyl chain.
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Like most antimicrobial peptides, the polymyxins are amphipathic 
molecules, possessing distinct hydrophilic and hydrophobic domains. 
The presence of six L-diaminobutyric acid residues, five of which 
display free Y-NH2 groups, give the molecule an overall positive charge 
and contributes to the hydrophilicity, while the acyl chain and the 
phenylalanine and leucine residues represent the hydrophobic region 
of the peptide (2).
Commercial polymyxin B sulfate is a mixture of several structurally 
related components and studies have sought to chemically separate and 
identify the individual molecular species (9,10). In total seven 
compounds have been isolated, all possessing the same amino acid 
structure, with the exception of Ile-polymyxin B1 that has isoleucine as 
the seventh residue. The length and degree of substitution of each of the 
acyl chains varies; Polymyxin B1 and B2 that constitute the majority of 
the mixture, have 6-methyloctanoic acid and 6-methylheptanoic acid as 
their acyl chains respectively. Another member of the polymyxin 
family, polymyxin E (colistin) is structurally identical to polymyxin B 
except for the substitiution of D-phenylalanine at position six with D- 
leucine (11).
3.1.3 Interaction with LPS and mechanism of action 
The interaction of polymyxin with lipopolysaccharide and Gram- 
negative bacteria has been extensively studied over the past decades. 
Investigations have sought to discover the molecular basis of the 
interaction using fluorescent probes (12,13), nuclear magnetic resonance 
spectroscopy (14,15), surface plasmon resonance studies (16,17), 
isothermal calorimetry (18,19) and by monitoring the trans-membrane 
flux of various inorganic/organic ions (20). Results of these studies
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suggest that the polymyxins exert their antimicrobial activity via a two- 
stage mechanism.
The initial interaction between the peptide and the surface of the 
bacterium is facilitated by electrostatic interactions between the 
positively charged primary amines of the L-2,4-diaminobutyric amino 
acid residues and the negatively charged KDO-Lipid A region of LPS. 
The peptide displaces the divalent magnesium and calcium cations that 
bridge the LPS molecules, thus destabilising the outer membrane of the 
Gram-negative bacteria. Additionally, this interaction serves to bring 
the fatty acyl chain of the peptide into close proximity with the Lipid A 
region of LPS to allow insertion of the hydrophobic tail into the outer 
leaflet of the outer membrane (21-23). The result is a loosening of the 
packing of lipid molecules and expansion of the outer leaflet of the 
membrane. Following this initial interaction and disruption of the 
immediate cellular barrier, polymyxin follows a self-promoted uptake 
pathway to permeate the inner leaflet of the outer membrane i.e. it 
facilitates its own entry into the cell as opposed to being actively taken 
up (24,25). Once in the periplasmic space, polymyxin can disrupt the 
inner membrane simply via direct insertion leading to cytoplasmic 
leakage and an increased permeability to lysozyme, proteins and 
hydrophobic antibiotics, ultimately leading to bacterial cell death 
(5,26,27). An alternative mechanism in which the peptide facilitates the 
exchange of lipids between the inner leaflet of the outer membrane and 
the outer leaflet of the cytoplasmic membrane has also been proposed. 
Such exchange would result in a loss of the osmotic balance of the cell 
and subsequent cell death (2,28-30) (Figure 3.2).
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Figure 3.2: Mechanism of action of polymyxin B. Addition of polymyxin B (A) leads 
to displacement of divalent cations that bridge the LPS molecules in the outer 
membrane, thus destabilising the membrane and facilitating the self-promoted uptake 
of the peptide. Once it has traversed the outer membrane and entered the periplasmic 
space (B) the peptide disrupts the cytoplasmic membrane, enters the cell and brings 
about cell lysis either by ‘'flip-flopping' across the leaflets of the inner membrane (1), 
through facilitating lipid exchange between the two leaflets of the cytoplasmic 
membrane (2) or by direct insertion and aggregation into micelle type structures in 
the membrane (3). Adapted from (25).
The amphipathicity of the peptide, particularly the acyl chain, is vital 
for its antimicrobial activity; studies with polymyxin B nonapetide (i.e. 
polymyxin B that has undergone ficin/papain treatment to remove the 
final diaminobutyric acid residue and acyl chain), demonstrate little/no  
antimicrobial activity; the nonapetide has MIC > SOO^gmb1 against E.coli 
and Salmonella spp. compared to lpgm b1 for the native peptide (31). This 
analogue however retains the ability to permeate the outer membrane 
of Gram-negative bacteria thus making them more susceptible to other
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antibiotics and the effects of complement (23,31-36). The polymyxins 
are considered one of the strongest binders of LPS and therefore a 
potent anti-endotoxin, a property that is believed to be separate from its 
antimicrobial activity as nonapeptide analogues are capable of binding 
and neutralising the in vivo effects of LPS (27,35,37-41).
Although resistance to the polymyxins has rarely been reported, the 
number of resistant isolates is on the increase, particularly in 
Mediterranean areas and south-east Asia (6). This is leading to a 
generation of extremely drug resistant Gram-negative pathogens for 
which there is no known effective antibiotic treatment. It is via 
modification to the outer membrane, particularly the chemical structure 
of LPS, that Gram-negative bacterium develop resistance to the peptide 
antibiotic. The general mechanism for conferring resistance in E.coli and 
Salmonella spp., is through a reduction in the net negative charge of the 
lipid A portion of LPS, thus interfering with/inhibiting the initial 
interactions between the peptide and the bacterium. This is achieved 
via the esterification of the phosphate groups with 4-amino-4-deoxy-L- 
arabinose and/or phosphoethanolamine, a process controlled by a two- 
component regulatory system (PhoP-PhoQ and PmrA-PmrB) that is 
activated under inappropriate cell culture conditions (for example, 
grown in Mg++ deficient media) or during exposure to sub-lethal 
concentrations of the peptide (2,4-6). Other bacteria such as Neisseria 
spp., Providencia spp. and Proteus spp. are intrinsically resistant to the 
actions of polymyxin as are Gram-positive organisms (6).
3.1.4 Clinical uses
Reports of neuro- and nephrotoxicity associated with the clinical 
administration of polymyxin intravenously severely limited its use after 
the mid 1970's (5,42). At that time however, many patients were also co­
administered a plethora of other medications in an attempt to sustain
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life, some of which may also have possessed nephrotoxic side effects. It 
is therefore difficult to retrospectively distinguish the effects caused by 
the administration of the antibiotic and other therapies and today, 
especially with the advent of superior intensive care medicine and 
support, the polymyxins are considered to be less toxic than was once 
believed (43,44). Indeed polymyxins, in the case of extreme antibiotic 
resistance, are finding their way into the clinic where associated toxicity 
can often be controlled through careful observation of the patient with 
subsequent modification of the dose and often spontaneously subside 
following withdrawal of treatment. Although still not widely used for 
the treatment of systemic infections in the UK, polymyxin B is found in 
a number of topical preparations for otic, ophthalmic and dermal 
infections of bacterial origin (e.g. Otosporin ear drops, Polyfax skin and 
eye ointments, Maxitrol eye drops/ointment (45)). Polymyxin E 
(colistin) has also continued to find use, particularly in inhalational 
therapy for cystic fibrosis patients. Administered via a nebuliser or 
intravenously as the inactive pro-drug colistimethate sodium, the 
antibiotic effectively treats Ps. aeruginosa and multi-drug resistant 
Acinetobacter infections with few adverse effects (4,11,46).
Use of polymyxin B immobilised on the surface of a solid support in 
extracorporeal apheresis has been investigated as a therapeutic 
intervention in sepsis, septic shock and associated multi organ failure 
(47-50). Toraymyxin (Spectral Diagnostics), a polymyxin 
haemoperfusion cartridge, has been used clinically in Japan since the 
early 1990's (51) with positive results and few adverse effects. It is 
currently the subject of a multi-centre, double-blind phase III clinical 
trial taking place in the USA (EUPHRATES: Evaluating the Use of 
Polymyxin B Hemoperfusion in a Randomized controlled trial of 
Adults Treated for Endotoxemia and Septic Shock (52)). In other 
studies, immobilised polymyxin has been found to mimic the outer
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membrane permeabilisation effects of the free peptide resulting in 
inhibition of cell growth (53,54) in addition to acting as an endotoxin 
sequestrant.
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3.1.5 Aims and objectives of Chapter Three
Polymyxin B is being used in this study as the high affinity peptide 
ligand for lipopolysaccharide to provide evidence for the proposed 
peptide-polymer system described in Chapter One.
The key objectives of this work were:
1. To successfully immobilise polymyxin on the surface of the resin.
2. To use the chemistries outlined in Chapter Two to bring about 
peptide-target capture within a polymer matrix.
3. To evaluate the binding efficiency of the peptide-resin and 
peptide-polymer hybrid system.
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3.2 Materials and Methods
3.2.1 Materials
All chemicals were purchased from Sigma-Aldrich, Poole, UK and were 
used as received unless otherwise stated. All organic solvents were of 
HPLC grade and were obtained from Fisher Scientific, Loughborough, 
UK unless otherwise stated.
3.2.2 Synthesis of dansyl-polymyxin B
The method described by Schindler and Teuber (55) was used to 
synthesise the dansyl derivative of polymyxin B. Briefly, 40 mg (28.9 
nmol) polymyxin B sulfate (Enzo Life Sciences, Exeter, UK) in 1.2 ml of
0.1 M sodium bicarbonate buffer (pH 8.4) was incubated with 10 mg 
(37.1 nmol) dansyl chloride in 0.8 ml acetone for 90 minutes at room 
temperature, protected from light. The mixture was subsequently 
loaded onto a Sephadex G50 column and the dansyl-polymyxin eluted 
with 10 mM sodium phosphate (pH 7.1)/0.145 M sodium chloride 
buffer. Fractions (20 x 5 ml) were collected and a handheld UV lamp 
used to detect the dansyl derivative (dansyl-polymyxin is yellow in 
colour whereas unreacted dansyl chloride is blue - green). All fractions 
containing dansyl-polymyxin were extracted into half a volume of 
butanol and dried under vacuum overnight prior to being resuspended 
in 3 ml HEPES buffer (5 mM, pH 7) and stored as 100 \x\ aliquots at -20 
°C.
3.2.3 Dinitrophenylation assay
The method reported by Bader and Teuber (56) was used to determine 
concentrations of polymyxin with some modifications. A calibration
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curve was prepared from a 1 mgml-1 stock solution of polymyxin B in 
deionised water. To each sample, 200 pi of a 1 %w/v aqueous solution 
of sodium borate and 25 pi of 100 mM l-fluoro-2,4-dinitrobenzene in 
ethanol was added and the solutions incubated at 37 eC for 1 hour. 
Hydrochloric acid (2 M, 1 ml) and 1 ml butanol was subsequently 
added and the samples vortexed. The butanol phase was analysed 
using a Perkin Elmer Lambda 5 UV/Vis Spectrophotometer, reading at 
370 run. A calibration curve was used to determine concentrations of 
polymyxin in unknown samples following the synthesis of dansyl- 
polymyxin.
3.2.4 Dansyl polymyxin binding assays
The dansyl-polymyxin synthesised was subsequently used to 
determine affinities of polymyxin for lipopolysaccharide. 
Lipopolysaccharide from E. coli 0111:B4 at concentrations of 1 and 100 
pgml*1, was incubated with a range of dansyl-polymyxin concentrations 
(0 -1  pM, 0.1 pM increments) and the fluorescence intensity at 485 nm 
(tax 330 nm) recorded.
3.2.5 Immobilisation of polymyxin on Merrifield Resin
3.2.5.1 Imidoester linker
Dimethyl adipimidate dihydrochloride (490.3 mg, 2 mmol) was 
incubated with 100 mg amine-modified resin (~2 mmol NH2/g ,  
synthesised as described in Chapter 2) in 10 ml 0.2 M triethanolamine 
buffer, pH 8.0 for 1 hour at room temperature with gentle stirring. The 
resin was then filtered and washed with three 25 ml volumes of 0.2 M 
triethanolamine buffer, pH 8.0. Polymyxin B sulfate (207 mg, 0.15
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mmol) was subsequently reacted with 50 mg (maximum 0.1 mmol) 
dimethyl adipimidate modified resin in 10 ml 0.2 M triethanolamine 
buffer, pH 8.0, for 1 hour at room temperature with gentle stirring. The 
resin was then filtered and washed with three 25ml volumes of 0.2 M 
triethanolamine buffer, pH 8.0. The filtrate plus all three washes were 
analysed by reverse phase HPLC (section 3.2.6) to allow the loading of 
polymyxin on the surface of the resin to be estimated.
a) Binding assays
Polymyxin-modified and control resins (10 mg) were incubated with 
various concentrations of FITC-labelled LPS from E. coli 0111 :B4 in 
deionised water in 1 ml SPE cartridges fitted with 20 \im porosity 
polyethylene frits. The incubation was carried out at room temperature 
under non-equilibrium (less than 10 minutes) and equilibrium (16 
hours) conditions. Fluorescence of the filtrates were analysed using a 
FLUOstar OPTIMA platereader (BMG Labtech GmbH, Ortenburg, 
Germany) at an excitation wavelength of 485 nm and emission 
wavelength of 520 nm. All samples were prepared in triplicate.
b) Effect of free polymyxin and dimethyl adipimidate on fluorescence of 
FITC-LPS
To investigate the effect of any free dimethyl adipimidate or polymyxin 
on the fluorescence of FITC-LPS, various concentrations of each were 
incubated with 1 pgml-1 FITC-LPS overnight in glass specimen tubes. 
The fluorescence of the solutions were measured and compared to a 
standard 1 pgml'1 FITC-LPS solution.
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3.2.5.2 Click Chemistry
a) Synthesis of alkyne polymyxin
Polymyxin B sulfate (100 mg, 72 nmol) was reacted with glycidyl 
propargyl ether (7.76 pi, 72 pmol) in 10 ml methanol and stirred at 40 °C 
for 16 hours. The mixture was rota-evaporated to dryness and the 
resulting polymyxin residue re-suspended in de-ionised water.
b) Immobilisation of alkyne polymyxin on azide resin
Following the original Sharpless procedure (57), alkyne derivitised 
polymyxin (100 mg) and sodium ascorbate (59 mg, 0.3 mmol) were 
dissolved in 12 ml deionised water and copper (II) sulfate (4.78 mg, 0.03 
mmol) added. Azide resin (200 mg) was subsequently added to the 
solution and stirred at room temperature for 16 hours. The resin was 
then filtered and washed with three 100 ml volumes of deionised water, 
100 ml water/methanol (50/50) and 50 ml methanol and was then 
dried under vacuum at 40 °C for sixteen hours.
c) Standard binding assay
Polymyxin modified and control resins (10 mg) were incubated with 
various concentrations of FITC-labelled LPS from E. coli 0111 :B4 in 
deionised water at room temperature for 16 hours. Samples were 
subsequently filtered through Whatman 1 paper and the fluorescence of 
the filtrate analysed. All samples were prepared in triplicate.
d) Hot-cold assay
Polymyxin-modified resin (5 mg) was incubated with various ratios of 
hot (FITC-labelled) and cold (unlabelled) LPS from E. coli 0111 :B4
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(Table 3.1) at room temperature for 16 hours. Samples were 
subsequently filtered through Whatman 1 paper, the fluorescence of the 
filtrates analysed (section 3.2.5.1 a) and the amount of FITC-LPS bound 
calculated from a calibration curve. All samples were prepared in 
triplicate.
Sample [Hot] (pgml*1) [Cold] (pgmF)
1 5.00 0.00
2 4.00 1.00
3 3.00 2.00
4 2.00 3.00
5 1.00 4.00
6 0.5.0 4.50
7 0.25 4.75
8 0.05 4.95
9 0.00 5.00
Table 3.1: Various ratios of hot (FITC-labelled) and cold (unlabelled) E. coli 0111: B4 
LPS used in the hot cold assay. A t  all ratios the mass of resin used was 5mg and the 
total volume of the system  was lm l.
e) Selectivity assay
FITC-LPS from £. coli 0111 :B4 (2.5 pgmh1) was incubated with 
polymyxin modified resin in the presence of a variety of other 
lipopolysaccharides (2.5 pgmF, E. coli 0111 :B4 unlabelled, Klebsiella  
pneum oniae, Pseudom onas aeruginosa  serotype 10, Salm onella enterica  
serotype Minnesota and Serratia m arcescens) at room temperature for 16
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hours. Samples were subsequently filtered through Whatman 1 paper 
and the fluorescence of the filtrate analysed. Binding of FITC-LPS and 
the competitors was determined relative to 2.5 pgml*1 and 5 pgmT1 FITC 
LPS (£. coli 0111 :B4) standards.
3.2.6 HPLC analysis of polymyxin B sulfate
HPLC analysis was performed using an Thermo Scientific HPLC 
automated system fitted with a Gracesmart, 5 pm, C18,25 mm x 4.6 mm
i.d column (Alltech Associates Applied Science Ltd., Lancashire, UK) 
The mobile phase consisted of 22.25 % acetonitrile: 50 % sodium sulfate 
(0.7 %w/v): 5 % phosphoric acid (6.8 %v/v): 22.75 % deionised water, 
with UV detection at 215 nm (58). A 20 pi injection volume and a flow 
rate of 1 mlmin*1 were used.
3.2.7 Linear polymyxin B
A linear analogue of polymyxin B (decapeptide without the acyl chain) 
was synthesised by collaborators at Tromso University, Norway. The 
peptide was alkyne derivitised and attached to azide-modified resin in 
the same way as the cyclic form (see sections 3.2.5.2 a and b). Binding 
assays were performed as outlined in section 3.2.5.2 c.
3.2.8 Synthesis of polymyxin B-polymer hybrids
a) Immobilisation of polymyxin B on iniferter modified resin 
Azide/sodium dithiocarboxy sarcosine (~ 50/50) modified resins (for 
attachment of iniferter species see section 2.2.11 in Chapter Two) were 
incubated with alkyne modified polymyxin B as described in 3.2.5.2 b).
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b) Polymer growth assay
To assess the effect of polymer growth on the performance of the 
peptide, polymyxin B (cyclic)/sodium dithiocarboxysarcosine (~ 50/50) 
modified resin was polymerised for a variety of time periods and the 
binding properties of the hybrid systems evaluated. Resin (50 mg) was 
dispersed in an acrylamide (70 mg)/methylene bisacrylamide (7.5 mg) 
solution (4 ml deionised water). Polymerisation was initiated by UV 
and allowed to proceed for 30, 60 and 90 mins. Samples were filtered 
and washed with water (100 ml), methanol/water (50/50, 100 ml) and 
methanol (100 ml) before being dried under vacuum overnight at 40 °C. 
LPS binding was assessed via the overnight incubation of 5 mg of each 
resin with 1 pgml'1 FITC labelled E. coli 0111:B4 LPS. Samples were 
filtered through Whatman 1 paper and the fluorescence of the filtrate 
analysed. All samples were prepared in triplicate.
c) Equilibrium time point assay
An assay was conducted to determine the time necessary for the 
equilibrium in the binding of LPS by polymyxin modified Merrifield to 
be attained. Polymyxin resin (5mg) was incubated with 1 pgml*1 FITC 
labelled E. coli 0111:B4 LPS. The samples were filtered through 
Whatman 1 paper and the fluorescence of the filtrate analysed at 
various time points (10 minutes, 30 minutes, 1 hour, 3 hours, 6 hours 
and 24 hours). All samples were prepared in triplicate.
d) Polymerisation
Resins (polymyxin (cyclic and linear)/iniferter modified) were 
suspended in 10 ml deionised water. E. coli 0111 :B4 LPS (200 pg) was 
added and the mixture stirred gently for 4 hours at room temperature. 
LPS was omitted from the control non-imprinted resin. Following
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incubation with LPS, acrylamide (175 mg) and methylene 
bisacrylamide (18.75 mg) were added to all resin samples and the pre­
polymerisation mixtures thoroughly sparged with nitrogen. All 
samples were stirred gently (-100 rpm) whilst irradiated with UV light 
(100 mw/cm2, 325 nm at a distance of 8 inches) for 60 minutes. The 
samples were then filtered and washed with water (150 ml) before 
being incubated in each of the following mixtures for 1 hour; sodium 
deoxycholate (1 %w/v), water and 50/50 water/methanol. Between 
each of the incubation steps the resin was filtered and washed with 150 
ml water. A final wash with methanol (no incubation) was performed 
before the resins were dried under vacuum at 40 °C overnight. The 
ability of the resins to bind LPS was assessed through the incubation of 
5 mg of resin with 1 pg FITC labelled E. coli 0111 :B4 LPS in 1 ml water 
overnight at room temperature. Samples were subsequently filtered 
through Whatman 1 paper and the fluorescence of the filtrate analysed. 
All samples were prepared in triplicate.
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3.3 Results and Discussion.
3.3.1 Synthesis of dansyl-polymyxin B
Dansyl polymyxin B, first synthesised in 1955 (59), has been employed 
over the last six decades as a probe for determining the affinity of 
various peptide antibiotics for lipopolysaccharide (55,60,61). The 
reaction between dansyl chloride and a primary or secondary amine 
group, of which polymyxin B has five, generates a stable, fluorescent 
sulfonamide group (Figure 3.3) exhibiting an emission wavelength of 
~530nm. When bound to lipopolysaccharide a characteristic blue shift 
and a disproportionate increase in fluorescence intensity occurs, 
allowing affinities to be estimated.
N.
-H+C|-
Figure 3.3: Reaction of dansyl chloride w ith a prim ary amine group. In this study the 
amine is provided by one of the five  y-amino groups of the L-diaminobutyric acid
residues of polym yxin B
The conjugation of dansyl chloride to polymyxin B was successful using 
the method described in section 3.2.2. Figures 3.4 and 3.5 show the 
separation of the product (yellow) from the unreacted dansyl chloride 
(blue-green) on the Sephadex column and in the fractions collected.
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Figure 3.4: Column purification o f  dansyl -  polym yxin  B. A s  the reaction m ixture  
elutes through the Sephadex column, dansyl-polym yxin  B (yellow band) separates 
from  the unreacted dansyl chloride (blue - green band)
Figure 3.5: Fractions (~3m l volum es) are collected as they elute from  the column. 
Illum ination w ith  a hand-held U V  lamp allows the fractions to be separated into  
dansyl-polym yxin  B and unreacted dansyl chloride.
Those fractions that contained dansyl-polymyxin B were subsequently 
extracted into half a volume of butanol to remove buffer salts and dried 
under vacuum at 40 °C. Following re-suspension in 5 mM, pH 7 HEPES 
buffer, the compound was analysed by fluorescence spectrometry 
(Figure 3.6) and NMR (Figure 3.7) to confirm structure.
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Figure 3.6: Fluorescence scan o f dansyl-polym yxin B to determine excitation and
emission wavelengths.
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Figure 3.7: !H N M R spectra of polym yxin B (top) and dansyl-polymyxin B (bottom)
in D 2O.
Several new signals are apparent in the dansyl polymyxin B sample 
(bottom) when compared to the underivitised polymyxin B (top) in the 
NMR spectra in Figure 3.7. The peaks observed between 3 and 4 
ppm are indicative of the two methyl groups attached to the nitrogen
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group of dansyl chloride, while those seen at ~8 ppm are due to the 
aromatic protons of the fluorophore.
A paper by Gmur et al. (62) used dansyl chloride to derivatise 
polymyxin B to allow analysis of the antibiotic in rat plasma samples by 
HPLC. They report the synthesis of the penta-dansyl derivative using a 
ten-fold excess of dansyl chloride in the reaction. In the reaction 
presented in this study, only a slight excess of the fluorophore is used 
(1 : 1.3 mol equivalents) and therefore one would expect the mono- 
dansyl product to predominate. It is important that not more than two 
of the free amine groups are derivitised since the number of 
amines/positive charges is important for efficient binding of LPS by 
polymyxin B (47,63).
3.3.2 Quantification of dansyl-polymyxin B via dinitrophmylation 
assay
Samples of the dansyl derivative of polymyxin B (5 pi and 20 pi) were 
analysed using the dinitrophenylation assay to determine the quantity 
of dansyl polymyxin synthesised. Dinitrophenylation of terminal 
amine groups of amino acids using l-fluoro-2,4-dinitrobenzene was 
first suggested by Frederick Sanger in 1945 when he used the technique 
to determine the free amino groups in insulin (64) and although it has 
been largely superseded by other fluorescent molecules, peptidases and 
other amino acid sequencing techniques, it remains a useful tool for 
determining peptide structure. The basis of the assay relies on the 
dinitrophenylation of primary amine groups on peptides to form 
coloured N-substituted 2,4-dinitroanilines (Figure 3.8) that can be 
extracted into solvents such as cyclohexane and butanol, while the 
excess reagent is hydrolysed to 2,4-dinitrophenol (65).
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Figure 3.8: Schematic o f the dinitrophenylation o f amines to generate a N-substituted
2,4-dinitroaniline
A UV scan of dinitrophenylated polymyxin B (without dansyl tag) 
(Figure 3.9, left) was performed to determine the appropriate 
wavelength to measure the absorbance at and a standard curve was 
generated to ensure a linear response (Figure 3.9, right).
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Figure 3.9: U V  scan of dinitrophenylated polym yxin B (a) and example o f calibration 
curve (b, dinitrophenylation of polymyxin w ithout the dansyl tag) used to determine 
dansyl polym yxin concentrations following the reaction and column purification.
Since the calibration curve was produced using polymyxin B that had 
not been reacted with dansyl chloride, the response observed is based 
upon dinitrophenylation of five free amino groups. As dansyl 
polymyxin has one less free amine group (assuming the monodansyl 
species predominated), the value obtained for the samples of unknown 
concentration from the standard curve needed to be multiplied by 1.25 
to obtain the true concentration of polymyxin. The results suggest a 
polymyxin concentration of ~ 3.3 mgmF, meaning that ~ 12 mg of
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dansylated polymyxin is obtained following column purification of the 
reaction mixture.
3.3.3 Dansyl polymyxin binding assays
The method of Moore et al. (60) was used to determine the affinity of 
polymyxin B for E. coli 0111 :B4 lipopolysaccharide in solution. Freshly 
synthesised dansyl polymyxin was incubated with a solution of 
lipopolysaccharide and an excitation/emission scan performed to 
determine the degree of shift in tam upon binding of dansyl polymyxin 
to LPS. LPS alone did not display any fluorescence over the wavelength 
range used for the fluorescence scans. A shift in emission maxima from 
538 nm to 490 nm when LPS is introduced to the dansyl polymyxin 
solution was observed, while the excitation wavelength (347 nm) 
remained constant. This blue shift in fluorescence is consistent with 
reported X-Em (60) and is caused by the alteration of the immediate 
environment around the fluorophore upon binding of LPS to the 
labeled peptide.
The assay relies on determining the affinity of dansyl polymyxin B for 
LPS at sub-saturation concentrations through comparison with the 
fluorescence observed when all available binding sites on the peptide 
are saturated with LPS. To determine the appropriate concentrations for 
use in the assay, varying quantities of LPS were added to a 1 pM 
solution of dansyl polymyxin until the fluorescent response remained 
constant i.e. saturation of the peptide with LPS had been achieved. 
Figure 3.10 shows an initial disproportionate enhancement in 
fluorescence on the first addition of LPS (-3800 at 0 pgml-1 to -10800 at 
0.1 ugml'1 LPS concentration) followed by a steady increase up to 10 
pgml'1 LPS. Saturation is achieved between 10 and 100 pgml-1. 
Assuming an average molecular weight of 10,000 for E.coli LPS (66), 10
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pg is equivalent to 1 nmol thus suggesting an approximate 1:1 mole 
ratio of LPS to dansyl polymyxin.
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Figure 3.10 Saturation o f dansyl polym yxin (1 pM ) by E.coli 0111 :B4 
lipopolysaccharide. Saturation is achieved between 10 and 100 pg/ml LPS.
Based on the results of the saturation assay, 100 pgml*1 LPS was used as 
the 'super-saturated' concentration, to which the fluorescence response 
observed on addition of the 'sub-saturation' concentration (1 pgml*1) 
was compared. A simple binding isotherm (Figure 3.11) and Scatchard 
plot (Figure 3.12) was generated for the interaction between LPS and 
dansyl polymyxin to allow for the calculation of Kd (0.21 pM - 0.30pM). 
These affinities are in good agreement with those reported for 
polymyxin B sulfate and lipopolysaccharide (0.3 -  0.5pM (60)).
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Figure 3.11: Binding isotherm o f dansyl polym yxin and E. coli LPS. A ll samples were 
prepared in triplicate, error bars -  +/- standard deviation.
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Figure 3.12: Scatchard plot o f the above binding isotherm. A ll samples were prepared 
in triplicate, error bars = +/- standard deviation.
In the study conducted by Moore et al. (60), they report co-operativity in 
the binding of dansyl polymyxin B to LPS with approximately 4 moles 
of peptide bound per mole of LPS, an observation that was not evident
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in the current study. It is important to note that the study by Moore et 
al. used lipopolysaccharide from P. aeruginosa and attributed the high 
ratio of dansyl polymyxin bound per mole of LPS to the relatively large 
degree of phosphorylation in this LPS strain (60). The LPS used in the 
current work was from the enterobacterial species E. coli 0111 :B4 and 
although P. aeruginosa lipopolysaccharides have the same general 
molecular structure as enterobacterial LPS moieties, differences are 
observed in the composition of the acyl chains of lipid A and in the 
degree of phosphorylation (67). Other studies that have investigated the 
interaction of polymyxin with LPS from Salmonella, another species of 
the enterobacteriaceae family, have reported stoichiometric 1:1 binding 
of the peptide to the bacterial toxin (18,68-70). Lipopolysaccharides 
from E.coli and Salmonella species are structurally similar and therefore 
one would expect their interaction with antimicrobial peptides, such as 
polymyxin B, to also be similar. Given that the initial interaction 
between the peptide and the surface of the Gram-negative bacterium is 
facilitated by electrostatic interactions between the cationic L-2,4- 
diaminobutyric acid residues and the anionic core-lipid A region of 
LPS, it would seem unlikely that the binding of the peptide to LPS , 
thus altering the overall charge of the LPS moiety, would then 
positively influence the binding of an another peptide molecule.
3.3.4 Immobilisation of polymyxin on Merrifield resin 
HPLC was used to estimate the amount of polymyxin attached to the 
surface of Merrifield resin through analysis of the filtrates and washes 
following reaction of polymyxin with the resins. A typical 
chromatogram is shown in Figure 3.13. As explained earlier, 
commercial polymyxin B sulfate is a mixture of several structurally 
related compounds, hence a number of peaks are observed in the 
chromatograph. For the purposes of determining an approximation of
126
Chapter 'Three: Polymyxin Studies
the amount of peptide immobilised to the resin, the areas of two peaks 
(identified in Figure 3.13) were monitored. Based on a previous study 
by Orwa et al. (58) these peaks can most likely be attributed to 
polymyxin B2 (peak 1, retention time: 22 minutes) and polymyxin Bi 
(peak 2, retention time: 47 minutes). Typical calibrations for each peak 
are illustrated in Figure 3.14. Limits of quantitation were approximately 
25 pM for peak 1 and 12.5 pM for peak 2, based on peak heights equal 
to 10 times the value of noise obtained from calibration curves.
100
80
60
40
20
Peak 1
I
10 is 20 25 SO
Minutes
35 40
Peak 2
45 50 55 60
Figure 3.13: Typical chromatogram o f polym yxin B sulfate (chromatography 
conditions: 22.25% acetonitrile : 50% sodium sulfate (0.7% wfv) : 5% phosphoric acid 
(6.8% v/v) : 22.75% deionised w ater mobile phase, lm lm in-1 flow  rate, U V  detection at
215nm , 20p i injection volume).
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Figure 3.14: Typical calibrations obtained for peak 1 (polymyxin B2, left) and peak 2
(polymyxin B l, right)
The amounts immobilised on the surface of the resin are discussed in 
sections 3.3.4.1 and 3.3.4.2 b.
3.3.4.1 Immobilisation of polymyxin on Merrifield resin using an 
imidoester linker
Imidoesters, or imidates, are commonly employed as cross-linkers in 
the conjugation of biomacromolecules via amine groups. They display 
minimal cross-reactivity with other nucleophilic groups (71) but react 
efficiently with primary amines under mildly alkaline conditions (pH 8- 
9) to generate amidines (71,72). Dimethyl adipimidate (DMA), an 
example of a homobifunctional imidoester cross-linker, was employed 
in the current work to immobilise polymyxin B to the surface of amino- 
functionalised Merrifield resin. A schematic of the immobilisation 
process is provided in Figure 3.15.
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Figure 3.15: Immobilisation o f polym yxin B on the surface ofamino-functionalised 
Merrifield resin via dim ethyl adipimidate.
The immobilisation of polymyxin was carried out in two steps as 
described in section 3.2.5.1 HPLC analysis of the filtrate plus the resin 
washes suggested approximately 54 pmoles (13.3 mg) of DMA was 
attached to the surface of 200 mg bifunctionalised Merrifield (ca. 0.2 
mmol amine available for reaction) with approximately 16 pmoles (18.7 
mg) of polymyxin being subsequently immobilised.
a) Binding assays
It was observed that the physicochemical characteristics of the resin 
were altered following immobilisation of the peptide. In particular the 
resin became dispersible in aqueous solvent systems, while the control 
resins (Merrifield and bi-functionalised resins) remained poorly 
wetable. As a consequence, the way in which binding assays were 
performed was optimised to allow efficient and complete separation of 
the bound and free fractions. Centrifugation was not feasible due to the 
hydrophobicity of the control resins, while filtration of the samples 
through nylon 0.2 pm membranes resulted in virtually complete loss of 
FITC-LPS from the calibration standards (<10% fluorescence remained 
following passage through the membrane) and variability between 
repeats was significant. As a result, resins were loaded into empty 1ml
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SPE cartridges fitted with a 20 \im porosity polyethylene frit. A typical 
calibration curve for the assay is shown in Figure 3.16. In these 
experiments various concentrations of FITC-LPS were incubated in 
empty 1ml SPE cartridges overnight to account for adsorptive losses to 
the walls of the container. There was negligible loss of fluorescence 
following passage of the solution through the frit (< 10%) and variation 
between repeats was significantly reduced.
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Figure 3.16: A  typical calibration curve obtained following incubation of FITC-LPS in 
a lm l SPE cartridge fitted  with a 20 pm  porosity polypropylene frit.
Polymyxin immobilised on solid supports has found use in the removal 
of LPS from formulations (Detoxi Gel, Thermo Scientific (73)) and in 
therapeutic apheresis of the septic patient (Toraymyxin, Spectral 
Diagnostics Ltd. (51)). In both applications, the LPS contaminated fluid 
is simply filtered through the polymyxin supports and therefore initial 
experiments with polymyxin modified Merrifield resin were performed 
under non-equilibrium conditions i.e. incubation time of less than 10
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minutes. The results from these preliminary assays are illustrated in 
Figure 3.17.
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Figure 3.17: A m ount of FITC labelled E.coli 0111:B4 LPS (nmol) bound to 10 mg of 
polymyxin modified resin (blue, PM X-M R), dim ethyl adipimidate modified resin 
(purple, D M A-M R) and unmodified M errifield resin (black, M R) under non­
equilibrium conditions.
The immobilised polym yxin was shown to possess a Kd value similar to 
that observed with the dansyl polym yxin experiments (0.18pM 
(calculated from the binding isotherm in Figure 3.17) compared to 
0.21 pM, Figure 3.11), Non-specific binding to the control, dimethyl 
adipimidate modified resin w as however high, whilst minimal binding 
to the original, unmodified, chloromethyl Merrifield resin was 
observed.
One of the advantages of dimethyl adipimidate as a homobifunctional 
linker in bioconjugation reactions is that it retains the overall charge of 
the macromolecule, as it possesses two positive charges (74). The
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loading of the linker onto amine-modified Merrifield resin was 
estimated to be approximately 3.5 fold higher (mole per mole) than that 
of polymyxin, most likely as a consequence of the relative sizes of the 
two molecules and/or an increasing inefficiency of the reaction with 
time. Based on this estimated molar ratio, coupled with the fact that 
each molecule of dimethyl adipimidate posseses two positive charges 
and polymyxin has an overall charge of + 4 (assuming four of the five 
L-2,4-diaminobutyric acid amines remain unmodified), the relative 
density of charge on the surface of the resins would be approximately 
7 : 4 (dimethyl adipimidate resin : polymyxin resin). It is therefore 
unsurprising that such high non-specific binding is observed with the 
dimethyl adipimidate modified resin, given that the initial interaction 
between the peptide and lipopolysaccharide is electrostatic in nature.
The performance of the resins was subsequently evaluated under 
equilibrium conditions, following the same conditions for the non­
equilibrium binding assay except with an overnight (16 hour) 
incubation. Again non-specific binding to the dimethyl adipimidate 
resin was significant, however of more concern was the considerable 
variation in results between experiments. Analysis of fluorescence 
following overnight incubation on occasions suggested that the 
polymyxin-modified resin was performing as expected, while at other 
times an increase in fluorescence intensity in the polymyxin and 
dimethyl adipimidate resin samples was observed relative to the LPS 
standards and control Merrifield resin. An example of the raw data is 
given in Table 3.2.
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Sample Average fluorescence 
( ii-3 )
Blank w a ter 3290
FITC-LPS fro m  E. coli 0111:B 4 (1 figm l'1 standard) 24060
FITC-LPS fro m  E. coli 0111 :B4 (1 fx g m l1) p lus
M errifield  resin 22330
FITC-LPS fro m  E. coli 0111 :B4 (1 f ig m l1) p lu s
dim ethyl adipim idate m odified M errifie ld  resin 51150
FITC-LPS fro m  E. coli 0111 :B4 (1 p g m T 1)  p lu s
p o lym yx in  m odified M errifie ld  resin 51420
Table 3.2: Raw fluorescence readings fallowing overnight incubation oflO m g of resin 
with lp g m l1 FITC LPS from E.coli 0111:B4. In the presence of dimethyl adipimidate 
and polymyxin modified resins, the fluorescence doubles compared to the LPS
standard.
It was hypothesised that the linker and/or peptide was being desorbed 
from the surface of the resin and bringing about the change in results. 
Although the amidine bond formed via the reaction of an imidoester 
and an amine is stable in acidic and neutral environments, at alkaline 
pHs (> 10) it is susceptible to cleavage (71). As the incubation of the 
resin with LPS was carried out in an unbuffered system, it is possible 
that the pH of the system was changing during the course of the 
incubation, resulting in cleavage of the amidine bond with subsequent 
release of polymyxin and dimethyl adipimidate. Incubation of the resin 
in 0.2 M triethanolamine buffer (pH 8.2) however, yielded similar 
results.
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b) Effect of free polymyxin and dimethyl adipimidate on the 
fluorescence ofFITC-LPS
To further investigate the reason behind the increase in fluorescence, 
several studies were undertaken to assess the effect of dimethyl 
adipimidate and polymyxin on FITC-LPS in solution. Various 
concentrations of polymyxin and dimethyl adipimidate were incubated 
overnight with 1 pgml4 FITC-LPS and the fluorescence of the solutions 
analysed the following day. The results presented in Figure 3.18 show a 
gradual increase in fluorescence relative to the control FITC-LPS 
solution (i.e. 0 pgm F polymyxin) as the peptide concentration 
increases. At 2.5 mgmh1, the fluorescence of the solution is double that 
of the FITC-LPS standard. Polymyxin alone exhibited no significant 
fluorescence at the excitation and em ission wavelengths employed in 
the study. It is possible that the increase in fluorescence was due to the 
formation of LPS micelles at higher polym yxin concentrations but this 
is highly speculative.
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Figure 3.18: Effect of various concentrations of polymyxin (PMX) on the fluorescence 
of a 1 pgm h1 solution ofFITC LPS. Fluorescence is plotted as percentage fluorescence 
relative to a FITC-LPS control solution (0 pgmF2 PM X).
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A similar pattern was observed following the addition of dimethyl 
adipimidate up to a concentration of 7.5 pgmh1 (Figure 3.19). At 
concentrations greater than 10 pgmh1, the fluorescence of the FITC-LPS 
solution returned to 85-105% of the standard solution before dropping 
to around 50% of the standard at concentrations above 1 mgml*1. This 
reduction in fluorescence at higher concentrations was surprising and is 
not obviously explainable. As a consequence of these experiments, the 
reliability of previously performed binding assays was reconsidered; 
even when a decrease in fluorescence was observed with resin treated 
samples, it would be difficult to distinguish between a real 'binding 
event' and an artifactual decrease precipitated by the release of 
increased amounts of dimethyl adipimidate from the resin. In the light 
of these studies an alternative attachment strategy was sought.
■ v  <d  - v -  * >  ^
[DMA] (jg/ml
Figure 3.19: Effect of various concentration of dimethyl adipimidate (DM A) on the 
fluorescence of a 1 pgm b1 solution ofFITC LPS. Fluorescence is plotted as percentage 
fluorescence relative to a FITC-LPS control solution (0 pgm l'1 DM A). All samples 
were prepared in triplicate, error bars = +/- standard deviation.
It was anticipated that using a neutral cross-linker would help to 
reduce non-specific binding, as LPS, being anionic, relies on charge 
interactions as its initial m ode of binding. Disuccinimidyl suberate 
(DSS, Figure 3.20) was investigated as an alternative homobifunctional
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linker, however binding assays suggested no significant immobilisation 
of polymyxin on the surface of DSS-modified resin, with the resin 
performing similarly to controls. It is possible that the reaction 
conditions employed in attaching the linker resulted in hydrolysis of 
the NHS ester, regenerating the free carboxylate group, before 
polymyxin was introduced to the system. The DSS-resin did however 
display less non-specific binding than the DMA resin.
Figure 3.20: D isuccinim idyl suberate
3.3A.2 Immobilisation of polymyxin on Merrifield resin using click 
chemistry
The synthesis of amino- and bi-functionalised Merrifield resins 
described in Chapter Two proceeds via an azide intermediate. The resin 
is therefore amenable to reaction with terminal alkyne groups in a 
Huisgen cycloaddition reaction ("click" chemistry) to generate a 1,4- 
disubstituted 1,2,3-triazole. Advantages of this approach are that the 
linking reaction proceeds efficiently at room temperatures in a range of 
solvents and without the need for pH control. Additionally, due to an 
absence of azide and alkyne groups in many biological systems the 
reaction proceeds with few side reactions and with high regio- 
selectivity when catalyzed with copper (57,75,76).
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a) Synthesis of alkyne polymyxin
Glycidyl propargyl ether (Figure 3.21) was used to introduce alkyne 
functionality to polymyxin B. Glycidyl ethers are know to react 
efficiently with amines under a variety of conditions, however reactions 
occur at a greater rate when polar protic solvents are used (77,78). 
Glycidyl propargyl ether is not miscible in water and therefore the 
reaction was performed in methanol using a 1:1 molar ratio of glycidyl 
propargyl ether to polymyxin B. Carbon NMR was used to confirm 
formation of the product. Figure 3.22 compares the carbon NMR 
spectra of the product with polymyxin B. The three new signals at ~ 58 
and 72 ppm (up) and at 76 ppm (down) in the top spectra represent the 
C, CH2 and terminal CH groups of glycidyl propargyl ether 
respectively. Glycidyl propargyl ether is a liquid and therefore any 
excess is removed during the evaporation process; a clean carbon NMR 
was achieved following the rotary-evaporation of glycidyl propargyl 
ether in methanol.
Figure 3.21: G lycidyl propargyl ether
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Figure 3.22: Carbon N M R  o f alkyne derivitised polym yxin (top) and polymyxin B 
(bottom) in D 2O. Extra signals a t ~  58 and 72 ppm  (up) and at 76 ppm (down) in the 
top spectrum demonstrated the successful derivitisation of the peptide w ith an alkyne
group.
b) Immobilisation of alkyne polymyxin on azide modified resin.
The original method of Sharpless was used to attach the alkyne 
derivitised peptide to the azido-polystyrene resin (57). Copper (II)
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sulfate was employed as the copper catalyst and sodium ascorbate as 
the reducing agent to ensure a continuous supply of Cu(I) ions 
throughout the course of the reaction. A schematic illustrating the 
immobilisation of the peptide on the surface of azide/chloro 
bifunctionalised resin via click chemistry is given in Figure 3.23. A 
disadvantage of the "click" reaction is the use of copper as the catalyst 
that has the potential to contaminate the final product. Copper has been 
shown to be toxic to cells and it is therefore important that complete 
removal of any remaining copper is ensured if the system is to be used 
in any biological approaches.
Copper (II) Sulphate 
Sodium ascorbate 
H20. RT, 16hrs
Figure 3.23: Generation o f polym yxin  modified resin via the attachment of alkyne 
derivitised polym yxin to azide/chloro bifunctional M errifield resin. The N H  group is 
donated by one o f the L-2,4-diam inobutyric acid residues of polym yxin B while the R  
group represents the rest o f the peptide moiety.
Following an overnight incubation at room temperature the resin again 
become dispersible in aqueous solvents, just as the imidoester linked 
polymyxin resin had done. HPLC analysis of the supernatant plus 
washes of the resin (4 x 20 ml deionised water) suggested that 
approximately 10 mg of polymyxin B was successfully immobilised per 
100 mg of azide-modified (100%) Merrifield resin. The resin was also
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analysed by FTIR. The spectrum given in Figure 3.24 demonstrates the 
presence of azide groups (characteristic signal at -  2100 cm-1) and 
peptide (carbonyl stretch and amino stretch apparent at ~ 1650 cm-1 and 
3200 -  3400 cm*1 respectively).
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Figure 3.24: FTIR spectra ofbifunctionalised azide/polym yxin Merrifield resin. The 
azide stretch is evident at ~ 2 1 0 0 cm 1 while small carbonyl and amino stretches from  
the peptide are also apparent a t ~ 1650cm 1 and ~3200-3400cm 1 respectively.
An azide signal remains on the spectra due to the reaction conditions 
employed in the conversion of Merrifield resin to azidomethyl 
polystyrene and the subsequent attachment of polymyxin B. The 
synthesis of azide functionalised resin was performed in DMF (section 
2.2.2) to swell the resin to ensure maximal conversion of chloro groups 
to azides, therefore the estimated loading of azide groups per gram of 
resin is ~ 2 mmol. The immobilisation of the peptide to azide modified 
resin was performed in water due to solubility constraints and therefore 
the large majority of the azide groups would not have been available 
for interaction due to the compacted nature of the resin in aqueous 
conditions. Only those azide groups exposed on the surface of the resin
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would have been able to react with the alkyne group of the peptide. 
Additionally due to size of polymyxin B it was envisaged that not all of 
the surface confined azides would have participated in the reaction due 
to steric hindrance, therefore the decrease in azide number is most 
likely insignificant relative to the total loading of the resin.
c) Standard binding assay.
Using polymyxin-modified resins (generated from 100 % azide and 
bifunctionalised (i.e. ~ 50 % azide, 50 % chloro) resins) (section 3.2.5.2
b), standard binding assays were conducted to assess LPS binding 
performance. Figure 3.25 illustrates the binding isotherm obtained. Kd 
values for the two polymyxin-modified resins were calculated as 
0.277pM (100% resin) and 0.220pM (50% resin) while the Bmax values 
were 0.070 nmol/mg (700 ng/m g based on average molecular weight of 
10,000 for E. coli 0111:B4) for the 100 % polymyxin modified resin and
0.055 nmol/mg (550 ng/mg) for the 50 % resin. The derivitisation of the 
peptide with alkyne functionality and the subsequent immobilisation 
on the resin's surface appear to have had little affect on the affinity of 
polymyxin for LPS. Importantly the problem of high non-specific 
binding, as observed with the dimethyl adipimidate resins, was not 
significant for the azide-alkyne click resin system.
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Figure 3.25: S tandard binding isotherm  fo r  p o lym yx in  modified resins, generated  
from  100% azide resin (red) and 50%  azide/chloro bifunctional resin (blue). A z id e  
resins (100%  - purple and 50%  - orange) w ere used as controls in the experim ent. A ll 
sam ples w ere prepared in trip licate, error bars = + /- standard deviation.
d) Hot cold assay.
An assay was undertaken to determine the relative affinities of 
polymyxin for the unlabelled and labelled versions of E. coli 0111 :B4 
LPS. Assuming the labelling of LPS does not influence the binding of 
the molecule to the peptide, then a linear relationship should be 
observed as the ratio of hot (labelled) to cold (unlabelled) LPS is varied 
("Line of equivalence" in Figure 3.26). The various ratios of hot : cold 
LPS are defined in Table 3.1. A minor deviation from the line of 
equivalence is observed in Figure 3.26 suggesting that polymyxin  
displays a slightly higher affinity for the FITC labelled LPS species.
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Fluorescein isothiocyanate possesses a carboxylic acid group that 
would be deprotonated at physiological pH. Although the loading of 
FITC per milligram of LPS is relatively low (3.80 pg/mg) it is possible 
that the negative charge conferred by the deprotonated acid could 
influence the affinity of polymyxin for the LPS, given that electrostatic 
interactions play a significant role in the binding event.
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Figure 3.26: Am ount o f FITC-LPS bound by 1 mg of polymyxin modified resin at 
various ratios of labelled: unlabelled LPS from  E. coli 0111: B4. The corresponding 
unlabelled LPS concentration for each FITC-LPS concentration is given in Table 3.1. 
A ll samples were prepared in triplicate, error bars = +/- standard deviation.
e) Selectivity assay.
To assess whether polymyxin B displays any selectivity between 
different bacterial LPS species, the system was challenged with a 
variety of competitors at a single concentration. The resin was 
incubated with 5 pgml'1 (0.5 pM) and 2.5 pgml'1 (2.5 pM) of FITC-LPS in 
the absence of any competitors to evaluate the resins binding capacity . 
Subsequently, polymyxin modified resin was incubated in a 1 ml 
solution containing 2.5 pg of FITC-LPS from E. coli 0111:B4 plus 2.5 pg
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of a non-labelled LPS competitor overnight. Following filtration and 
analysis, the relative binding of the fluorescent analogue was 
determined. Binding of the competitor was estimated based on the 
assumption that 1 mg of the resin is capable of binding roughly 0.038 
nmol of LPS from a 5 pgml'1 (0.5 pM) input; the amount of FITC-LPS 
bound in the presence of each competitor was deducted from this value 
to give an approximation of the amount of competitor LPS bound. The 
values obtained are presented in Figure 3.27.
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Figure 3.27: A m ou n t o f LPS bound by 5m g o f  resin over a range o f  com petitor species. 
Uness otherwise stated, the total concentration o f the system  was 5 pgml-1 (0.5pM )  
made up o f2 .5 p g  o f  FITC-LPS from  E. coli 011V.B4 and 2.5 p g  o f an unlabelled 
com petitor species. A ll samples were prepared in triplicate, error bars = +/- standard
deviation.
It was assumed that all LPS species were equal in terms of molecular 
weight (thus assuming an equal mole ratio of FITC-LPS : competitor 
LPS) when this assay was performed. However, the molecular weight 
varies considerably not only between bacterial species but also at an
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intra-species level depending on the stage of biosynthesis when LPS 
was extracted from the outer membrane. MALDI-MS analysis would 
enable an average molecular weight for each species to be determined, 
therefore allowing equal mole ratios to be employed in the assay giving 
a more realistic perspective of relative affinities for the different LPS 
species. This assay does however, serve as a comparator for later assays 
utilising the peptide-polymer system.
3.3.5 Linear analogue of polymyxin B.
When developing the original hypothesis presented in Chapter One, it 
was always envisaged that a linear peptide would be more amenable to 
our imprinting process than a cyclised species due to the difference in 
conformational flexibility. A cyclic peptide is already conformationally 
restrained and therefore our imprinting process is likely to have little 
effect on its overall structure. A linear peptide on the other hand, has a 
much greater degree of flexibility and it was anticipated that through 
interaction with its target during the polymerisation process, the 
peptide could be "locked" into a position that is more favourable for 
binding. Cyclic polymyxin B was simply used as a cost-effective and 
readily available peptide to provide proof-of-principle for our 
hypothesised system.
Over the past two to three decades, many groups have investigated 
ways in which to reduce the toxicity associated with polymyxin B, with 
studies focussed on removing the hydrophobic tail and final L-2,4- 
diaminobutyric acid residue to generate polymyxin B nonapeptide. 
Indeed, reduced toxicity is observed but antimicrobial activity is also 
severely compromised. The nonapeptide does however retain the anti­
endotoxin properties of the parent peptide (39). Polymyxin B 
nonapeptide is also cyclised and therefore offers little to the current
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study except for the observation that the fatty acid chain is not a 
prerequisite for efficient LPS binding. A linear, decapeptide, analogue 
of polymyxin B with an N-terminal alkyne group (4-pentynoic acid) 
was synthesised by colleagues at Tromso University, Norway (sequence 
given in Figure 3.28).
o
L-Dab - L-Thr - L-Dab - L-Dab - L-Dab - D-Phe - L-Leu - L-Dab - L-Dab - L-Thr 
Figure 3.28: Sequence o f the alkyne derivitised, linear analogue of polymyxin B.
The peptide was attached to bifunctionalised resin (~ 50/50 
azide/chloro) as described in section 3.2.5.2 b and assays performed to 
assess its binding efficiency (3.2.5.2 c). The results obtained are 
presented in Figure 3.29 (blue line). The graph compares the linear 
polymyxin resin to the cyclic peptide modified resin (red line) and 
demonstrated a decrease in apparent Kd for the linear species (1.53 pM 
compared to ~ 0.22 pM (Figure 3.25)). There was a concomitant increase 
in Bmax (approximately 2.5 fold) from 0.055 nmol/mg (cyclic) to 0.129 
nmol/mg (linear) which was thought to be due to less steric hindrance 
conferred by the linear analogue compared to the cyclic species. The Kd 
value obtained for the linear decapeptide was not dissimilar to that 
reported for polymyxin nonapeptide (1.3 pM (33)).
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Figure 3.29: Binding isotherm fo r  the linear analogue o f polym yxin B (blue) and the 
natural peptide (red) im m obilised on bifunctionalised (i.e. ~ 50/50 azide/chloro) resin. 
A ll samples were prepared in triplicate, error bars = +/- standard deviation.
3.3.6 Synthesis of the peptide-polymer hybrid,
a) Polymer growth assay
Using the hydrophilic iniferter modified resins developed through the 
work described in Chapter Two, a series of experiments were 
undertaken to determine the effect of polymerisation time on peptide 
performance. Polymyxin B (cyclic) was immobilised on resin to which 
the iniferter species, sodium dithiocarboxysarcosine, had previously 
been attached. Polymerisation was initiated and allowed to proceed for 
various periods of time. At each time point the binding efficiency of the 
resin was evaluated. The results are presented in Figure 3.30 and 
demonstrate a reduction in the ability of the peptide resin to bind LPS 
as the polymerisation time increased. A linear decrease in amount 
bound was observed between 0 and 60 minutes, after which a plateau is
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achieved. This suggested that following polymerisation for 60 minutes 
the polymer had overgrown the peptide, thus hindering the access of 
LPS to the binding sites. As a result of this assay, all imprinted resins 
(and non-imprinted controls) were polymerised for 60 minutes.
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Figure 3.30: Percentage o f FITC-LPS bound from  a lp g m l1 input by 5mg of 
PM X/iniferter resin follow ing various polymerisation periods in 
acrylamide/methylene bisacrylamide solution. A ll samples were prepared in triplicate, 
error bars = +/- standard deviation.
b) Determining saturation concentration of LPS for imprinting 
experiments.
During the imprinting process it is vital that sufficient LPS is added to 
the system to ensure that a high proportion of the surface immobilised 
polymyxin is complexed with template, so that the access is not 
hindered through the growth of polymer over the peptide. The 
concentration of LPS required to saturate the resin was calculated from 
extrapolation of the isotherm for 100% polymyxin resin (red line, Figure 
3.25) using the equation of the curve (Y = Bmax*X/(Kd + X)) and the
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generation of a line of conservation of ligand (dashed line in Figure 
3.31). The line of conservation of ligand was generated based on a 
hypothetical experiment where 10 ml of a 2 pM LPS solution was 
incubated with 1 mg (Figure 3.31 a) or 50 mg (Figure 3.31 b) of 
polymyxin modified resin. The x intercept is a theoretical point where 
all ligand is free and therefore equals the starting ligand concentration. 
The y intercept is a theoretical point when all ligand is bound and is 
therefore equal to the total amount of ligand in the system divided by 
the mass (mg) of polymer used in the experiment. The equilibrium 
point is where the line of ligand conservation intercepts the binding 
isotherm. This intercept should be through the plateau region of the 
isotherm to ensure maximum occupancy of the binding sites.
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Figure 3.31: Binding isotherm used to calculate the amount of LPS to incubate with  
polymyxin/iniferter resin prior to polymerisation to ensure complete saturation of  
binding sites. The line o f conservation o f ligand (dashed line) intercepts the binding 
isotherm near the Bmax and was calculated based on an input concentration of 10 ml of 
a 2.0 p M  solution ofE.coli 0111:B4 LPS w ith  lm g  (a) or 50 mg (b) of polymyxin
modified resin.
As is evident from Figure 3.31 b, incubation of 50 mg of resin with a 2 
pM solution of LPS results in the line of conservation of ligand 
intercepting the isotherm near to the plateau/ Bmax region. A
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concentration of 2 \xM (20 pgml'1 LPS) and a mass of resin of 50mg was 
a compromise to ensure sufficient resin to conduct the relevant assays 
while trying to maintain the concentration at or below the critical 
micelle concentration (CMC). The CMC value will vary depending on 
the species of LPS but an estimated value for E coli 0111:B4 LPS is 22 
pgml'1 (79). Above this concentration, LPS will mainly exist in an 
aggregated form. Although polymyxin B is able to recognise and bind 
to LPS aggregates and whole bacterial cells, the previous experiments 
in the current study, including the equilibrium time point assay (section
3.3.6 c), have investigated binding activity up to a concentration of 10 
pgml*1. At and below this concentration, LPS would most likely have 
existed in a mainly monomeric form, which may impact on time taken 
to reach equilibrium. At a concentration of 20 pgml*1, it is likely that 
some of the LPS moieties will have aggregated, however it is also likely 
that a proportion of monomeric LPS will remain. It may be important 
for future applications of the synthetic receptor that it is capable of 
recognising LPS in a variety of aggregated forms. From a clinical 
perspective typical systemic concentrations of LPS are in the high 
picogram/low microgram per millilitre but a multitude of forms exist 
including free LPS, intact bacterial cells and membrane blebs.
c) Equilibrium time point assay.
An assay was performed to allow estimation of the time needed for the 
binding of LPS to polymyxin-modified resin to reach equilibrium. The 
results presented in Figure 3.32 suggested that equilibrium was 
attained between 3 and 6 hours; continuing the incubation of LPS with 
peptide resin for more than 6 hours showed little increase in the overall 
amount bound. Based on this assay, all resins to be used in the 
imprinting strategy were pre-incubated with LPS for 4 hours to ensure 
maximal occupancy of binding sites prior to polymerisation.
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Figure 3.32: Percentage o f a l p g m l1 FITC LPS input bound as a function of time. A ll 
samples consisted of5m g 100% polym yxin modified resin and were prepared in 
triplicate, error bars = +/- standard deviation.
d) Evaluation of the peptide-polymer hybrid system.
Following polymerisation of the cyclic and linear peptide/iniferter
resins, binding assays were performed to evaluate the effect of
imprinting on the peptide -  polymer hybrid systems. The results are
presented in Figure 3.33. The peptide modified resins prior to
polymerisation bound ~ 70 % and 50% (cyclic (PMX resin) and linear
(Linear resin) polymyxin) of a 1 pgm l1 FITC LPS solution. Following
polymerisation however, binding efficiency was reduced to ~ 45 %
(PMX MIP) and 24 % (Linear MIP). A small imprinting effect was
observed, with the non-imprinted counterparts binding ~ 36 % (PMX
NIP) and 19 % (Linear NIP). It is important to note that although the
amount bound to the peptide resins prior to polymerisation was greater
than that observed for their polymerised counterparts, this does not
necessarily indicate reduced affinity of the hybrid systems compared to
the simple peptide resins. Following polymerisation it would be
expected that the number of sites containing accessible peptides would
be lower than the number of accessible peptides available for binding
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pre-polymerisation. This would manifest itself as a reduction in Bmax. 
The observed variations in amount of ligand bound in the current assay 
are therefore likely to be a function of changes in Bmax and /or Kd. The 
reasons for the apparent altered binding efficiencies could be 
deconvoluted through the construction of a full isotherm.
8 O-1
Resin
Figure 3.33; Evaluation o f  the binding efficiency o f cyclic and linear polym yxin  
im printed resins prepared from  "click" immobilised resins. A ll samples contained 5 
mg o f the respective resin plus 1 pg o f FITC -  labelled E. coli 0111:B4 LPS in 1 ml o f  
water. A ll sam ples were prepared in triplicate, error bars = + /- standard deviation. 
(P M X  resin = po lym yxin  modified resin prior to polym erisation, P M X  M IP = P M X  
resin that has been polym erised in the presence ofE . coli 0111:34 LPS, P M X  N IP = 
P M X  resin that has been polym erised w ith ou t LPS, Linear resin = resin modified w ith  
the linear decapeptide form  o f polym yxin  B, Linear M IP  and Linear NIP are the same 
as P M X  M IP  and P M X  NIP but w ith  the linear analogue o f polym yxin).
The results in Figure 3.33 were somewhat disappointing compared to 
those obtained during the first attempt at imprinting using the resins 
employing dimethyl adipimidate as the linker. In that assay, a clear 
imprinting result was evident (Figure 3.34). The amount of LPS bound
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to the polymyxin MIP (~ 42 %, PMX MIP) was significantly greater than 
that bound to its non-imprinted antipode (~ 18 %, PMX NIP). 
Encouragingly, the polymyxin MIP also appeared to bind slightly more 
LPS (~ 6 %) than the conventional polymyxin resin (MR -  PMX). The 
polym yxin resin appears to bind less than in the current assay due to 
different resin m asses and incubation concentration of FITC LPS (10 mg 
resin and 10 pgml'1 LPS compared to 5 mg and 1 pgml'1 in the current 
assay).
■o
c3O
CD
nP0s
Resin
Figure 3.34 : Evaluation o f  the b in din g  efficiency o f  cyclic po lym yxin  im printed resins 
prepared from  dim ethyl adipim idate linked resins. A ll samples contained 10 m g o f  the 
respective resin p lu s 10 p g  o f  FITC -  labelled E. coli 0111:B4 LPS in 1 m l o f  water. 
A ll sam ples were prepared in triplicate, error bars = + /- standard deviation. (M R = 
standard M errifield resin, P M X  resin = po lym yx in  modified resin prior to 
polym erisation, P M X  M IP  = P M X  resin th at has been polym erised in the presence o f  
E. coli 0111:B4 LPS, P M X  N IP  = P M X  resin that has been polym erised w ith ou t
LPS).
The main difference between these tw o systems, other than the 
attachment chemistry, is the w ay in which the iniferter species were
MR PMX resin PMX MIP PMX NIP
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introduced. The iniferter was attached to resin used in the click 
approach in a swollen state and therefore the relative densities of 
iniferter to peptide most likely differ considerably to that displayed by 
the dimethyl adipimidate linked resin. Additionally, since the resin 
possessing more iniferter groups is likely to be more hydrophilic, the 
degree of swelling observed in aqueous solutions may also be greater. 
This could possibly allow greater access of monomers to the interior of 
the resin resulting in more significant polymerisation observed over the 
same time period. Whether this is the reason for the difference in 
behaviour between the two assays remains to be elucidated.
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3.4 Conclusion
Polymyxin resins, produced via the immobilisation of alkyne 
derivitised polymyxin B on the surface of azidomethyl polystyrene via 
"click" chemistry, were able to efficiently bind LPS from aqueous 
solutions with an apparent Kd of ~ 0.2 pM. Although the development 
of the peptide -  polymer hybrid system using these resins appeared 
somewhat unsuccessful, whether the reduction of binding observed is 
due to changes in the Bmax or of the Kd remains to be elucidated. The 
assay performed with the polymerisation samples produced using resin 
displaying polymyxin immobilised via a dimethyl adipimidate linker, 
suggest that the hypothesised approach is feasible but that optimisation 
of a number of variables is needed before definitive results can be 
obtained.
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4.1 Introduction
4.1.1 General Overview
Phage display is a powerful in vitro tool used in the selection of 
peptides that possess high affinity for a target molecule. Conventional 
methods of screening or panning for the desired peptides rely on the 
immobilisation of the target molecule to a surface, typically a well of a 
microtiter plate or bead type structure. Phage display targeting LPS has 
been carried out using both immobilisation methods. The work by 
Noda et al (1), Zhu et al (2), Thomas et al (3) and Guo and Chen (4) all 
utilised adsorption of LPS or lipid A moieties onto the surface of 
multiwell plates. None of the four studies were able to enrich consensus 
sequence clones, although homology between the peptides in terms of 
the properties of the amino acid residues e.g. hydrophobicity and 
charge, were shown to exist. Studies conducted in 2005 and 2006 by 
Kim et al (5,6) immobilised LPS to the surface of epoxy beads which 
resulted in identification of identical or highly homologous peptide 
sequences. The authors attributed this increase in observed homology 
to increased variability in the conformational presentation of LPS and 
to the increased surface area available for interaction with phage 
conferred by the use of a bead-type support (5).
The initial aim of this section of work was to exploit the increased 
surface area conferred by bead-like supports, whilst attempting to 
display the LPS moiety in a more bio-representative manner. When LPS 
was immobilised to the epoxy bead, a variety of conformations would 
have resulted due to the large number of hydroxyl attachment points in 
the LPS moiety. Additionally the non-specific adsorption of LPS or lipid 
A to the wells of a microtiter plate also provides very little control over 
the conformation. In reality, the LPS structure is an integral component 
of the outer membrane of Gram-negative bacteria by virtue of its lipid
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A region (7). It was hypothesised that forming a self-assembled 
monolayer of LPS on the surface of magnetic nanoparticles, the cellular 
architecture could be more closely mimicked. It was anticipated that 
displaying LPS on the surface of a magnetic particle would prove 
advantageous in the panning procedure, as no further immobilisation 
would be necessary as the particles would be held in position using 
magnetic force. Additionally the whole process should be much cleaner 
as the LPS-coated particles and consequently the bound phage, can 
simply be "pulled out" of solution by use of a magnet, thus allowing 
easy separation of the bound and free fractions without the need for 
centrifugation. Streptavidin coated magnetic beads (e.g. MagneSphere 
paramagnetic particles (8 )) are finding increased use in a number of 
phage display protocols due to the improved presentation of target and 
the relative ease of the process. Although the work did not progress in 
this direction, it was envisaged that magnetic nanoparticles could 
provide a useful platform for future downstream biosensing 
applications of the peptide-polymer recognition system.
4.1.2 Magnetite
Magnetite (Fe3C>4), the first substance discovered to possess magnetic 
properties, is a ferrimagnetic iron oxide that displays the strongest 
magnetism of all natural minerals (9). Its magnetic properties arise from 
the fact that its crystal structure is composed of iron in two different 
oxidation states: Fe^ and Fe3+. These ions occupy different sub-lattices 
within the structure of magnetite and their magnetic moments are 
antiparallel, however as one moment dominates, the material possesses 
permanent magnetisation. If magnetite is synthesised sufficiently small 
(< 1 0 0  run) the particles exist as a single domain resulting in larger 
magnetic susceptibilities and a loss of magnetic memory i.e. it displays 
superparamagnetism (1 0 ).
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Magnetite with pre-defined magnetic and physicochemical properties 
can readily be synthesised in the laboratory (10,11)- Synthesis via the 
co-precipitation of ferrous and ferric salts was developed by Ren6  
Massart in 1981 and remains one of the most common approaches used 
today (12). The reaction is simple, efficient and produces large yields, 
however control of size and dispersity of the nanoparticles is poor (1 1 ). 
Careful optimisation of salt ratios, pH and temperature is needed to 
ensure efficient and reproducible synthesis of nanoparticles. As a 
consequence, over recent years research into methods to produce more 
defined/tuneable nanoparticles has intensified and a number of 
alternative methods now exist, examples of which include the use of 
surfactant "nanoreactors" (13), sol-gel methods (14) and high 
temperature thermal decomposition of organic iron precursors (15).
Iron oxides such as magnetite have found extensive use in biomedical 
applications due to their excellent biocompatibility and the ease of 
synthesis of particles with a range of useful coatings (16-19). Magnetic 
nanoparticles have been used as targeted drug delivery systems (2 0 -2 2 ), 
as contrast agents in magnetic resonance imaging (MRI) (23,24), in the 
treatment of a range of cancers through the induction of hyperthermia 
(25,26) and also in cellular separations (18,27-29) and biosensing (30,31).
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4.1.5 Aims and objectives of Chapter Four
The overall aim of this section of work was to synthesise 
superparamagnetic nanoparticles and investigate their utility in 
biological assays.
The key objectives of this work were:
1. To synthesis magnetite nanoparticles that display desirable 
magnetic and physicochemical properties.
2. To mimic the cellular architecture of a Gram-negative bacteria 
through the immobilisation of LPS on the surface of the 
nanoparticles.
3. To immobilise polymyxin B on the surface of the magnetite 
particles and evaluate the ability of the system to sequester LPS 
from solution.
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4.2 Materials and Methods
4.2.1 Materials
All chemicals were purchased from Sigma-Aldrich, Poole, UK and were 
used as received unless otherwise stated. All organic solvents were of 
HPLC grade and were obtained from Fisher Scientific, Loughborough, 
UK unless otherwise stated.
4.2.2 Synthesis of magnetite nanoparticles (I)
The method of Li et al (32) was used to prepare water dispersible 
magnetite nanoparticles. Iron (III) chloride hexahydrate (FeCb- 6 H2O) 
was used as the single iron source for the reaction. Briefly, 10 mmol 
(2.70 g) FeCb 6 H2O was dissolved in 100 ml 2-pyrrolidone and the 
solution purged with nitrogen for 15 minutes. The mixture was 
refluxed for 10 hours under an inert atmosphere. After cooling to room 
temperature, an excess (~ 5 x volume) of diethyl ether was added to 
precipitate the magnetite, which was subsequently washed with 
acetone to remove residual solvent and then dried overnight to yield a 
crystalline, black powder.
4.2.3 Synthesis of magnetite nanoparticles (II)
The method of Sim et al (15) was used to prepare magnetite 
nanoparticles that can be dispersed in non-polar or weakly polar 
solvents. Iron (III) acetylacetonate (Fe(acac)3) was employed as the 
single iron source in the reaction. Briefly, 2  mmol (706 mg) Fe(acac)3, 6  
mmol (1.90 ml) oleic acid, 6  mmol (1.98 ml) oleylamine and 10 mmol 
(2.03 g) 1 ,2 -dodecanediol were added to 2 0  ml benzyl ether and the 
mixture stirred under a flow of nitrogen. The mixture was heated to 200
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°C and maintained at this temperature for two hours before being 
heated to reflux (~ 300 °C) for an additional hour under an inert 
nitrogen atmosphere. The magnetite nanoparticles were precipitated 
with 40 ml ethanol. The black precipitate was re-dissolved in hexane in 
the presence of trace amounts (50 pi) of oleic acid and oleylamine, and 
centrifuged to remove undispersed residue. The supernatant was again 
precipitated with ethanol and centrifuged once more. The pellet was 
dried overnight to yield a black, crystalline powder.
4.2.4 Immobilisation of lipopolysaccharide on magnetic nanoparticles 
Magnetite nanoparticles (oleic acid coated, 10 mg) were incubated with 
£. coli 0111:B4 LPS (500 pg in 1  ml water for injections) and the mixture 
sonicated for 3 x 15 minutes. The particles were removed magnetically 
and washed with 5 x 10 ml deionised water before being dried 
overnight at 40 °C under vacuum.
4.2.5 Raman spectroscopy
Magnetite nanoparticles were analysed by Raman spectroscopy by 
colleagues in the School of Chemistry, Cardiff University.
4.2.6 Immobilisation of polymyxin B on magnetite nanoparticles 
Magnetite nanoparticles (oleic acid coated, 100 mg) were added to a 5 
ml aqueous solution of polymyxin B (100 mg) and the mixture 
sonicated for 15 minutes. The nanoparticles were magnetically pulled 
down and the remaining solution decanted. The particles were washed 
with copious amounts of water before being dried overnight under 
vacuum at 40 °C. Control nanoparticles were prepared in the same 
manner, with the exclusion of polymyxin from the solution.
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4.2.7 Binding assays with polymyxin modified nanoparticles 
Polymyxin modified and control magnetite nanoparticles (5 mg) were 
incubated with various concentrations of FITC-labeled LPS from E. coli 
0111:B4 in deionised water at room temperature for 10 minutes. 
Samples were subsequently subjected to magnetic force to remove the 
bound fraction and the fluorescence of the supernatant analysed using 
a FLUOstar OPTIMA platereader (BMG Labtech GmbH, Ortenburg, 
Germany) at an excitation wavelength of 485 nm and emission 
wavelength of 520 nm. All samples were prepared in triplicate.
4.2.8 Ligand exchange w ith  11-mercaptoundecanoic acid
Using the method of Bagaria et al. (33) with some modification, the oleic 
acid on the surface of the magnetite nanoparticles was exchanged for 
11-mercaptoundecanoic acid. Briefly, 50 mg of magnetite nanoparticles 
suspended in 500 jil hexane were added to 2 g 11-mercaptoundecanoic 
acid in 20 ml cyclohexanone. The mixture was vortexed to form a 
homogenous suspension and heated at 100 °C for 16 hours. The 
particles precipitated over this time and were pulled down with 
magnetic force to allow for the supernatant to be discarded. 
Cyclohexanone was added (10 ml) and the suspension vortexed, the 
particles pulled down using a magnet and the supernatant discarded. 
This process was repeated twice with cyclohexanone, followed by two 
1 0  ml washes with ethanol with a final 2 0  ml acetone wash before the 
particles were dried under vacuum overnight at 40 °C. The 
nanoparticles were analysed by FTIR.
4.2.9 Conversion of thiol groups to azides
Conversion of the thiol groups on 11-mercaptoundecanoic acid 
modified magnetite to azide groups was attempted using the method of
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Iranpoor et al. (34). Magnetite nanoparticles (50 mg) were added to 6  ml 
dry dichloromethane. Triphenylphosphine (393 mg, 1.5 mmol), tetra-n- 
butylammonium azide (568 mg, 2 mmol) and 2,3-Dichloro-5,6- 
dicyanobenzoquinone (454 mg, 2 mmol) were added to the suspension, 
the mixture vortexed and incubated at room temperature overnight. 
The magnetite nanoparticles were subsequently recovered magnetically 
and washed with 3 x 20 ml acetone before being dried under vacuum 
overnight at 40 °C. The nanoparticles were analysed by FTIR.
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4.3 Results and Discussion.
4.3.1 Synthesis of magnetite nanoparticles (I)
Hydrophilic magnetite nanoparticles were synthesised following the 
method of Li et al (32). Refluxing iron (III) chloride hexahydrate with 2- 
pyrrolidone for 1 0  hours successfully produced particles that were 
magnetic in nature and dispersible in aqueous solvents. The method 
however was somewhat inconsistent; several repeats were conducted 
that produced particles that differed in both their physical and 
magnetic nature. The precipitate produced following the addition of an 
excess of diethyl ether to the reaction mixture was sticky and tar-like 
and was therefore difficult to wash. As a result it was virtually 
impossible to remove the residual 2-pyrrolidone. The repeated washes 
appeared to have a detrimental effect on the coating of the particles as it 
became much more difficult to form a stable dispersion in water as the 
number of washes increased. Following the reflux reaction, the surface 
of the magnetite is coated with an adsorbed layer of 2 -pyrrolidone 
molecules, coordinated to the surface of the nanoparticles via the 
ketone oxygen (Figure 4.1). It is therefore possible that a proportion of 
the 2-pyrrolidone molecules are being replaced by acetone. However, 
upon drying, the more volatile acetone could have been removed, thus 
leaving uncoated magnetite nanoparticles.
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Figure 4.1: Proposed structure o f 2-pyrrolidone coated nanoparticle. The oxygen atom 
of the 2-pyrrolidone ketone group co-ordinates w ith  the surface of the magnetite
nanoparticles (35).
It was envisaged that synthesis of hydrophilic magnetite would allow 
the encapsulation of the nanoparticles within the inner aqueous space 
of a liposome to create an artificial cell-like structure. However, the 
inconsistency and length of time taken to synthesise the particles, 
coupled with the intrinsic variability of liposomes and the 
encapsulation of materials within them, lead to the idea of self­
assembled monolayers being utilised as an alternative way of 
mimicking the surface morphology of a bacterial cell.
4.3.2 Synthesis of magnetite nanoparticles (II)
The thermal decomposition of iron (III) acetylacetonate in the presence 
of a reducing agent (1 ,2  -  dodecanediol) and stabilisers (oleic acid and 
oleylamine) reproducibly resulted in the formation of stable, oleic acid 
coated magnetic nanoparticles (Figure 4.2). The increased consistency 
observed with this method compared to that used to synthesise water
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dispersible m agnetite (section 4.2.2) can be attributed to the m ethod of 
heating used in the experim ental procedure; by heating the Fe(acac)3 
m ixture to 200 °C and m aintain ing the tem perature for tw o  hours 
before refluxing at -3 0 0  °C for a further hour, nucleation of the 
m agnetite crystals is con trolled  thus producing m onodisperse particles 
w ith  consistent m orp h ology  (15,36). This in turn produces particles 
w ith  the desired  m agnetic properties and dispersibility.
Oleic acid is a b identate ligand  that interacts w ith  the surface of the 
m agnetite via its carboxylate group  (Figure 4.2) (37). A s a result of the 
nature of the interaction i.e. b identate as op p osed  to the m onodentate  
nature of the 2-pyrrolidone interaction (Figure 4.1), the coating of the 
particles is significantly m ore stable and d oes  not appear to be affected  
to any significant d egree by the w a sh in g  and centrifugation processes  
em ployed . The d ispersions form ed in  hexane w ere stable and  
ferrofluidic in nature.
Benzyl ether. 200°C 2 hours 
Reflux(300°C) 1 hour 
Nitrogen atm osphere
OH*"*jC
OH
OH
F igure 4.2: S ch em atic  o f  the s y n th e s is  o f  m a g n e ti te  n an opartic les fro m  an iron (III) 
ace ty lace ton a te  p recu rso r an d  the n a tu re  o f  th e in tera c tio n  betw een  the carboxyla te  
fu n c tio n a li ty  o f  oleic acid  a n d  the su rfa ce  o f  the m a g n e tite  n an oparticles.
O leylam ine has been sh o w n  to act as both a reducing agent and as a 
stabiliser w hen  present as the o n ly  surfactant source in the synthesis of
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magnetite (38). It is not clear how the amine would co-ordinate with the 
surface of the magnetite, however when an equimolar ratio of long 
chain acid to long chain amine is employed co-ordination of the acid 
group would appear to dominate. The combination of acid and amine 
provides good control over the growth of the particles during the 
synthesis (36). It is believed that the presence of an amine aids in the 
stabilisation of the nanoparticles by promoting the adsorption of oleic 
acid to the surface; it is thought that acid-base complexation leads to 
enhanced deprotonation of the oleic acid (39).
FTIR analysis was used to confirm the presence of oleic acid on the 
surface of the magnetite. The spectrum presented in Figure 4.3 is typical 
of oleic acid coated magnetite. The two sharp bands at 2926 and 2854 
cm*1 are attributed to the asymmetric and symmetric stretch of CH2 
groups respectively, while the stretches observed at 1604 and 1531 cm-1 
demonstrate the presence of a deprotonated carboxylate group (vCOo- 
symmetric and asymmetric). The interaction can be described as 
chelating bidentate as the wavenumber separation between the 
asymmetric and symmetric stretches of the carboxylate group is less 
than 110 cm*1 (40). Additionally the spectrum shows no evidence of the 
characteristic carboxylic acid carbonyl stretch at ~ 1700 cm*1, again 
suggesting the co-ordination of the deprotonated form of oleic acid at 
the surface of the magnetite.
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Figure 4.3: FTIR spectra o f  oleic acid stabilised m agnetite.
4.3.3 Immobilisation o f lipopolysaccharide on magnetic nanoparticles 
It was hypothesised that by simply incubating magnetite with LPS 
under the appropriate experimental conditions, a self-assembled 
monolayer of LPS should form on the surface of the nanoparticles. The 
as-synthesised nanoparticles are stabilised with oleic acid making them 
hydrophobic. Under aqueous conditions and in the presence of LPS, it 
should be more thermodynamically favourable for the nanoparticles to 
become "coated" with LPS, via intercalation of lipid A with oleic acid 
chains, in order to disperse in the solvent. A schematic of the proposed 
LPS-coated nanoparticles is given in Figure 4.4.
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LPS
Lipid A
Magnetite
nanoparticle Oleic acid
Figure 4.4: Schematic show ing the proposed im m obilisation o f  LPS on the surface o f  
oleic acid coated m agnetite nanoparticles. The lip id  A  region o f LPS intercalates w ith  
the surface bound oleic acid grou p to fo rm  a self-assembled monolayer.
Self-assembled monolayers (SAMs) can be broadly thought of as the 
spontaneous adsorption of m olecules to a surface (41,42). The most 
common example of the formation of self assembled monolayers is 
alkanethiols on the surface of gold (42) however Fu et al, (43) 
demonstrated the formation of a self assembled monolayer of lauric 
acid on the surface of magnetite nanoparticles, followed by the 
deposition of a second layer of decanoic acid molecules to form a 
bilayer structure. It was therefore hypothesised that a monolayer of LPS 
on the surface of oleic acid stabilised magnetite could be formed in a 
similar manner. It was anticipated that this would have a less 
substantial effect on the magnetic properties of the system compared to
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the encapsulation of nanoparticles in the aqueous space of a liposome, 
since there w ould be a less significant change in the hydrodynamic 
volum e of the particles and the issue of encapsulation efficiency is 
circumvented. During the course of this work, Piazza et al 
demonstrated the successful immobilisation of LPS on the surface of 
magnetic nanoparticles. They used the LPS modified particles to 
investigate the ability of LPS to trigger signalling via the TLR4 receptor 
(44).
Following sonication of the magnetite particles in an aqueous solution 
of E. coli 0111 :B4, basic dispersibility tests suggested that LPS had been 
successfully immobilised (Figure 4.5). The control nanoparticles (OA, 
Figure 4.5) had been sonicated in water in the absence of LPS while the 
sample on the right had been sonicated in water containing 500 pg of E. 
coli 0111 :B4 LPS. When LPS w as present in the system, the magnetite 
particles became dispersible in aqueous solvents. Following extensive 
washing of the nanoparticles, they remained dispersible in water.
oa
Figure 4.5: Aqueous dispersions o f  m agnetite nanoparticles fo llow ing  sonication in 
w ater (left) and 500pg/m l LPS in w a ter (right). Sonication o f particles w ith  LPS  
produced a stable aqueous dispersion that suggested successful im m obilisation o f  LPS
on the surface o f  magnetite.
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The nanoparticles were analysed by Raman spectroscopy (School of 
Chemistry, Cardiff University) to provide further evidence for the 
immobilisation of LPS on the surface. Reiman analysis of commercially 
available magnetite (Sigma-Aldrich, UK) plus LPS from E. coli 0111 :B4 
provided the reference spectra. A good spectrum was obtained for 
magnetite (Figure 4.6 a), however a clear spectrum could not be 
achieved for the LPS standard (Figure 4.6 b). This was possibly due to 
the presence of a large number of structurally related sugar moieties. A 
similar, non-distinct spectrum was obtained when the LPS coated 
nanoparticles were analysed (Figure 4.6 c, black line). Interestingly, if 
the sample was exposed to 1 0 0  % power of the argon ion laser the 
surface material could be visibly burnt off and the magnetite spectrum 
recovered (Figure 4.6 c, red line).
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Figure 4.6: Raman spectra o f  m agn etite from  Sigm a-Aldrich, U K  (a), E. coli 0111:B4 
LPS (b) and IP S  coated m agnetite (black line, c). O n increasing the pow er o f  the laser, 
the LPS surface coating could be rem oved to regain the spectrum  fo r  m agnetite (red
line, c).
Although a good spectrum could not be obtained for the LPS standard, 
the fact that a similar spectrum w as observed with the coated 
nanoparticles suggested that an LPS layer might be present. This was 
further supported by the observation that the spectrum for magnetite 
could be regained by exposing the underlying material through
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burning off the outer layer. Additionally, the earlier dispersibility 
studies also suggested successful immobilisation. An alternative 
method for detecting LPS on the surface if the particles is needed to 
provide definitive proof of the formation of a LPS monolayer. It is 
anticipated that these particles will be used in a future phage display 
strategy (section 4.1.1) to identify high affinity peptide ligands for LPS, 
following further characterisation of the system.
4.3.4 Immobilisation of polymyxin B on magnetite nanoparticles 
Following on from the studies with LPS, it was hypothesised that 
polymyxin B could be immobilised in a similar fashion. The peptide 
possesses a 7/8 carbon aliphatic tail, depending upon the structural 
isoform, that was anticipated to interact with the surface of oleic acid 
stabilised magnetite in the same manner proposed for LPS (Figure 4.4).
Following sonication of magnetite nanoparticles in an aqueous solution 
of polymyxin B, basic dispersibility tests suggested that polymyxin had 
been successfully immobilised (Figure 4.7). The control nanoparticles 
(OA, Figure 4.7) had been sonicated in water in the absence of 
polymyxin while the PMX sample had been sonicated in water 
containing the peptide. A stable aqueous dispersion of particles was 
achieved following extensive washing of the sample sonicated in the 
presence of the peptide.
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P u tt
Figure 4.7: Aqueous d ispersion  o f  m agn etite  nanoparticles fo llow in g  sonication in  
w ater (left) and 100 m g / 5  m l p o lym yx in  B in w a ter  (right). Both sam ples have been 
washed extensively w ith  w ater. The p o lym yx in  appears to "coat" the nanoparticles 
producing a stable dispersion  in aqueous solvents.
The ability of polymyxin -  m agnetite nanoparticles to recognise and 
bind LPS in aqueous solutions w as evaluated in a simple binding assay. 
As-synthesised oleic acid coated m agnetite served as the control for the 
experiment. Based on the equilibrium tim e point assay performed with 
polymyxin modified Merrifield resin (Figure 3.32) and also in an 
attempt to minimise non-specific association of LPS with oleic acid 
coated magnetite, the incubation period used in the binding assay was 
less than 10 minutes. Figure 4.8 clearly show s increased binding of LPS 
to polymyxin-modified magnetite at all concentrations compared to the 
control nanoparticles. Apparent Kd values calculated from the binding 
isotherm were 0.18 pM and 1.21 pM for polymyxin and oleic acid 
coated magnetite respectively. The value for the polymyxin magnetite 
is not dissimilar to that observed w ith polym yxin modified Merrifield 
resin (0.27 pM, Figure 3.25). The immobilisation of polymyxin on 
magnetite is assumed to proceed via hydrophobic interactions of the 
acyl chain of the peptide with surface bound oleic acid, therefore all five 
amines from the L-2,4-diaminobutyric acid residues are available for
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interaction w ith  LPS. In the Merrifield system , one of the am ines is 
involved  in the im m obilisation of the peptide to the resin surface and 
hence on ly  four am ines are free to participate in the interaction w ith  the 
target. The sm all apparent increase in affinity observed w ith  polym yxin  
m agnetite m ay be attributable to the availability of an extra am ine 
group.
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Figure 4.8: S tan dard  b in din g  iso th erm  f o r  p o ly m y x in  m odified  m agn etite  (P M X  M ag, 
red line) an d  control oleic acid coated  m a g n e tite  (O A  M ag, green line). In all sam ples 
5  m g o f  nanoparticles w ere in cu ba ted  w ith  va r io u s con centrations o fF IT C  labeled E. 
coli 0111 :B4 LPS in a to ta l vo lu m e o f  lm l.
As discussed in Chapter One, there is a real, unmet, clinical need for a 
rapid diagnostic assay for sepsis. M agnetic nanoparticles have been  
utilised in the detection of bacteria (45,46), D N A  (47) and other 
biological m acrom olecules (48,30). Binding events bring about changes 
in the hydrodynam ic vo lu m e of the particles that in turn affects their 
m agnetic properties. These alterations in the magnetic characteristics of
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the system can be detected by measuring the magnetic susceptibility of 
the particles. It is therefore envisaged that the nanoparticles developed 
during the course of this work will be investigated as potential 
biosensor systems.
These studies provide preliminary data for the use of peptide modified 
magnetic nanoparticles in the removal of LPS from solution, however 
for the strategy developed thus far to be useful the stability of the 
peptide coating would need to be ensured. Additionally, it is 
anticipated that similar peptide-polymer hybrids (Chapter Three) could 
be grown from the surface of magnetite particles. For this to be possible 
an alternative method of peptide immobilisation would be needed.
4.3.5 Ligand exchange with 11-mercaptoundecanoic acid 
Ligand exchange at the surface of the nanoparticles occurs readily 
under appropriate experimental conditions. The oleic acid groups on 
the surface of magnetite were substituted for a long chain, thiol- 
terminated acid through the incubation of particles with an excess of 
11-mercaptoundecanoic acid. Following synthesis, particles were 
analysed by FTIR spectroscopy (Figure 4.9). The two sharp bands at 
2926 and 2854 cm*1, attributed to the asymmetric and symmetric stretch 
of CH2 groups remained on the spectrum, while small shifts in the 
stretches previously observed at 1604 and 1531 cur1 for oleic acid 
magnetite (Figure 4.3) were noted (1597 cm4 and 1546 cm4). This 
interaction can again be described as chelating bidentate. Although no 
stretches indicative of thiol functionality were observed, the typical S-H 
stretching band at 2500 cm-1 is often weak and the C-S bond is normally 
observed below 700 cm-1. The particles did however disperse in 
aqueous solvents following the exchange reaction (Figure 4.10),
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suggesting the presence of 11-mercaptoundecanoic acid on the surface
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Figure 4.9: FTIR spectra o f  11-m ercaptoundecanoic acid coated m agnetite
Figure 4.10: Aqueous dispersion o f  m agn etite  nanoparticles fo llow ing the exchange o f  
oleic acid (O A ) surface groups w ith  11-m ercaptoundecanoic acid (SH). Both samples 
have been washed ex ten sively  w ith  water.
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4.3.6 Conversion of thiol groups to azides
The exchange of oleic acid surface groups with 11-mercaptoundecanoic 
acid was conducted as it was anticipated that the thiol group could 
subsequently be converted to an azide using the method of Iranpoor et 
al. (34). The presence of azide functionality on the nanoparticles would 
have enabled attachment of polymyxin B through the "click" reaction 
described in section 3.2.5.2. FTIR analysis of the nanoparticles (Figure 
4.11) however suggested that the reaction was unsuccessful; a 
characteristic azide stretch at ~ 2100 cm*1 was not apparent on the 
spectrum. Furthermore it appeared that the carboxylate stretches 
observed in Figures 4.3 and 4.9 have diminished, suggesting a reduced 
density of surface stabilising groups.
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Figure 4.11: FTIR spectrum of magnetite nanoparticles following the attempted 
conversion of thiol groups to azides. The characteristic azide stretch at ~ 2100 cm-1 is 
absent, thus suggesting that the conversion of thiol groups to azides was unsuccessful.
The reaction used anhydrous dichloromethane as the solvent and this 
resulted in poor dispersibility of the thiol modified particles.
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Additionally the reaction conditions, particularly the relative molar 
quantities of the reagents, needed to be carefully controlled to ensure 
that the triphenylphosphine did not reduce the azido groups to amines 
(Staudinger reaction, Figure 2.1). An alternative approach needs to be 
investigated.
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4.4 Conclusions.
Magnetite nanoparticles have been successfully synthesised via the 
high temperature decomposition of the organic iron precursor, iron (III) 
acetylacetonate. They appeared to behave in a superparamagnetic 
manner and form stable dispersions in non-polar solvents such as 
hexane. It was demonstrated that LPS and polymyxin B could be 
immobilised on the surface of oleic acid stabilised particles using a self- 
assembly approach. Polymyxin-modified magnetite was shown to 
recognise and bind FITC labeled £. coli LPS with an apparent Ka of 0.18 
fiM. Increased binding of LPS to the peptide modified particles was 
observed at all concentrations compared to the oleic acid coated control 
particles.
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5.1 General Overview of Thesis
Sepsis is the leading cause of death in non-coronary intensive care units 
w orldw ide w ith mortality rates of up to 50% and is a significant 
economic burden on the healthcare system (1). Despite this, it remains 
under-recognised and poorly understood because of inadequate 
diagnostic assays and a lack of scientifically targeted clinical treatments. 
LPS is ubiquitous in sepsis and its presence in the bloodstream has been 
correlated w ith  a w orse prognosis (2,3). With a growing number of 
bacteria d isplaying resistance to an ever-increasing number of 
antibiotics, d iseases of infectious origin such as sepsis are likely to 
become more prevalent (4,5). The over-arching aim of this project was 
therefore to develop a peptide-polym er hybrid system capable of 
recognising and binding LPS in a variety of biologically relevant 
environments. We hypothesised that through the integration of target 
specific peptide receptors into the backbone of a polymer support, the 
issues surrounding the im printing of biomacromolecules could be 
circumvented. There were a number of technological challenges 
associated w ith this project, each have been addressed in the preceding 
chapters of this thesis.
In Chapter Two, the developm ent of an appropriate solid support was 
undertaken. Merrifield resin w as selected as the support as it was 
anticipated that the chlorom ethyl functionality w ould allow for a 
multitude of chemistries to be displayed on the resins surface. Initial 
studies were concerned w ith bifunctionalisation of the resin to generate 
two independent chemical tethers to facilitate the attachment of a 
peptide species and an iniferter group. By using the Staudinger reaction
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to reduce an azidomethyl intermediate, resins possessing controlled 
molar ratios of chloro and amino groups were produced.
Early studies were focused on achieving efficient polymerisation in 
ethanolic conditions as the peptide under investigation, TR401, was 
shown to be both stable and capable of binding its target (Texas red) in 
this solvent. The attachment of sodium diethyldithiocarbamate to the 
resin was achieved through reaction with the chloromethyl 
functionality and the polymerisation of an aerylamide/methylene 
bisacrylamide solution was demonstrated. Although the control resin 
was observed to also initiate polymerisation, through the photolytic 
cleavage of benzyl chloride to generate a reactive benzyl radical, 
aggregation and solution phase polymerisation was problematic. The 
benefits of using an iniferter species to initiate polymerisation were 
clear.
Modification of this system was necessary to allow for polymerisation 
under aqueous conditions required for the imprinting experiments with 
lipopolysaccharide. The diethyldithiocarbamate iniferter modified 
resins were not suitable for aqueous polymerisation experiments, since 
the resins (iniferter modified and conventional Merrifield) did not 
disperse in water even with continuous stirring. They aggregated at the 
surface of the solvent, which resulted in the formation of disc like 
structures after extended periods of polymerisation. At earlier time 
points, there was little evidence of polymerisation suggesting that 
possibly the dissociation of the iniferter species was slower in water 
than in ethanol due to the hydrophobicity of the dithiocarbamyl radical. 
A more hydrophilic iniferter, sodium dithiocarboxysarcosine, was 
synthesised and attached to the surface of the resin in a similar manner. 
This resin was significantly more dispersible and a stable dispersion in 
water could be achieved with gentle, continuous stirring.
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Polymerisation experiments performed resulted in the growth of a 
polymer layer on the surface of the resin.
An important consideration in this study was the effect of experimental 
conditions on the swelling of Merrifield resin. The initial 
bifunctionalisation experiments were performed in DMF, a good 
swelling solvent for the resin. Under these conditions, elemented 
analysis suggested that controlled molar ratios of two chemical 
functionalities could be achieved but also that all chloromethyl groups 
could be converted to amines suggesting good access to the porous 
interior of the resin. Attachment of the iniferter species was carried out 
in ethanol and therefore the resin would have existed in a less swollen 
form than when DMF was used. Elemental analysis suggested that ~ 
70 % of the available chloromethyl groups served as attachment points 
for the iniferter group. It was assumed that all of these iniferter groups 
would have been capable of initiating polymerisation under ethanolic 
conditions since the degree of swelling of the resin would have been 
similar, however when polymerisation was attempted in water the 
resin would have existed in a non-swollen state due to its 
hydrophobicity. Therefore it was unsurprising that the 
diethyldithiocarbamate resin performed poorly in the aqueous 
experiments since it was reasonable to assume that the majority of 
iniferter groups were unavailable to initiate polymerisation. 
Modification of the resin with the dithiocarboxysarcosine species 
yielded a more hydrophilic resin. However, since the iniferter was 
attached under aqueous conditions it was likely that the observed 
increase in dispersibility was a consequence of the presence of 
dithiocarboxysarcosine groups on the outer surface of the resin, whilst 
the interior surfaces of the resin were assumed to remain unmodified 
and hydrophobic. This resin was shown to initiate polymerisation of an 
aqueous acrylamide/methylene bisacrylamide solution. It was later
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found that the iniferter was soluble in 50/50 methanol and DMF; 
conditions conducive to a swollen state. Successful attachment of 
iniferter was confirmed by FTIR and elemental analysis. Polymerisation 
experiments using this resin were not performed but warrant further 
investigation since the increased hydrophilicity conferred by the 
iniferter species may also impact on the swelling of the resin in aqueous 
conditions. In hindsight, a more hydrophilic solid support might have 
been more appropriate.
Chapter Three investigated the use of the bacterial derived peptide 
polymyxin B as the high affinity peptide ligand for incorporation into 
the peptide-polymer hybrid system described in Chapter One. Alkyne 
derivitisation of polymyxin B followed by immobilisation on azide 
modified resin via a "click" reaction successfully produced peptide 
modified resins. Polymyxin resin was shown to bind LPS with an 
apparent Kd of ~ 0.2 pM with negligible non -  specific binding to azide 
control resin. The azidomethyl polystyrene support possessed ~ 0.2 
mmol of azide groups per 100 mg, however only 7 pmoles (~ 10 mg) of 
peptide was estimated to be immobilised. The principle reason for this 
relatively low loading of polymyxin is the hydrophobicity of the resin 
prior to the immobilisation of the peptide. As the resin would have 
existed primarily in a non-swollen state under aqueous conditions, only 
surface azide groups would have been available for reaction. The Bmax 
of polymyxin resin produced from 100 % azidomethyl polystyrene was 
estimated to be 0.07 nmolmg-1 (700 ngmg-1). If the estimated loading of 
polymyxin is accurate, this would suggest that at Bmax only 1 in 1000 
peptides are associated with LPS. The true significance of this is 
difficult to gauge as the labelling of LPS with the FITC tag is low; 
approximately 1 in 10 LPS molecules are labelled based on 3.80 pg of 
FITC per 1 mg of LPS and assuming an average molecular weight of 
10,000 for LPS. A recent study by Triantafilou reports efficient labelling
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of LPS (5 :1, label: LPS) using Alexa 488 hydrazide (6). These levels of 
labelling would enable detection of much lower concentrations of LPS 
than is currently possible (current limit of detection using FITC labelled 
LPS is ~ 50 ngml'1) and would allow a more accurate estimate of 
occupancy to be obtained.
Despite performing well in water, when binding assays were 
performed in serum the efficiency of the polymyxin resin was 
significantly reduced. In water, 5 mg of polymyxin resin bound ~ 80 % 
of a 1 pgml*1 FITC LPS solution. This was reduced to ~ 20 % when a 
50/50 mix of water and foetal bovine serum (FBS) was used and to < 
5 % when FBS was used alone (data not shown). Although 
disappointing, this result was not surprising given that LPS is bound by 
a number of serum proteins (specifically the high affinity 
lipopolysaccharide binding protein, LBP), some of which possess 
affinities for LPS that are orders of magnitude greater than the Kd of 
polymyxin. For the system to be useful in detecting LPS in in vivo 
samples, it must possess affinities equal to or greater than those 
displayed by endogenous proteins (i.e. low nanomolar/high picomolar 
range). As the Kd of polymyxin for LPS is ~ 0.2 pM it is unlikely that 
affinities required will be achieved through use of this peptide in the 
proposed hybrid system. During the course of this work, Matsumoto 
and colleagues identified a series of peptides displaying low nanomolar 
(1 -  10 nM) affinities for LPS via a phage display procedure (7). The 
sequence of the highest affinity 13-mer peptide is given in the paper 
and it is therefore anticipated that this will be made use of in future 
studies.
The results obtained from the proof-of-principle imprinting 
experiments using the cyclic and linear forms of polymyxin 
immobilised via "click" chemistry were somewhat disappointing. 
Previous attempts at imprinting using resin to which polymyxin had
205
Chapter Five: General Discussion
been immobilised using the dimethyl adipimidate linker, demonstrated 
a clear imprinting effect. In that particular assay the influence of the 
template was clear; the amount of LPS binding to the polymyxin MIP 
was significantly greater them that binding to its non-imprinted 
antipode (polymyxin NIP). Repeating this assay with the click modified 
resins however failed to demonstrate a profound imprinting effect and 
the polymyxin MIPs (cyclic and linear) did not bind as much LPS as the 
respective peptide resins prior to polymerisation. The main difference 
between these two systems, other than the attachment chemistry, is the 
way in which the iniferter species were introduced as discussed in 
Chapter Three. Whether this is the reason for the difference in 
behaviour between the two assays remains to be elucidated. There are a 
number of complex variables that require investigation/optimisation 
including choice of monomer, polymerisation time, solid support and 
the nature and position of the peptide tether.
From a conventional imprinting perspective, it would be interesting to 
evaluate the approach of the Shea group used to surface imprint 
melittin. Amino acid sequences from melittin were modified with 
various lengths of hydrocarbon chains to allow for the formation of a 
micelle type structure in an emulsion polymerisation strategy (8). Given 
that LPS is naturally amphiphilic by virtue of the lipid A and 
polysaccharide regions, it may be possible to develop an imprinted 
polymer that recognises the O-antigen region of LPS as opposed to the 
lipid A/KDO portion of the molecule. If successful, it is envisaged that 
the polymer would be able to not only detect the presence of LPS but it 
could also potentially provide information about the causative bacterial 
species. This would be a significant development from a clinical 
perspective both in terms of diagnosis and treatment.
Chapter Four provided preliminary data for the use of peptide 
modified magnetic nanoparticles in the sequestration of LPS from
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solution. Although the system based on Merrifield resin developed in 
Chapters Two and Three provided useful information about the 
feasibility of the proposed system, it is not immediately applicable to 
incorporation within a sensor platform or to a clinical setting. Magnetic 
nanoparticles on the other hand possess useful properties for use in 
both clinical and biosensing approaches. A more effective therapeutic 
strategy for the treatment of sepsis is urgently needed. Extracorporeal 
removal of LPS from the blood of septic patients using a polymyxin 
fibre (Toraymyxin) is the focus of a current multicenter clinical trial 
(9,10). This strategy has been used with some success for more than a 
decade in Japan, however it is likely to only remove free LPS from the 
blood as the affinity of LPS for polymyxin is several orders of 
magnitude lower than for acute phase serum proteins such as LBP and 
BPI (Chapter One). We hypothesise that magnetic nanoparticles 
displaying high affinity receptors for LPS could not only be used in a 
similar strategy, but also play a role in the in vivo sequestration of the 
toxin. Introduction of the magnetite nanoparticles to the systemic 
circulation of an infected host would hopefully reduce the immuno- 
stimulatory effects of LPS by acting as a decoy receptor, much like the 
soluble forms of CD14 and TLRs (11). Haemofiltration under a 
magnetic field would allow for the nanoparticles, coated with LPS, to 
be removed and possibly be fed into a direct sensor to allow for both 
treatment and rapid diagnosis. It is likely that the surface of the 
magnetite would require some modification to reduce the rate of 
clearance from the blood stream by the reticuloendothelial system.
It is anticipated that the immobilisation of LPS on the surface of 
magnetite particles will allow for the selection of high affinity peptide 
ligands via a phage display strategy. Peptides generated in this manner 
will be used in future studies to further investigate the utility of the 
peptide -  polymer hybrid system. Immobilisation of polymyxin B via
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the same self-assembly method used for LPS produced nanoparticles 
that were able to recognise and bind LPS rapidly from aqueous 
solutions with an apparent Kd of 0.18 pM. The system will require 
modification however if the peptide-polymer strategy outlined in 
Chapter One is to be transferred to the magnetic nanoparticles. 
Currently the nanoparticles are monofunctionalised with oleic acid and 
although initial attempts to functionalise the particles with azide 
groups were not obviously successful, it is anticipated that this will be 
readily achievable in the future.
i
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